Intelligence Enlightens Life
for a Shared Future
Sustainability
Report
Stock Code: 688139.SH
Content
About This Report 3 Appendix
ESG Performance Indicators 94
Chairman's Statement 4
Shanghai Stock Exchange Guidelines Index 96
About Haier Biomedical 5
GRI Standards Index 97
Company Profile 5
UNGC Principles Index 100
Milestones 6
Honors and Awards 7
Sustainability Governance 9
Special Feature
Innovation-Led: Integrity and Shared Sharing the Future: Green Symbiosis:
Global Technology Expansion, Safeguarding the Life Success: Ensuring Leading People-Centered Driving Ecological
Serving Global Health: Barrier Steady Development Shared Prosperity Harmony
Operational Roots: Building a 1.1 R&D and Innovation 23 2.1 Compliance Operations 34 3.1 Stimulating Individual 57 4.1 Green Products 78
Localized Service Network 17 Potential
Program Leadership: Building a 3.2 Contributing to Healthy 71
Scenario-Based Digital Ecosystem 17 1.3 R&D Achievements 30 2.3 Product Quality and Safety 44 Communities 4.3 Resource Usage 83
Tech Synergy: Empowering Global 1.4 Intellectual Property 34 2.4 Customer Rights and 51 4.4 Emissions Management 87
Cutting-Edge Research 18 Protection Quality Service
Green Empowerment: Innovative
Low-Carbon Solutions 19 4.6 Biodiversity Conservation 93
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
About This Report
Introduction Preparation Procedures
This is the fifth Sustainability Report (hereinafter referred to as "the Report") issued by Qingdao Haier This Report is prepared according to fixed procedures, including determining the report boundary,
Biomedical Co., Ltd. The Report discloses the Company's practices and performance in 2025 across identifying and categorizing important ESG issues, collecting relevant data and information,
economic, environmental, social and corporate governance responsibilities. It aims to facilitate effective preparing the report, and verifying information.
communication with stakeholders and systematically respond to their expectations and concerns.
Reliability Assurance
Reporting Scope
Qualitative and quantitative information presented in this Report is derived from the Company's publicly
The reporting scope is consistent with the Annual Report of Haier Biomedical in 2025. The information available information, internal documents, and relevant statistical data. The Board of Directors of the
hereof covers Haier Biomedical and the subsidiaries within the scope of consolidation. The reporting Company confirms that this Report contains no false records or misleading statements, and assumes
period is from 1 January 2025 to 31 December 2025. Accordingly, the period may be extended to a responsibility for the truthfulness, accuracy, and completeness of its contents.
time before the release of this Report in 2026.
Approval of the Report
Reporting Guidelines
After the review by the ESG Working Group, the Report was approved by the Board of Directors of the
This Report is prepared with reference to the Sustainability Reporting Standards of the Global Reporting Company on 27 March 2026.
Initiative (GRI) and the Guidelines No. 14 of the Shanghai Stock Exchange for Self-Regulation of Listed
Companies—Sustainability Reporting (Trial) issued by the Shanghai Stock Exchange. It also responds
to the questionnaire indicators of the S&P Global Corporate Sustainability Assessment (CSA), and is Access to the Report
developed in light of the Company's current stage of development and its actual ESG practices.
The Report is available, to view and download, at the website of the Shanghai Stock Exchange
Definitions (www.sse.com.cn) and Haier Biomedical's official website (https://www.haierbiomedical.com/).
Address: No.280 Fengyuan Road, High-tech Zone, Qingdao, Shandong
For concise, coherent and easy reading, "Qingdao Haier Biomedical Co., Ltd." in the Report is also
referred to as "Haier Biomedical", "the Company", or "we". Tel: 0532-88935566
Postcode: 266000
Email: haierbiomedical@haierbiomedical.com
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Chairman's Statement
Evolving from an Industry Player to an Intelligent Platform Industry Transformation - From "Isolated Breakthroughs" to "Value
Chain Empowerment". We are embedding AI capabilities throughout
After two decades of focused development, we recognize that the the entire life sciences and biomanufacturing value chain,
value of standalone products is increasingly giving way to the strength continuously amplifying the value of our intelligent platform through
of integrated platform ecosystems. At the core of our strategy is a industry collaboration. This goes beyond efficiency gains; it is about
deliberate transition from industry participant to platform builder. using technology to guide the value chain toward a future that is
We are committed to building three interconnected platforms: lower-carbon, more transparent, and more compliant.
• An AI-centered intelligent technology platform spanning Responsibility at the Core: Harnessing Intelligence with Care
the full value chain, from sample management and research
support to biomanufacturing; As we embrace AI, we do so with a profound sense of responsibility.
• An industry platform connecting research institutes, We rely on robust governance to ensure AI is developed and applied
healthcare providers, pharmaceutical companies, and other responsibly. Through the establishment and implementation of our
stakeholders across diverse scenarios, enabling value creation Medical Technology Ethics and Governance Policy, principles such
throughout a broader ecosystem; as fairness, transparency, and privacy protection have become non-
• Our Responsibility Platform embeds sustainability into the negotiable requirements in algorithm development. Certifications
core of our operations, ensuring that every technological such as ISO 27001 further ensure that we protect data with the
advancement supports environmentally responsible same rigor we apply to safeguarding biological samples.
development and expands equitable access to life science We also foster responsible AI through ecosystem collaboration.
solutions. Ongoing employee training worldwide, joint responsibility-
Three Transformations Building the Foundation of Our Platform building with supply chain partners, and green initiatives
launched through industry alliances all form part of a broader
Over the past year, we have advanced along three clear pathways, responsibility network that helps ensure the benefits of
Chairman of the
turning our vision of an intelligent platform into tangible change. technology are shared fairly and the costs of development are
Board of Qingdao collectively managed.
Haier Biomedical Capability Transformation - From "Sample Storage" to "Intelligent
Co., Ltd. Enablement". We are reshaping research and clinical workflows Our experience over the past year has reinforced one belief: the true
through the integration of AI and automation. In partnership with value of a platform lies in every minute saved for scientists, every
Guangzhou Laboratory, we co-developed the world's first high- gram of carbon emissions reduced for the planet, every vaccine
throughput, fully automated PBMC extraction and purification protected for remote communities, and every improvement in
workstation. By enabling standardized, high-throughput processing, dignity and safety for workers across the value chain.
this innovation improves reproducibility and reduces manual
intervention, supporting more efficient laboratory operations, Closing Remarks
As the transformative wave of artificial intelligence sweeps enhancing workforce productivity, and enabling scalable, high- Haier Biomedical is evolving from a specialized equipment
across the globe, we stand at the cusp of a historic inflection quality sample processing for research and clinical applications. manufacturer into a world-class life sciences brand with platform
point. This shift extends beyond incremental tool upgrades, capabilities and a global perspective. We know that this journey
fundamentally redefining productivity and cognitive paradigms. Network Transformation - From "Global Sales" to "Local Integration".
Our localized operating networks across 18 countries represent has only just begun.
For Haier Biomedical, with over two decades of focus in life science
instruments, it is clear that a new era, shaped by data, algorithms, more than market expansion; they demonstrate the global Guided by two decades of industry insight and grounded in a
and automation, is rapidly unfolding. applicability of our intelligent platform capabilities. In Italy, our commitment to technological excellence and the wellbeing of
intelligent blood management system is helping improve the people and the planet, Haier Biomedical will continue to advance
Amid the convergence of technological advancement and mission- efficiency of the public healthcare system. In remote regions of in partnership with scientists, industry partners, investors, and
driven purpose, Haier Biomedical has further clarified its strategic Africa, solar-powered vaccine refrigerators equipped with intelligent communities worldwide.
positioning. We are committed to becoming a global leader in temperature control systems are helping safeguard children's
integrated life science tools and intelligent productivity platforms, health. A truly intelligent platform is not defined by standardized Together, we look forward not only to a new era in life sciences
leveraging AI-driven innovation to enable smarter, more efficient technology exports alone, but by its ability to integrate with local powered by AI and greater efficiency, but also to a healthier, more
operations across the life sciences and biomanufacturing sectors. ecosystems and continue evolving alongside them. equitable, and more sustainable world.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
About Haier Biomedical
Company Profile
Haier Biomedical (Stock Code: 688139.SH) focuses on the The Company adheres to its localization strategy and continues
upstream of the life science industry, with the goal of creating to strengthen its global business presence. Its products and
the best user experience. Its business covers low-temperature solutions have been applied in more than 160 countries and
storage, laboratory solutions, smart medication, and blood regions worldwide. In the domestic market, the Company
technology. The Company provides digital scenario solutions serves tens of thousands of end users, including hospitals,
for users such as universities and research institutions, pharmaceutical and biotech enterprises, universities and
pharmaceutical and biotech enterprises, hospitals, CDCs, research institutions, CDCs, plasma stations, and testing Vision
blood stations, and primary public health institutions. We are institutions. Well-known customers include Shanghai Ruijin
committed to becoming a globally trusted world-class brand Hospital, WuXi AppTec, Shanghai Fudan University, China Well Life Forever
in life science and building a globally leading integrated life
science tools and intelligent productivity platform.
CDC, Hualan Biological, Hengrui Medicine, and Fosun
Pharmaceutical. In the international market, the Company
(Healthy Life, Forever)
has established a distribution network of over 800 resellers
The Company is always committed to technology leadership, and maintains long-term, ongoing cooperative relationships Mission
driving innovation and leading industrial transformation. We
have achieved breakthroughs in biomedical low-temperature
with nearly 80 international organizations, including the Committed to Everyone’s
World Health Organization (WHO) and the United Nations
technology, breaking foreign monopolies, with its related Children's Fund (UNICEF). Localized operations have been Lifelong Health by
R&D and industrialization capabilities reaching internationally rapidly strengthened, with the Company establishing localized Technology and Service
leading levels. Through continuous R&D investment, the operations in 18 countries, including the United Kingdom, the
Company has successively achieved breakthroughs in core Netherlands, the United States, Singapore, and Japan, precisely
Innovation
technologies such as multi-parameter high-precision control addressing the diverse needs of regional users.
technology, high-speed centrifugal separation of biological Philosophy
substances, polymer material surface modification technology, Building on its current position, Haier Biomedical is
high-precision identification, positioning and handling accelerating its "Three Transitions":
Your Health Our Priority
technology, and cup-based plasma apheresis technology. These
have formed an open innovation R&D system comprising four • Advancing global expansion through localisation;
horizontal and four vertical technology platforms, consisting of
• Driving industrial transformation through strategic
four general technology platforms (AI, automation, intelligence,
mergers and acquisitions;
and materials) and four vertical technology platforms
(refrigeration, environmental control, sorting and separation, • Shaping future innovation through AI-driven capabilities.
and biological applications), with a total of 1,620 patents
accumulated. Building on this foundation, the Company Looking ahead, the Company will continue to harness the
has integrated emerging technologies such as IoT, cloud momentum of digital intelligence, globalisation, and platform-
computing, and AI to creatively launch comprehensive digital based development to unlock new possibilities across the life
scenario solutions represented by smart blood distribution and sciences sector.
smart vaccination, and has further expanded into scenarios
such as smart laboratories and smart medication, leading the
digital and intelligent transformation of the industry.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Milestones
• RKN temperature- • "Pharmacy Management
• Delivery of the Smart Medical Community project jointly
controlled container Scenario Large Model" project
developed with Sangzhuzi District, Shigatse City, Tibet.
received first FAA selected as a Shandong • Jointly built Xinjiang's first
design approval "Open Competition Blood Donation Care Cabin • Two ultra-energy-saving ultra-low temperature freezers
letter in Asia-Pacific. Mechanism" project. with Alar City. passed DIN testing.
March May June August
February April July November
• RAP-AT1 active • Guizhou’s first demonstration AI vaccination clinic • Dual-system variable frequency series ultra-low temperature • Led the formulation of
temperature-controlled launched in Guiyang. freezers obtained ACT certification. China's first national
container received CAAC standard for the Medical
• Received world's first EU MDR certificate for medical low- • The Application of Solar Direct Drive (SDD) Vaccine
CTSOA certificate. Liquid Nitrogen Storage
temperature storage equipment. Refrigerators selected as one of the first batch of cultivation
Systems .
cases of "DC100 International DC Application".
• Received the first humidity control certification certificate
for medical refrigerators. • Three industry standards led or deeply participated in by its
subsidiary Qingdao HB TempCon Aviation Technology Co.,
• Smart digital fully automatic cell culture workstation
Ltd. were officially released: the Technical Specification for
recognized as an outstanding typical case of future
Aviation Temperature-Controlled Containers, the Operational
industry innovation development by MIIT.
Specification for Public Air Transport of Temperature-
• Participated in the formulation and release of the Controlled Cargo , and the Technical Specification for
group standard Technical Specification for Deep Low- Aviation Fire-Resistant Containers .
Temperature Storage of Biological Samples .
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Honors and Awards
Technology and Innovation
Project Name Award/Honor Name Issuing Organization
R&D and Industrialization of Key Equipment and Supporting Systems of Haier 2025 National "Two Major Initiatives" Project in the Biological Field National Development and Reform
Biomedical Commission (NDRC)
Key Technology Development and Industrialization of High-Throughput Cell 2024 Outstanding Typical Case of Future Industry Innovation Ministry of Industry and Information
Automated Culture Equipment Development Technology (MIIT)
National Postdoctoral Research Station National Postdoctoral Research Workstation (Excellence Award) Ministry of Human Resources and
Social Security
Key Technology Development and Equipment Industrialization for High-Quality Excellence Award (Highest Award) in the National Finals of the 14th Ministry of Industry and Information
and High-Efficiency Cell Preparation China Innovation and Entrepreneurship Competition for Disruptive Technology (MIIT)
Technology Innovation
Fully Automated and Standardized High-Efficiency Cell Preparation Workstation National Disruptive Technology Innovation Competition Ministry of Science and Technology
R&D and Application of Key Technologies for Constant Temperature Green and 2024 Science and Technology Progress Award of China National China National Light Industry Council
Highly Reliable Refrigeration Equipment for Biomedical Safe Storage Light Industry Council
Key Technology Development and Industrialization of Compact Automated Shandong Provincial Science and Technology Progress Award Department of Science and
Biological Culture Equipment Technology of Shandong Province
R&D and Industrialization of Key Technologies and Series Equipment for Green 2025 Science and Technology Progress Award of Shandong Province Shandong Province Equipment
Low-Temperature Storage of Biological Samples Equipment Manufacturing Association Manufacturing Association
Development and Application of Flexible and Expandable Ultra-Low 2025 Science and Technology Progress Award of Shandong Province Shandong Province Medical Device
Temperature Fully Automated Biological Sample Storage Technology and Series Medical Device Industry Association Industry Association
Products
R&D and Industrialization of Key Technologies and Series Equipment for Green 2025 Science and Technology Progress Award of Shandong Province Shandong Province Medical Device
Low-Temperature Storage of Biological Samples Medical Device Industry Association Industry Association
R&D and Industrialization of Key Technologies and Series Equipment for Green Qingdao Science and Technology Progress Award Qingdao Municipal Bureau of Science
Low-Temperature Storage of Biological Samples and Technology
Key Technology Development and Equipment Industrialization for Fully Qingdao Science and Technology Progress Award Qingdao Municipal Bureau of Science
Automated Cell Preparation and Technology
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Social Awards
Award/Honor Name Organizer
Selected for S&P Global's 2025 Sustainability Yearbook (China Edition) S&P Global
The 3rd Guoxin Cup · ESG Technology Leading Golden Bull Award China Securities Journal
Securities Star 3rd ESG New Benchmark Enterprise Securities Star
Future 20 · 2025 A-Share Listed Company Annual Growth Enterprise Jointly initiated by China Business Network, EY (China), Xiya Asset
Management, and Shanghai Jiading New City Development Co., Ltd.
– Sustainable Development Leader ESG Technology Leading
Golden Bull Award
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Sustainability Governance
Haier Biomedical implements the LIFE sustainable development strategy and is dedicated
to promoting the harmonious integration of corporate development with the environment
and society. We continuously improve our sustainability governance structure and execution
mechanisms, further deepen sustainability practices across the entire value chain, establish
diverse communication channels for stakeholders, actively fulfill our responsibilities as a
corporate citizen, and "respect" life with responsibility.
Sustainability Governance Structure
Haier Biomedical has established an ESG governance structure consisting of the Board of
Directors, the Strategy and ESG Committee, and the ESG Working Group, which ensures the
decision-making, management, and execution of sustainability-related matters and effectively
fulfills the responsibilities of sustainability management.
Haier Biomedical Sustainability Governance Structure
The Board of Directors is the highest decision-making body on and
ultimately responsible for our ESG matters. Its responsibilities include
reviewing and overseeing the Company's ESG-related management
Board of policies, strategies, and related risks, guiding the Company's ESG
Directors strategic direction and assuming ultimate responsibility for ESG
matters.
The Strategy and ESG Committee is led by the chairperson and
composed of Board members. Its responsibilities include formulating
ESG management policies and strategies; defining ESG development
Strategy and objectives and coordinating ESG work arrangements; overseeing the
ESG Committee planning and implementation of ESG initiatives; and reporting key
ESG matters to the Board periodically.
The ESG working group comprises heads of ESG-related functional
departments. Its responsibilities include formulating the annual work
ESG plan based on the Company's ESG policies and strategies, executing
Working Group specific tasks, and ensuring the achievement of objectives.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Stakeholder Engagement
Haier Biomedical recognizes that the opinions of stakeholders are critical to the Company's operations and development. We consistently pay attention to the opinions and demands of internal
and external stakeholders, listen to and respond to their needs through comprehensive, multi-channel communication mechanisms, and integrate their expectations into our daily management
and decision-making as appropriate, with the aim of building long-term, mutually trusting partnerships that create shared value.
Key Stakeholders Issues Communication Channels
Governments and regulators • Compliant operation • Green manufacturing • Government consultation • Working conferences
• Information security • Biodiversity • Information disclosure • Responses to inquiries
• Responsible marketing • Corporate governance • Topic reporting
Shareholders and investors • Corporate governance • Anti-corruption • Information disclosure • Online platforms
• Compliance operation • Investor relations • Shareholders' meetings • Roadshows
• Protection of intellectual • Performance briefing • Institutions’ research meetings
properties
Customers • Customers’ rights and interests • Quality service • Product launch • Customers’ communication
• Product Innovation • Responsible marketing • Satisfaction survey and complaint channels
• Cooperation and communication • Information security • Official WeChat account
• Product quality and safety
Suppliers and partners • Protection of human rights • Supply chain management • Empowerment and training • Industry activities
• Responsible procurement • Anti-corruption • Working conferences • Online or offline regular
communication
Employee • Employees' rights and interests • Talent attraction and retention • Employee symposiums • Employee training
• Occupational health and safety • Diversity & equal opportunities • Meetings of employee • Employees' complaint and
• Employee development and • Protection of human rights representatives reporting mechanism
training • Labor union • Culture discussion platform
• Balance between work and life
Environment and communities • Community investment • Energy and resource conservation • Charity projects and • Regular communication with
• Low-carbon technologies • Responsible purchasing fundraising platforms media
• Waste management • Green office • Information disclosure • Joining social organizations
• Water management • Climate change • Media-related conferences
• Emission management • Access to health care
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Double Materiality Analysis
Based on the double materiality principle and the requirements of the Guidelines No. 14 of the Shanghai Stock Exchange for Self-Regulation of Listed Companies—Sustainability Reporting (Trial) ,
Haier Biomedical has systematically identified and assessed the ESG issues related to its business operations. We conducted a comprehensive analysis of the impacts of our business activities on
the external environment and society (hereinafter referred to as "impact materiality"), as well as the potential effects of relevant issues on the Company's financial performance, business model,
and costs (hereinafter referred to as "financial materiality").
Through the above analysis process, we identified a total of 29 material issues this year, three of which are financially material. Based on the assessment results, we developed the materiality
matrix below to support the Company in further identifying key sustainability management priorities and formulating action plans. For the identified financially material issues, we have
disclosed them in the relevant sections of this report in alignment with the four dimensions of "Governance – Strategy – Impact, Risk and Opportunity Management – Metrics and Targets".
Double Materiality Assessment Process Double Materiality Matrix
Environmental issues Product quality and
Identification of We identify material issues by considering external ESG safety
Material Issues standards, regulatory requirements, capital market rating Social issues
criteria, and stakeholder concerns. Governance issues
R&D and
Customer rights and quality service
innovation
Protection of intellectual properties
Double Impact Materiality:
Responsible marketing
Materiality We assess the likelihood and magnitude of impacts (including Talent attraction
and retention Cooperation and
Assessment scope, scale, and irremediability), and collect stakeholder communication
Anti-commercial bribery and anti-corruption
ratings on the impact materiality of each issue through surveys.
Financial materiality
Low-carbon technologies
Information security and privacy protection
Financial Materiality: Employee development
Sustainable supply chain management
Diversity & equal opportunities Compliant operation
We assess the likelihood and magnitude of financial effects and training
Risk management
(including continuity of resource use and operational Protection of employees' rights and interests
Green office
dependencies), and collect stakeholder ratings on the financial Community contributions Occupational health Corporate governance
and safety
materiality of each issue through surveys. Energy and resource Biodiversity conservation Communication with stakeholders
management Access to health care
Circular economy
Results Guiding The Board of Directors reviews and approves the materiality Climate change Emission management
Rural revitalization
Sustainability assessment results, which serve as the basis for systematically
Disclosure and advancing targeted disclosures and continuously improving Waste management
Practices ESG management practices.
Impact materiality
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Sustainable Development Strategy Sustainability Model
Haier Biomedical embeds sustainability into its corporate
strategy, and has developed and continuously iterated its
unique "LIFE" sustainability model to provide clear guidance Leadership Integrity
for its sustainability actions. We fully support and implement
the United Nations Sustainable Development Goals (SDGs), p In
hi te
actively respond to the United Nations Global Compact and rs
e
G
gr
its ten principles, and are committed to demonstrating our
ad
it y
Le
firm belief in and responsibility for sustainable development
to all stakeholders through concrete actions.
Sustainability Concept S LIFE
Guided by the vision that "Intelligence enlightens life for a
shared future", Haier Biomedical is committed to respecting
life with sincerity, safeguarding life through technology, and
collaborating to forge a sustainable future. With a steadfast
em
E
Fu
ur y
st
focus on protecting public health, we make every effort to e os
t
advance our journey toward sustainability. Ec
Future Ecosystem
Sustainable Development Model
Reflecting on the insights from our materiality matrix and
sustainability assessments, we have crafted and continuously
enhanced our LIFE model, which drives us toward efficient
and effective sustainability governance. LIFE encapsulates
the four fundamental pillars of our approach: Leadership,
Integrity, Future, and Ecosystem.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical and SDGs
Pillar UN SDGs Strategic Focus of Haier Biomedical Progress of Haier Biomedical in 2025
Innovation-Led Adhere to innovation-led development and Defined the "create a world-class brand in the life sciences that is trusted globally" strategic direction as
strive to be a technical leader in the life the fundamental driving force of technological innovation. Implemented this through domestic "Three
science and medical innovation fields and Expansions and Two Focuses" and overseas "Country-by-country Strategy" market strategies.
industry.
Expanded the openness pattern and integrated internal and external resources through four forms—
Empower global public health through self-developed, co- research, mergers and acquisitions, and incubation—to build a diversified and
innovative achievements and serve national complementary R&D ecosystem. Deeply integrated artificial intelligence into product R&D and launched
strategies. a series of "AI+" solutions.
Drive industry progress and collaborate Completed the R&D and launch of over 70 new models based on core platforms such as ultra-low
with multiple parties to achieve co-creation temperature storage, automation, cell culture, and centrifugation.
and win-win results.
Accumulated 1,620 authorized patents and 428 software copyrights.
Integrity and Build a solid bottom line for compliant Continuously refined the corporate governance and risk management system to solidify the foundation
Shared Success operations and create a stable, high-quality for stable development.
corporate governance level.
Strengthened the construction of a business ethics culture and conducted business ethics and anti-
Remember product responsibility and corruption training and promotional activities for all employees to enhance compliance and legal
solidify the foundation of product safety awareness and create a clean business environment.
and quality to provide trustworthy products
and services for customers and the industry. Formulated the Medical Technology Ethics and Governance Policy to adhere to technological ethical
guidelines and codes of conduct in R&D activities such as scientific research, technological development,
and application.
Required all suppliers to sign the Supplier Code of Conduct, clarifying requirements for quality control,
integrity, green procurement, human rights protection, and conflict mineral management to drive
upstream and downstream enterprises in the supply chain to practice green development concepts.
Established a comprehensive product quality management system to support the "zero defect" goal by
clarifying responsibilities, strictly controlling processes, and scientifically setting standards.
Obtained the EU Medical Device Regulation (MDR) certification and the South Korean KGMP certification
to further expand global market access.
Guided by the "zero complaint" service goal, continuously deepened the construction of the customer
service guarantee system from three dimensions—service guarantee upgrade, service efficiency
improvement, and digital platform construction—to enhance service capability and quality.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Pillar UN SDGs Strategic Focus of Haier Biomedical Progress of Haier Biomedical in 2025
Sharing the Take the initiative in corporate responsibility Optimized the talent structure, introduced technological innovation talents, talent with advanced
Future and share development fruits with the degrees, and industry experts, and supported internal employee mobility to promote rational allocation
industry and society. and efficient utilization of talent resources. During the reporting period, we introduced 22 core talents for
key positions, with 33.64% of vacancies filled by internal employees.
Continuously create social value and meet
the social needs of the times to promote Implemented globalization and specialization strategies and customized multi-dimensional specialized
equal, inclusive, and diversified global training for employees to help them systematically improve professional capabilities and management
social development and support common literacy. During the reporting period, granted no more than 1.2 million A-share ordinary shares to no more
prosperity. than 309 employees to share the fruits of enterprise development with core talents through equity.
Systematically upgraded the "139 Safety Management System," clarified the safety responsibility list
for all employees, and implemented an all-staff, comprehensive, and whole-process health and safety
management model.
Partnered with global ecological partners such as government agencies, NGOs, and universities to
promote the global development of access to healthcare and assist in the construction of public health
systems in underdeveloped regions. The Company's products and solutions have entered more than 80
"Belt and Road" countries and regions.
Launched the full-process smart vaccine solution to ensure the quality and safety of medicines and
vaccines throughout the production, storage, and transportation chain through smart cold chain
technology, improving grassroots vaccination rates and medical smart management capabilities. This
solution has covered more than 140 countries and regions globally.
Green Focus on the welfare of the next generation Integrated green concepts into the full lifecycle stages of product R&D, design, raw material selection,
Symbiosis and strive to protect the green home of manufacturing, logistics, transportation, and recycling. During the year, we obtained 122 energy-saving
humanity and mitigate climate change. and environmental protection certificates, including 75 product models and 2 new registered models
with U.S. Energy Star certification.
Integrate the green concept into corporate
operations to achieve green and low-carbon Implemented green operations and strictly controlled pollution management to build a resource-saving
transformation and build an environment- and environment-friendly enterprise.
friendly and resource-saving enterprise.
Continuously refined the climate change and "dual carbon" governance system and deepened the
Collaborate with all sectors of society identification of and response to climate risks and opportunities. Used energy saving and carbon
and leverage the advantages of Haier reduction as the core strategy and path to enhance business resilience and climate adaptation capability.
Biomedical to contribute to environmental
issues such as green transformation across Provided innovative biodiversity conservation solutions and empowered global germplasm resource
the entire industrial chain and support for banks, biological sample banks, and genetic resource protection by relying on leading ultra-low
biodiversity conservation. temperature, automated storage technology, and IoT solutions.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
ESG Highlight Performance
Integrity and
Innovation-Led Shared Success Sharing the Future Green Symbiosis
The proportion of R&D Total R&D investment Percentage of Percentage of female Obtained ISO 45001 occupational Passed the annual audit of the ISO 14001
personnel reached amounted to female directors senior executives health and safety management system environmental management system
Continuously carried out energy-saving
Total number of employees
The number of newly with non-storage- Anti-corruption education sessions for middle and carbon-reduction actions throughout
granted invention
patents increased by
related invention
patents accounting for
and senior managers
A total of
Integrity and self-discipline awareness
training coverage 36.29 hours 2.367 million kWh
in renewable energy consumption within the
been obtained Employee training percentage
campus
A total of Supplier integrity agreement signing rate 100% accounting for
recognized as reaching the 100 % 18.18 %
international leading level Total public welfare donation amount reached of the Company’s total electricity consumption
Accumulated
Achieved annual target of RMB 1.406 million Invested and
technology awards
defect rate
RMB 257,700 2,139 hours
Number of working days lost due to
work-related injuries in environmental in environmental
Quality training sessions protection funds protection initiatives
Cumulatively led or participated in the
formulation of
national, industry, and group standards
and technical specifications.
Customer On-time customer
valid patents per
RMB million
software copyrights
per RMB million 99.94 % 99.32 %
revenue revenue
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Special Feature
Global
Technology
Expansion,
Serving Global
Health
Haier Biomedical is committed to building a more resilient and We are building a new global ecosystem of shared growth and
sustainable global health ecosystem through technological innovation technology empowerment. Anchored in localized services with global
and localization. Against the backdrop of evolving global public coverage, driven by innovative scenario-based solutions, supported by
health needs and infrastructure upgrades in emerging markets, Haier superior technological products, and committed to low-carbon and
Biomedical's internationalization has evolved from single-product energy-saving contributions, we are developing scalable, trustworthy,
sales to delivering comprehensive solutions centered on "product + and affordable health technology infrastructure and public health
service". Driven by technological innovation, anchored in localized systems. This initiative aims to promote the efficient allocation of
services, and oriented toward sustainable operations, the Company medical resources and the inclusive extension of services.
has achieved a leap from merely delivering equipment to providing
full lifecycle value services.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Operational Roots: Building a Localized Service Network Collaborating with major Korean airlines to build a new temperature-
controlled ecosystem
CASE
Haier Biomedical has integrated into the local ecosystem to build a full-cycle service capability
covering pre-sales, delivery, and after-sales together with partners. We transform standardized The Qingdao Honghu team under Haier Biomedical has
products and technologies into flexible, locally adapted, reliable, and efficient localized service established strategic partnerships with major Korean
solutions. This ensures that our solutions precisely meet local needs, facilitating a value shift airlines, including Korean Air, T’way Air, and Air Premia.
from "equipment supplier" to "long-term service partner". The team applies its independently developed active
air cargo temperature-controlled containers to their
route networks and engages in deep collaboration on
Kenya Localized Collaborative Service Model CASE
optimizing temperature-controlled logistics solutions
and defining service standards. This initiative drives
In Kenya, we collaborated closely with our local partner, an upgrade from equipment supply to ecosystem
Ray Pharmaceuticals, to provide customized ultra-low co-construction, providing more efficient and secure
temperature storage solutions for the Strathmore University solutions for global temperature-sensitive material
Medical Center. transportation.
To address the center's stringent requirements for stable
ultra-low temperatures below -80°C, intelligent monitoring,
and energy-saving quiet operation, both parties jointly Program Leadership: Building a Scenario-Based
analyzed Nairobi's climate characteristics and laboratory
usage habits. The DW-86L338J ultra-low temperature
Digital Ecosystem
freezer was selected, and a joint response mechanism was
Haier Biomedical is committed to deeply integrating smart hardware, data platforms,
established, forming a complete localized service model
and industry knowledge. Targeting key scenarios such as public health, life sciences, and
spanning precise pre-sales selection to continuous post-
pharmaceutical distribution. The Company provides end-to-end digital solutions that enable
sales support.
global customers to enhance workflow intelligence, efficiency, and reliability.
Zero-Downtime Upgrade of Biosafety Cabinets at the Laboratory of Smart Liquid Nitrogen Tanks for South African Blood Banks CASE
Queen Mary University of London CASE
At the South African National Blood Service, our
At Queen Mary University of London, facing the challenge of large-capacity liquid nitrogen tanks are equipped
replacing 64 biosafety cabinets with "zero interruption and precise with the Cryosmart smart monitoring system. The
alignment", we established a special task force combining "local system utilizes high-precision sensors to provide
UK expertise and global R&D". Within 48 hours, we completed a 24/7 real-time monitoring of the tank’s temperature
customized solution design and executed precision construction and liquid level. Data is synchronized to the cloud,
involving "removal of old units and installation of new ones, room- and alerts are immediately triggered upon detection
by-room rotation", successfully achieving a seamless transition of anomalies. Management personnel can remotely
between the old and new equipment. This response not only monitor device status via mobile devices, enabling
efficiently met user needs but also validated our capability to digital, visual, and alert-based safety control of
rapidly mobilize local and global resources to address complex blood samples, and transforming traditional storage
scenarios, laying the foundation for deepening cooperation. into intelligent monitoring systems.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Brazil Laboratory Procedure Cooling Instrument CASE
Tech Synergy: Empowering Global
At the laboratory in Curitiba, Brazil, the Cutting-Edge Research
Haier Biomedical controlled-rate freezer
enables digital control for low-temperature Haier Biomedical continues to invest in core technological innovation, providing professional
experiments. The equipment supports and reliable low-temperature storage, biosafety, and sample processing equipment to
precise adjustment of the cooling rate support the cutting-edge research of top universities and research institutions worldwide. Our
within a wide range of 0.1–99.9°C/min, with products have become a trusted choice for global research institutions conducting frontier
temperature fluctuations stabilized within research, marking the increasingly vital supporting role that our products have become a
±0.5°C. Its 7-inch touchscreen interface trusted choice for leading research institutions worldwide, supporting advanced scientific
makes the complex cooling process discovery and reflecting the growing global recognition of high-end medical technologies.
intuitive and provides real-time display of
liquid nitrogen levels with automatic alerts. Collaborative Project with the Australian Childhood Cancer Institute CASE
This transforms processes previously reliant
on manual expertise into standardized,
We delivered 6 liquid nitrogen tanks and 11 ultra-
stable, and traceable digital procedures.
low impact -80?C temperature freezers to the
Australian Childhood Cancer Research Centre.
Through advanced low-temperature storage
Smart Centrifuge for Australian Research Institute CASE
technologies, we support the center’s research
into childhood cancer, enabling scientists to
At the Westmead Medical Research accelerate progress toward new breakthroughs.
Institute in Australia, our centrifuges
meet the stringent requirements of
this leading global research institution Upgrade of Biosafety Protection at the Sorbonne University CASE
through precise, stable, and intelligent
performance. Advanced temperature
Our biosafety cabinets have been deployed at Sorbonne
control and intelligent management
University in France, providing reliable protection to
capabilities ensure the reliability of
support the institution’s advanced research activities.
experimental data and the efficiency
With high-performance containment and robust
of research processes, supporting
safety features, the equipment meets the stringent
cutting-edge translational medical
requirements for protecting personnel, samples,
research with robust digital solutions.
and the environment, ensuring safe and compliant
operation across life sciences research applications.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Support for Freeze-Drying Technology Research at The Hong Kong
Polytechnic University CASE
Green Empowerment:
Innovative Low-Carbon Solutions
Our freeze-drying machine was installed and
commissioned at the Hong Kong Polytechnic Haier Biomedical integrates sustainability principles throughout the entire product lifecycle,
University. As the Company’s first freeze- encompassing design, manufacturing, and service. Through energy-saving technologies, eco-
drying system deployed in Hong Kong, this friendly materials, and circular solutions, the Company not only helps customers reduce
solution delivers significant improvements operating costs but also supports them in achieving their sustainable development strategic
in operational efficiency, safety, and process goals, jointly creating long-term environmental value.
control. It meets the stringent requirements
of universities for freeze-drying applications in Ultra-Low Temperature Freezers Support Green Upgrades CASE
life sciences research and biopharmaceutical for Australian Research Institute
development, providing reliable technical
support for advanced scientific research. At the Westmead Medical Institute in Australia, our ultra-low temperature freezers provide
critical support through green technology. This series is the only Chinese brand to receive
ACT certification from My Green Lab. It utilizes eco-friendly hydrocarbon refrigerants,
achieving an annual carbon reduction of approximately 2,269 kilograms per unit and
ranking first in energy consumption performance on the U.S. Energy Star list. With its
superior green performance, this equipment serves as a significant enabler for customers
to achieve sustainable development goals.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Ultra-low Temperature Freezers Deployed at Top Universities CASE The Green Sample Library Initiative Supports Imperial College London CASE
in Europe and the United States Strides in Sustainability
Our -150°C ultra-low temperature We delivered a cryogenic biological sample
(ULT) freezers have been deployed storage solution to Imperial College London
at research institutions including the that significantly reduced liquid nitrogen
University of Halle in Germany and the consumption and associated carbon
University of Miami in the United States. emissions. This initiative supports the College’s
Additionally, our ultra-low impact, sustainability objectives and aligns with
energy-efficient ULT temperature programmes such as LEAF, demonstrating
freezers have been installed at the how technological innovation can contribute
Stanford University School of Medicine to more sustainable laboratory operations.
in the United States. These devices,
with their performance characterized
by "ultimate reliability" and "ultra-
low energy consumption," meet the From the seamless renewal of the London laboratory to the temperature-controlled ecosystem
comprehensive requirements of top- on Korean routes; from green carbon reduction at the Australian research institute to scientific
tier academic institutions regarding the support across top universities in Europe and the United States. These milestones collectively
reliability, advanced nature, and cost- demonstrate that Haier Biomedical's global presence has established a three-dimensional
effectiveness of research equipment. capability matrix covering localized services, digital solutions, cutting-edge technology, and
Th i s d e m o n s t ra t e s o u r t e c h n i ca l green sustainability.
expertise in providing efficient, low-
Looking ahead, Haier Biomedical will continue to deepen the "Global Technology Expansion"
carbon life science solutions.
strategy and further evolving from a provider of products to delivering sustainable health
solutions. We will continue to invest in strengthening our overseas localization and service
capabilities by expanding local teams and deepening collaboration with regional partners,
building a more agile and locally integrated service network. We are committed to aligning
integrating technological innovation with the real needs public health within different regions,
helping to address global health imbalances, and contributing long-term value to build a
more resilient and inclusive global health ecosystem.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Safeguarding the
Life Barrier
Against the backdrop of accelerating industrial transformation, technological
innovation has become the core engine driving high-quality enterprise
development. Haier Biomedical has consistently placed R&D innovation at
the core of its strategy. The Company continues to refine its R&D governance
system, strengthen core technical capabilities, and build an open innovation
ecosystem. With solid technical accumulation and an agile innovation
mechanism, Haier Biomedical actively addresses external risks and challenges
while seizing strategic opportunities to expand into high-end markets,
injecting sustainable momentum for the Company's long-term development.
Performance Highlights in this Section
The proportion of The number of newly A total of Accumulated
R&D personnel
reached
added invention
patents increased by 428 51 valid patents per RMB
software copyrights provincial-level or higher science million revenue
year-over-year SDG-related responses
in this Section
Total R&D investment with non-storage A total of Cumulatively led or participated
amounted to invention patents
RMB 323 million
accounting for
have been recognized as national, industry, and group
RMB million revenue
reaching the international standards and technical
leading level specifications.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
A global leading provider of integrated life science tools and intelligent productivity platforms, powered by AI
Independent R&D Improve the quality and Improve the quality of research AI empowerment
efficiency of operation and
Scientific and technological management Enhance the efficiency of Digital intelligence
innovation research commercialization application upgrading
Strengthen full-chain quality
assurance Digital Digital
intelligence intelligence
biobank laboratory
Digital operation
Digital Digital
intelligence intelligence
Intelligent manufacturing healthcare blood system
Self-developed Co-research M&A Incubation R&D mode
Build an ecosystem
of co-creation and
co-research
...... Ecosystem partners
Build a cornerstone Users Universities Scientific Industry
for innovation and research institutes partners
development
UADV open Six technology R&D system
R&D system platforms and platform
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Against the backdrop of rapid technological iteration in the life sciences sector and a reshaping
R&D innovation is the key pathway for Haier Biomedical to build long-term competitiveness.
of the global industrial landscape, Haier Biomedical leverages technological innovation as its
By optimizing our organizational structure and operating the "Four Horizontal and Four
fundamental driving force. The Company has clearly defined its strategic direction to "create a
Vertical" technology platform while building an open R&D ecosystem, we continuously
world-class brand in the life sciences that is trusted globally" and is advancing implementation
enhance innovation efficiency to provide solid support for capturing market trends and
through market strategies such as domestic "Three Expansions and Two Focuses" and overseas
achieving high-quality development.
"country-by-country strategy". At the same time, we focus on three product development directions:
Haier Biomedical has established a clear three-level R&D management structure to balance Drive the traditional storage business from a domestic No. 1 position
R&D resource allocation, efficiently advance technical breakthroughs, and accelerate new to a global No. 1 through continuous technological innovation
product development. This system is driven by core technological innovation and deep
insights into user needs. Through mechanisms such as milestone reviews by the Management
Achieve the completion of new scenario solutions, expand them into a
Committee, monthly R&D progress reports, and weekly operational meetings, it ensures that
series, and promote domestic substitution to strive for industry leadership
the R&D process remains highly aligned with the Company's strategy, driving product iteration
and enhancing competitiveness.
We have also established a comprehensive R&D policy system. Through systematic and Establish new scenario platforms for biopharmaceuticals and reagents
standardized process design and documentation standards, we provide a clear execution
framework for R&D activities to ensure R&D efficiency, quality control, and knowledge
accumulation through institutional mechanisms. Currently, Haier Biomedical has two level-2
procedural documents and 22 level-3 procedural documents in its R&D field. In advancing the implementation of our strategy, we have clearly identified and addressed
relevant risks and opportunities. Facing competitive pressures from both domestic and
international markets, we effectively responded through differentiated, high-value product
Haier Biomedical R&D Management Structure development and a comprehensive product line layout. To address challenges in product
validation, technical breakthroughs, and professional talent alignment during the R&D
Board of Directors process, we established a User Experience Validation Center, implemented technology pre-
research initiatives, and introduced a talent recruitment mechanism to systematically manage
R&D risks. At the same time, we actively seize the opportunities for breakthroughs in frontier
Management Committee technologies and the localization of high-end equipment driven by China's national strategy
for the "15th Five-Year Plan". Building on our technical expertise, we are expanding into high-
value growth markets, including laboratory equipment and biopharmaceutical processes.
Technology R&D During the reporting period, our strategic execution yielded significant results, with
technological breakthroughs and market leadership emerging simultaneously. In terms
of products, first-of-their-kind products such as rapid freezers and fully automated tumor
solution preparation robots have been delivered to users. Breakthroughs have been achieved
Digital &
Digital & Digital & Digital & in multiple technologies, including variable-capacity refrigeration unit and the 10W high-
Intelligent R&D Technology
Intelligent Intelligent Intelligent Blood speed centrifuge. In terms of market performance, the sales of the UltraEco Series exceeded
Research Platform Platform
Sample Industry Medical Industry Industry RMB 10 million; the low-temperature automated solutions rank first in the domestic market;
Industry
the pharmacy automation business demonstrated significant growth, and incubator products
maintained a leading market share among domestic brands.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
R&D Management System R&D Management Mode of Haier Biomedical
Haier Biomedical is positioned at the forefront of the life
sciences sector. The Company has established an innovation
roadmap centered on AI-driven biomedical solutions,
underpinned by IoT-enabled transformation and independent R&D process management Standard module management Technology platform management
innovation in low-temperature technologies. This approach Ensure the orderly R&D activities with Reasonably divide the content of Build cross-departmental and
aims to achieve customized scenarios and deliver integrated standardized process management R&D into standard modules by cross-field technology platforms to
solutions combining "automation + digitalization + ecosystem function, technology, etc. to improve integrate resources and advance R&D
integration", ultimately setting a benchmark for intelligent R&D efficiency collaboration and knowledge sharing
development within the life sciences industry.
Haier Biomedical Innovative Development Path Open R&D Pattern of Haier Biomedical
Independent Innovation in Self-developing to open resources Co-research to open ecology
Low-Temperature Equipment Fully utilize the foundation in industrial advantages, Engage leading industry users in co-creation under the
Independent R&D in low-temperature refrigeration integrate resources in parallel, and implement product leadership and participation of experts, focus on unmet
technologies, strengthening competitiveness in iteration quickly based on user demands scientific research and clinical needs, and quickly realize
a market historically dominated by international the transformation of scientific research achievements
brands
M&A to open boundaries Incubation to open teams
IoT transformation and upgrade
Focus on the Company's strategic direction and user Build an open platform to gather innovative elements,
Integrating IoT technology to create multiple demands, quickly address capability gaps in the value and promote the combination of innovation and
world first smart public healthcare scenarios chain and own product iterations with first-class market entrepreneurship, making rapid breakthroughs in projects
competitiveness
Low-temperature industrial automation + life
science EPS model innovation
Focus on professional application scenarios to Haier Biomedical has established the UADV open R&D system, guided by the creation of user value. This system embeds user
create a comprehensive, integrated "automated + participation throughout the entire product development lifecycle: users are invited to engage and provide feedback during the
digitalized + ecosystem" solution research and design phases; user experience issues are managed in a closed loop during the verification phase to ensure that
products meet user needs upon launch; and during the product application phase, continuous collection of user feedback drives
Provider of AI-driven intelligent product optimization and iteration, enabling the effective commercialization and continuous refinement of innovation outcomes.
biomedical solutions
Upgrade scenario customization capabilities and UADV Open R&D System of Haier Biomedical
realize personalized user experience
User participation in design User participation in validation User participation in application
To support the execution of the roadmap, we have also
User needs are studied and The reporting standards for user Zoom in on different user groups
established a systematic management mode. By standardizing
scenarios are created from their experience before product launch and create models that will
processes, implementing modular standards, and leveraging
perspectives are upgraded to accurately resolve become standard process systems
cross-departmental technical platforms, we have formed
pain points faced by our users
a standardized and highly collaborative R&D operational
framework.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
In 2025, we optimized our R&D management system around Global Layout Map of Haier Biomedical
platform reconstruction and efficiency enhancement. We
upgraded and built the "Four Horizontal and Four Vertical" UAE Global User Experience Centre Tianjin Haier Biomedical Tianjin R&D Center
UK Global Marketing Centre (under construction)
R&D technology platform. The platform integrates four
general technology platforms—AI, automation, intelligence,
a n d m a te r i a l s — a l o n g w i t h fo u r ve r t i ca l te c h n o l o g y Haier Biomedical Safety Qingdao
Shenzhen Haier Biomedical Science and Technology
platforms—refrigeration, environmental control, sorting and Innovation Industrial Park
US Global Logistics Centre Shenzhen
separation, and bio-applications, providing robust support Software
for the R&D, and integrated application of key technologies. Research Institute
To enhance R&D efficiency, the Company systematically Haier Biomedical Suzhou
advanced digitalization and process optimization. We Suzhou Science and
Technology Innovation
l a u n c h e d t h e p r o d u c t p o r t fo l i o m a n a g e m e n t a n d Industrial Park
discontinuation warning system to enhance the product
full lifecycle management system. By integrating data
management software with Haier Group's Product Data Haier Biomedicalf Nantong
Nantong Science and
Management (PDM) system, we achieved a 1.8% increase in Technology Innovation
module reuse rate within the year. During project operations, Industrial Park
we strictly implemented technical review and weekly follow-
up mechanisms, promoted the reuse of planning modules,
and advanced registration and certification processes Haier Biomedical Yangtze
Advanced Technology River
upfront, effectively shortening the development cycle.
Research Institute Delta
R&D Capability Building
Haier Biomedical aligns with the demands of life science Haier Biomedical Guangzhou Guangzhou
Laboratory R&D Center
and medical innovation, continuously optimizing its global India Global Marketing Centre
R&D layout, strengthening its hardware platforms and Chengdu Haier Biomedical
team, implementing innovation incentives, and enhancing Chengdu Science and Haier Biomedical Chongqing Chongqing
Nigeria Global User Experience Centre Technology Innovation Science and Technology
independent innovation capabilities to solidify a lasting
Industrial Park Innovation Industrial Park
foundation for growth.
In terms of R&D layout, Haier Biomedical further expanded Haier Biomedical has established a robust laboratory testing system to provide solid hardware and standards support for
its global R&D network during the reporting period by research, development, and innovation. The Company’s testing center has established more than 30 specialized laboratories
establishing R&D centers in Tianjin and Guangzhou, covering areas such as overall product performance, reliability, environmental adaptability, safety, and user experience.
building upon its existing coverage across 9 provinces and The testing center has obtained accredited testing capabilities recognized by the China National Accreditation Service for
municipalities in China as well as overseas networks in the Conformity Assessment (CNAS), covering 65 domestic and international standards and 609 testing items, thereby establishing
United States, the United Kingdom, and the United Arab comprehensive international inspection and testing capabilities across multiple dimensions, including software, hardware,
Emirates. These initiatives have effectively strengthened the scenarios, and applications. At the same time, the testing center has established a rapid prototyping line for new products,
foundation for R&D capabilities and improved R&D efficiency. forming an integrated R&D support platform spanning technology verification through product incubation. In addition, we
operate a user verification laboratory center that promotes the continuous enhancement of product design through product
performance testing and simulated user operation processes.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Laboratory of Haier Biomedical In terms of R&D team building, Haier Biomedical continues
to cultivate internal talent and actively recruit external talent, As of the end of the
committed to building a multidisciplinary technical team covering reporting period
multiple disciplines including biology, healthcare, the Internet of
Things, and artificial intelligence. During the reporting period, we
strengthened our talent base by attracting experienced industry
The number of R&D
professionals and R&D specialists, including four senior industry personnel at Haier
Refrigeration laboratory General equipment User validation experiment
leaders. The proportion of industry professionals increased to 43%. Biomedical worldwide
• Low temperature performance laboratory center
At the same time, we selected eight leaders across its technology
performance
• High and low temperature
• Dynamic balance testing
• Blast hut validation
•
•
Cell culture
Plant culture
platforms to leverage their guiding role in key technical areas and
drive the improvement of the team's innovation capability. 28.56 %
laboratory • Three-coordinate • Lyophilisation validation The proportion of
• EMC laboratory measuring • Programmed cooling To stimulate innovation vitality, we have established and R&D personnel
• Solar powered equipment • IoT laboratory • Centrifugation validation implemented a scientific research incentive mechanism to
testing laboratory • Computer board MFOP • …… accelerate the transformation of innovative results, ensuring that
• Extreme load laboratory • …… employees' value and sense of gain are realized throughout the During the
• …… innovation process. reporting period
Haier Biomedical Laboratory has obtained four categories of international certifications, including
the first UL Client Test Data Program (CTDP) laboratory qualification in China's industry, as well as
Collaborative R&D Ecosystem RMB 323 million
Haier Biomedical adheres to the philosophy of openness and Total R&D investment
T?V Rheinland Witness Laboratory accreditation, and CNAS laboratory recognition.
collaboration, continuously building and deepening an innovation
accounted for
cooperation ecosystem with universities, research institutions,
and industry partners. Through diversified cooperation models, it
advances the exploration of cutting-edge technologies and their
of total revenue
industrial transformation.
We maintain long-term cooperative Working hand in hand with multiple
relationships with renowned universities par tners to jointly establish and
Qingdao Key Labs Letter of Appointment to CNAS Laboratory
and scientific research institutions to incubate R&D center s , we tightly
Collaborating Laboratories Accreditation Certificate jointly conduct frontier technology integrate innovation resources with
research, promoting deep integration market demands to accelerate the
bet ween fundamental research and transformation and implementation of
industrial applications technological achievements
Haier Biomedical Innovation Ecosystem
We collaborate closely with ecosystem For specif ic technical requirements,
partners to integrate resources across we adopt commissioned development
th e e ntir e in d u s tr ial ch ain , a ch i e v e a p p r o a ch e s t o i n t r o d u c e e x t e r n a l
complementary advantages, and jointly prof es sional teams , enabling rapid
UL CTDP Laboratory T?V Rheinland T?V SUD Certificate address industry challenges technological breakthroughs
Accreditation Certificate Accreditation Certificate
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
During the reporting period, we continued to expand our During the product development process, we have embedded 1.1.4 Metrics and Targets
industry-academia-research cooperation network by initiating risk management into each stage, establishing a normalized
project collaborations with multiple universities, including mechanism: To evaluate the effectiveness of R&D innovation, Haier Biomedical
Xi'an Jiaotong University, Huazhong University of Science and has established quantitative targets for indicators such as
Technology, and Beihang University, as well as institutions R&D Risk Management Process invention patent applications, new product development
such as the Guangzhou National Laboratory. Concurrently, completion rates, and the proportion of revenue from new
we signed a strategic cooperation agreement with the State 1 products. During the reporting period, all indicators were
Key Laboratory of Biotherapy at Sichuan University. Focusing Planning and Proposal achieved and exceeded the set targets, demonstrating the
on the development needs of the biomedical and health Company's positive results in research and innovation.
The Product Manager
industries, we concentrated on technological innovation and
organize relevant personnel
product R&D in the interdisciplinary field of medicine and
to discuss key topics and Metrics Targets Progress in 2025
engineering. We established a comprehensive, in-depth, long- developed a comprehensive 2
term mechanism for mutual benefit to promote technological Risk Management Plan ; the Number of Invention
Design and R&D 100 148
research and the transformation of results. Development Department Patent Applications
conduct preliminary risk Analyze potential failure
identification and hazard modes of new materials, New Product Development
assessment, resulting in a new processes, and change Completion Rate
Risk Analysis Record . points for products to
Model DFMEA . 35% 38.3%
Implementation of
from New Products
Controls
Timeliness of Registration
Risk control activities and Certification
shall be fully recorded in
the Risk Control Process 4
Index Table . The project Post-marketing
managers record the
Signed a strategic cooperation agreement with the State Key The Quality Department is
review results and compile
Laboratory of Biotherapy at Sichuan University responsible for consolidating
them into the Risk
and evaluating production
Management Report .
and post-production
the Production and Post-
Management Production Risk Control
Processes Index Table .
Haier Biomedical has established a risk management
mechanism covering the entire R&D process. We formulated
and implemented the R&D Risk Management Control
While managing risks, we also conduct routine identification and
Procedure , established a risk management team, and executed
response to opportunities. We closely monitor macro policies,
end-to-end management covering risk planning, risk analysis,
industry trends, and technological developments related to R&D
risk assessment, risk control, and risk review reporting. innovation. By aligning with our actual development needs, we
identify potential opportunities and incorporate them into the
Company's R&D and business planning, and dynamically adjust
resource allocation and technical layouts to continuously seize
development opportunities.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
initiatives and achieved positive results. The contributions and outcomes have received
multiple recognitions from authoritative institutions.
Haier Biomedical places technology leadership and scenario-based innovation at the core of
its strategy, continuously driving digital transformation and standards development in the life
sciences industry. We actively build an open and collaborative industrial ecosystem, lead and Achievements and Honors in Standardization Work in 2025 CASE
participate in the formulation of industry standards, promote technological upgrades and
model innovation within the sector, and inject sustained vitality into industrial development. • The national standard project on Medical Liquid Nitrogen Storage System led by the
company, was approved for establishment, and a working group discussion meeting
Smart Pharmacy Scenario Solutions Lead the Construction of for the formulation of this national standard was convened.
CASE
Industry Ecosystems • The International Standards Working Group for IEC/PC130/ahG5 Medical Low-
Temperature Storage Equipment - Part 2-X: Performance Requirements and Test
In 2025, Haier Biomedical’s outpatient and sterile compounding pharmacy solutions Methods for Cold Storage Rooms has been established, with experts from Haier
Biomedical serving as the conveners.
were deployed in over 550 medical institutions globally, establishing an intelligent
management ecosystem covering the entire pharmaceutical lifecycle and achieving • The national standard for low-temperature storage cabinets has been recognized as a
a model upgrade from hardware equipment to systematic solutions. In China, we high-level basic standardization project by the Shandong Provincial Market Regulation
deepened strategic cooperation with hospitals such as the Second Affiliated Hospital Administration in 2025.
of Soochow University and Tsinghua Changgung Hospital, continuously advancing • The IEC 63590-2-1 standard titled Medical Low-Temperature Refrigerated Freezers —
the optimization of integrated inventory and distribution solutions and packaging Performance Requirements and Test Methods , which was led by the Company, was
machine schemes. Overseas, the Company completed localization benchmark awarded the Group’s Top Ten Standard Innovation Award for 2025.
projects in Saudi Arabia, the United Arab Emirates, Singapore, Vietnam, and other • "Haier Biomedical-led Working Group on Medical Cold Storage" and "Haier Biomedical-
countries, establishing global leadership capabilities that extend from product output led Mandatory National Standard for Energy Efficiency of Refrigeration Appliances for
to scenario ecosystem output. Medical and Laboratory Use" were selected as two of the Top 10 Standard Events of
Haier Group in 2025.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Drawing on practical experience accumulated in ecosystem building and scenario While transforming technological innovation into industry standards, Haier Biomedical also
implementation, Haier Biomedical actively converts innovation outcomes into industry fosters open collaboration and value co-creation across the industrial chain by establishing
standards. During the reporting period, the Company led or participated in the formulation high-level exchange platforms.
and revision of four national standards, including Laboratory Centrifuges (GB/T 30099-
logistics—Technical specification for performance qualification (GB/T 34399-2025), Technical and Innovation Ecosystem Conference"
Requirements and Testing Methods for Aviation Containers (GB/T 16299-2025), and Safety
requirements for electrical equipment for measurement, control and laboratory use—Part 11:
During the reporting period, Haier Biomedical hosted the "One INKON, Boundless Shared
Particular requirements for sterilizers and washer-disinfectors used to treat medical materials
Prosperity — Haier Biomedical Medical 20th Anniversary Entrepreneurship and Innovation
(GB 42125.11-2025), as well as multiple industry and group standards. The specific outcome
Ecosystem Conference". The event brought together over 150 national dealers and more
data are as follows:
than 200 industry elites. Through the integration of products, scenarios, and capabilities,
we jointly established the Haier INKON Life Ecosystem Alliance and released multiple
Haier Biomedical’s Leadership or Participation in Standard Issuance digital intelligence scenario solutions focusing on fields such as life sciences and smart
hospitals. The convening of this conference and the establishment of the alliance have
During the effectively promoted collaborative synergy within the industrial ecosystem, injecting new
reporting period including momentum into the digital and intelligent transformation and win-win development of
the healthcare industry.
we initiated or participated
in the release of 4 9 1
National Industry Group
Standards Standards Standards
new standards (Items) (Items) (Items)
As of the end of the
reporting period including
the Company has led
or participated in the
issuance of a total of
Number of Group Local International
Industry
Standards
(Items)
Standards
(Items)
Standards
(Items)
standards Standards 20th Anniversary Entrepreneurship and
Innovation Ecosystem Conference
(Items)
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Cryopreservation Solution"
CASE
Haier Biomedical continued to advance technological innovation and product iteration.
During the reporting period, the Company successfully developed and launched multiple In the field of cell therapy, Haier Biomedical’s doctoral
new products, achieved breakthroughs in several key technical areas, and obtained multiple team focused on the technical challenge of cell viability
provincial and municipal scientific and technological achievement certifications. At the loss in traditional cryopreservation protocols. Collaborating
same time, we are actively advancing the integration of artificial intelligence with biomedical with partners such as the Tianjin Institute of Hematology
technologies. We have launched multiple "AI+" innovative products and solutions to reshape and Xi’an Jiaotong University, the team conducted
business processes, thereby enhancing safety and efficiency. collaborative research to develop a multi-mechanism
protective solution for DMSO-free Haematopoietic Stem
Annual Product Matrix Cell Cryopreservation, integrating safe permeation, external
protection, antioxidant activity, and fully pharmacopeia-
During the reporting period, Haier Biomedical completed the R&D projects and launched compliant components. This effort led to the development
more than 70 new product models centered on core platforms including ultra-low of a DMSO-free and serum-free cell cryopreservation
temperature storage, automation, cell culture, and centrifugation. medium. The product is non-toxic, features stable and
safe ingredients, and has increased cell viability by 10%,
DMSO-free Hematopoietic Stem
reaching an internationally advanced level. Cell Cryopreservation Solution
Ultra-Low Temperature Product Platform Automated Platform
• Leveraging multi-stage precise • Developed two combinable and modular Our innovation achievements have received high recognition from the industry. In an
regenerative technology, we have launched high-performance sample storage authoritative appraisal organized by the China Medical Device Industry Association, two of our
four new products in the Super Energy- platforms capable of operating at -80°C. achievements—the "Multi-parameter Collaborative Precision Control Technology Platform and
Saving Series. • Completed the expansion of the 100T Series of Equipment for Biological Cultivation and Testing" and the "Thermo-sensitive High-
• Launched one dual-temperature and dual- freeze-thaw machine model. activity Liquid Nitrogen Cryopreservation Integrated System for Biological Resources"—were
control low-temperature storage unit. • Successfully launched five models of determined to possess overall technology at the international leading level. This marks a major
• Completed the overseas market laboratory-scale freeze-dryers. breakthrough in independent innovation by China in the field of key process equipment for
expansion for seven models of Hengyun cell and gene therapy (CGT). Furthermore, our medical ultra-low temperature storage cabinet
pharmaceutical storage cabinets. was selected for the fourth batch of the "Good Products of Shandong" list, serving as strong
evidence of our technological strength and innovative development results.
Incubator Product Platform Centrifuge Product Platform
• Launched three models of stacked orbital • Developed three new types of centrifuges:
shakers. high-speed benchtop, low-speed
• Launched one water-jacketed CO2 benchtop, and low-speed floor-standing
incubator. models.
• Launched five types of environmental
testing chambers, including light
incubators and biochemical incubators, to
further enrich the product matrix.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Deepen the innovation layout of "AI+" Fully Automated Cell Culture Workstation CASE
Haier Biomedical has deeply integrated artificial intelligence technology into product
During the reporting period, we launched an
development and launched a series of "AI+" solutions to address the core pain points of safety
automated cell culture workstation. This system
and efficiency in medical scenarios.
integrates technologies such as automated
control, environmental monitoring, and aseptic
Develop an "AI+" Safety Cabinet CASE
operation to achieve fully closed-loop automation
for the entire process, ranging from cell thawing
Addressing the pain points of manual reliance and and expansion culture to collection and storage.
high error rates in medication verification at the While ensuring efficient, high-throughput, and
Intravenous Admixture Services (PIVAS) center, we standardized production of cells, it has enhanced Fully Automated Cell Culture Workstation
integrated AI technology into biosafety cabinets to data traceability and effectively reduced labor
develop an "AI+" safety cabinet featuring intelligent costs and user safety risks.
verification capabilities. This product is trained on over
bottles. It can automatically identify drug information Our innovations in the "AI+" healthcare sector have also been recognized by authoritative
with an accuracy rate of 99%. It effectively identifies awards. The project "Development of Key Technologies for Fully Automated Cell Preparation
abnormal situations such as dispensing the wrong and Industrialization of Equipment" was awarded the Second Prize in the 2025 Qingdao
medication or returning drugs, significantly reducing Science and Technology Progress Award. The project "Development of Key Technologies for
human errors and enhancing medication safety. "AI+" Safety Cabinet Intensive Biological Automation Cultivation Equipment and Industrialization" was selected for
the First Prize in the Shandong Province Science and Technology Progress Award, significantly
promoting high-quality development of China's biopharmaceutical industry chain.
Key Achievements
+
Fine-grained data Edge Deployment Common Medicine Accuracy
annotation Bottle Cover
Launch of the Cytotoxic Drug Compounding Robot CASE
During the reporting period, we launched an automated compounding robot equipped
with a 3D-AI visual recognition system. This system automatically completes processes
such as dissolving, aspirating, and administering chemotherapy drugs in a closed, sterile
environment. It safeguards medical staff from exposure risks associated with hazardous
drugs while ensuring the precision and safety of medication preparation.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
to strengthen employees’ awareness of intellectual property
protection. During the reporting period, Haier Biomedical
Haier Biomedical attaches great importance to the protection
conducted an online special training session on "Patent Search
of intellectual property rights. The Company strictly complies
and AI-Assisted Invention Creation," covering more than 170
with laws and regulations such as the Patent Law of the
personnel in R&D, planning, and project management roles. The
People’s Republic of China and conducts intellectual property
training focused on patent search methodologies, the application
declarations, searches, and maintenance in accordance with
of AI-assisted tools, and technical intelligence analysis, enhancing
internal Intellectual Property Regulations . During the reporting
the team’s capabilities in drafting invention disclosure documents
period, we have obtained certification for the intellectual
and conducting novelty assessments.
property compliance management system in accordance with
GB/T 29490-2023, further strengthening the standardization
and effectiveness of our intellectual property management. As of the end of the
reporting period Among them:
In 2025, Haier Biomedical refined the patent review and Patent Search and
incentive mechanisms at the source to drive the generation Intelligence Analysis
Intellectual Property Training
of high-value patents. Simultaneously, it established a patent
Compliance Management
risk monitoring system to prevent infringement risks, thereby System Certificate The total number of The number of invention patents newly
strengthening its capabilities in the creation, protection, and patents granted granted in 2025
utilization of intellectual property.
The number of Haier Biomedical’s patents and software copyrights
Intellectual Property Management Initiatives
Optimize Patent Quality and Incentives Establish a patent intelligence analysis
and monitoring system The total number of The total number of The total number The total number of
invention patents utility model patents of design patents software copyrights
granted granted granted granted
• Establish Patent Review Board (PRB), • Establish a patent monitoring
which is responsible for the identification technology library to enable real-time
and extraction of high-value patents reporting and contingency disposal of
risk patents
• Implement the patent incentive policy to
award patent bonuses to inventors who • Conduct patent intelligence analysis
meet the eligibility criteria and organize and summarization on a quarterly
patent award reviews at the group level to basis
encourage high-quality inventions
• In response to the specific
• Provide patent search and AI tool training requirements of the chain group,
to all R&D, planning, and project personnel analysis results are promptly processed
to enhance innovation efficiency and feedback is provided
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Shared Success:
Ensuring Steady
Development
Haier Biomedical embeds compliant governance, responsible operations,
and collaborative development across its entire value chain. Guided by
strong corporate governance, supported by a sustainable supply chain,
underpinned by rigorous quality and safety systems, and extended
through customer service, we are building an integrated responsibility
ecosystem spanning management, production, and service. This
approach provides a solid foundation for the Company’s long-term,
sustainable growth and shared value creation for all stakeholders.
Performance Highlights in this Section
Percentage of Anti-corruption Supplier integrity Quality
female directors education sessions agreement training
senior managers
signing rate sessions
in this Section
Percentage of Integrity and self- Achieved annual Customer On-time customer
female senior discipline awareness target of satisfaction rate service response rate
executives training coverage
of employees reduction in
defect rate
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical firmly believes that excellent corporate governance is the cornerstone of Board of Directors
sustainable development. We have established a governance structure with clearly defined
roles and responsibilities, uphold the principle of integrity-driven and compliance-first
operations, and continuously enhance our governance effectiveness and risk resilience to
Strategy and ESG Audit Nomination Remuneration and
safeguard long-term and sustainable development.
Committee Committee Committee Appraisal Committee
Haier Biomedical has always valued the independence of the Board of Directors. During
Haier Biomedical has established a corporate governance system with a clear structure and the reporting period, we updated the Working System for Independent Directors to provide
well-defined roles and responsibilities, laying a solid foundation for the Company's scientific institutional support for the performance of their duties. As of the end of the reporting
decision-making and long-term development. We continuously optimize Board independence period, the Company had three independent directors on the Board, accounting for 33.3%
and diversity, improve information disclosure and investor relations management, enhance of the Board. The independent directors, in compliance with relevant regulations, attended
governance effectiveness, and ensure the Company's compliant and stable operations. Board meetings, shareholders' meetings, special committee meetings, and independent
director meetings. They fully utilized their professional knowledge to put forward reasonable
Board Operations suggestions and opinions, thus promoting the efficient operation and scientific decision-
making of the Board.
Haier Biomedical strictly abides by the Company Law of the People's Republic of China ,
the Securities Law of the People's Republic of China , the Code of Corporate Governance for During the reporting period, Haier Biomedical actively organized specialized governance
Listed Companies , the STAR Market Listing Rules of the Shanghai Stock Exchange and any training for its directors, senior management, and personnel in key positions across various
other relevant laws and regulations. We continuously improve our corporate governance departments. The training covered topics such as independent director workshops, market
structure, enhance Board diversity, and ensure the Company's compliant operations and value management, and ESG compliance, continuously enhancing their ability to fulfill their
value creation. duties in compliance with listed company governance requirements.
Haier Biomedical has established a governance structure consisting of the Shareholders' During the reporting period, Haier Biomedical held 2 Shareholders' meetings, 6 Board
Meeting, the Board of Directors, its specialized committees and management. All members meetings, 3 independent director special meetings, 8 special committee meetings, and 1
employee representative meeting. These meetings covered matters such as regular reports,
of the Board of Directors are elected by the Shareholders' Meeting. The Board of Directors
profit distribution, related-party transactions, the abolition of the Board of Supervisors, the
oversees the Company's affairs and makes operational decisions on behalf of the Company,
election of an employee representative director, equity incentives, and the revision of the
and has the right to appoint and remove the Company's senior management and make major
Company's Articles of Association and other systems.
decisions regarding the Company’s day-to-day operations.
Haier Biomedical always values Board diversity as a key factor in achieving the Company's
During the reporting period, in accordance with relevant regulatory requirements, Haier
sustainable development. When selecting Board members, we take into account multiple
Biomedical abolished the Board of Supervisors and transferred its duties to the Audit Committee, dimensions, including gender, age, cultural and educational background, professional
which assumed the responsibility for supervising the conduct of the Company's directors qualifications, as well as industry and work experience, to ensure the fairness and objectivity of
and senior management. In addition, the Company elected Mr. Liu Zhanjie as the employee the Board's decision-making and create long-term value for the Company and its stakeholders.
representative director on the third session of the Board of Directors, further optimizing the As of the end of the reporting period, the Company had three female directors on the Board,
Board's composition and enhancing the Company's level of standardized governance. accounting for 33.3% of the Board.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
List of Board Members and Diverse Backgrounds Investor Communication
Position Name Gender Educational Background Haier Biomedical strictly abides by the regulatory requirements of the Administrative
Measures for Information Disclosure by Listed Companies and the Working Guidelines for
Chairman Tan Lixia Female Doctor of Advanced Professional Studies in Applied the Relationship between Listed Companies and Investors , and has formulated the Haier
Finance Biomedical Investor Relations Management System . The Company continuously improves
the quality and transparency of its information disclosure, strengthens communication with
Director Zhou Yunjie Male Ph.D. in Business Administration
investors, and promotes investors' understanding and recognition of the Company.
Director Liu Zhanjie Male Ph.D. in Refrigeration and Cryogenic Engineering We ensure timely and transparent information disclosure through multiple channels, such
Master of Business Administration as holding performance briefings and Investor Day events, the SSE e-Interaction platform,
investor hotlines, and dedicated investor relations columns, continuously enhancing investor
Director Gong Wenwen Female Bachelor of Management and Economics trust. During the reporting period, we published 27 investor relations records, responded to
Director Chen Jie Female Master of Business Administration
events, engaged with nearly 100 investor visits, published 27 investor relations articles on our
Bachelor of Applied Chemistry with a Specialization official WeChat public account, and fielded hundreds of calls on our investor hotline.
in Ceramics
The Company places great emphasis on delivering returns to its shareholders and diligently
Director Hu Xiangde Male Bachelor of Economics protects their legitimate rights and interests. Since its listing, we have implemented a
dividend policy for six consecutive years, with cumulative dividends amounting to RMB 788
Independent Huang Sheng Male PhD in Economics, Washington University (St. Louis)
million. In 2025, the Company launched its third share buyback plan, with a total repurchase
Director
Master of Economics, University of Cambridge value of RMB 100 million.
Double Bachelor in History and Economics, Peking
University
Independent Niu Jun Male Doctor of Medicine, Shandong University
Director
Doctor of Medicine, University of Newcastle
Independent Xu Ming Male Postdoctoral Fellow in Strategic Management,
Director Guanghua School of Management, Peking
University
PhD in Industrial Economics, Fudan University
Proportion of Female Directors and Senior Management
Total Female Percentage(%)
Board of Directors 9 3 33.3
Senior Management 3 2 66.67
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
applied digital intelligence technologies and newly
Haier Biomedical strictly abides by relevant laws and regulations, and has developed internal risk management policies such established the AI Sentinel risk prevention system, which
as the Comprehensive Risk Management System Operating Standards and the Major Operational Risk Incident Reporting and now covers 86 key risk indicators across 7 core business
Handling Standards . These policies standardize risk management processes, strengthen risk control capabilities, and safeguard scenarios. The system sets dynamic thresholds based on
the Company's stable operations. historical data and industry benchmarks, and automatically
identifies anomalies through AI models, triggering a three-
We have established a risk management framework with clearly defined roles and responsibilities, as well as collaborative level (red, yellow, orange) early warning mechanism. This
coordination. The Board of Directors, Audit Committee, management, internal control team, and external audit institutions each enables early detection and intervention of risks, effectively
perform their respective functions within the risk prevention and control system, ensuring timely and effective risk prevention enhancing the accuracy of risk identification and the
and response. efficiency of risk control.
Haier Biomedical has established the Wanlian three-tier risk management system and the three-level internal control During the reporting period, we conducted a total of 7
management system, clearly defining three risk categories: field, operation, and execution. Corresponding internal control special and routine audits, and worked collaboratively with
management strategies have been formulated for managers at different levels (field, industry platform, and chain group), relevant business units to address issues such as process
ensuring that the internal control management system covers the smallest business units, all business types, and all operating gaps identified during these audits. At the same time, we
regions. During the reporting period, the Company carried out a comprehensive risk assessment project with reference to the continuously strengthened the verification and follow-up
COSO Enterprise Risk Management Framework and the Wanlian field three-tier risk management framework, identified over 27 of remediation measures to ensure the adaptability and
risk points, and defined prevention and control entities and strategies for each type of identified risk point. effectiveness of our risk management measures.
Furthermore, the Company strengthened its Three-Check System (self-inspection, mutual inspection, and specialized
inspection). Based on the PDCA (Plan-Do-Check-Act) and OODA (Observe-Orient-Decide-Act) cycle models, standardized
processes for internal control effectiveness verification were established across all nodes within the chain groups. This created
a comprehensive risk control system featuring self-identification of risks, root cause analysis, deviation closure, and closed-loop
management.
Three Inspection System
Self-inspection Mutual inspection Specialized inspection
By thoroughly understanding Execution gaps at other nodes are Specialized inspections are
business process standards, we promptly detected and addressed conducted to assign responsibility
conduct self-assessments and with corrective measures to prevent and develop resolution plans for
promptly correct issues to ensure escalation. identified issues, ensuring closed-
the quality of work. loop remediation.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
regulates the acceptance of gifts by employees and partners in business dealings, and requires
Haier Biomedical complies with relevant laws, regulations, applicable international business personnel to promptly consult the compliance officer and proactively report relevant
conventions, and customary international practices, and strictly adheres to the core principles situations. At the same time, the Company arranges for internal auditors to conduct in-depth
of anti-corruption, anti-unfair competition, and the prohibition of conflicts of interest, visits to key suppliers and distributors to promote compliance concepts, working together to
maintaining a zero-tolerance attitude toward business ethics violations. The Company foster a fair and just business environment.
continuously improves its internal business ethics management system, keeps whistleblowing
channels open, and deepens the development of an integrity culture, ensuring the Company's
During the reporting period, Haier Biomedical
honest and compliant operations, and effectively safeguarding the legitimate rights and
interests of its partners, users, and patients. Held dozens of warning
Held Conducted case training sessions for all
Anti-corruption Management anti-corruption education anti-corruption employees, achieving
sessions for middle and senior training session for
Haier Biomedical strictly abides by the Company Law of the People's Republic of China , the management, covering all after-sales personnel, % coverage
Interim Provisions on Banning Commercial Bribery and other relevant laws and regulations, management personnel and covering all regional
and has developed and improved internal management policies such as the Haier employees in key positions after-sales managers
Biomedical Code of Conduct for Employees and the Haier Group Code of Business Conduct,
which explicitly prohibit violations such as corruption, bribery, and the solicitation or
acceptance of bribes. In 2025, the Company's management signed the 2025 Platform Owner Reporting Mechanism
Integral Value between Staff and Customers ("Rendanheyi") Responsibility Agreement ,
directly linking compliance indicators to management performance assessments, thereby Haier Biomedical encourages employees, suppliers, customers, and all internal and external
stakeholders to actively report any violations of business ethics. The Company has established
ensuring the effectiveness of the Company's anti-corruption management system.
a whistleblowing website and compliance hotline independently operated by a third-party
Haier Biomedical has established and continuously improved its internal control and service provider, and has designated dedicated personnel to manage the whistleblower phone
line and email, ensuring that all reporting channels remain open and function effectively. In
compliance platform. The Internal Control and Compliance Department coordinates the
addition, in accordance with the Haier Group Whistleblowing Reward Policy, the Company
platform's management, with various departments and subsidiaries collaborating to ensure
provides rewards for reported leads that are verified and substantiated, thereby incentivizing
the efficient operation of the compliance system. In addition, the Company regularly conducts
employees to report misconduct and protect the Company's legitimate rights and interests.
anti-corruption inspections of all employees and partners. Any violations such as corruption
or bribery, once identified, are promptly reported and addressed. The Company places great
emphasis on this matter and has strengthened its integrity and anti-corruption culture Haier Biomedical Business Ethics Whistleblowing Channels
through various means, including open letters to all employees, warning case studies, and Report phone: 137-3095-3132
face-to-face communication, thereby enhancing employees' awareness and capability in
Compliance hotline: haierchina.ethicspoint.com
business ethics compliance.
Report email: haierbiomedical@haierbiomedical.com
jkjubao@haier.com
Employee Integrity Promotion jubao@haier.com
Haier Biomedical actively promotes the development of an integrity culture and regularly Internal platform: iHaier reporting channel for fraud reporting
conducts various business ethics and anti-corruption training and awareness campaigns for all
employees, fostering a clean and transparent business environment. In addition, we require all Haier Biomedical strictly fulfills its obligations relating to whistleblower protection and is
employees to sign the Letter of the Commitment to Integrity and Self-discipline, reinforcing committed to maintaining the confidentiality of whistleblowers' information and the content
their awareness of compliance and legality, and strengthening the defense line for ethical of their reports. The Company takes strict action against any acts of retaliation against
conduct at work. whistleblowers, thereby effectively safeguarding their legitimate rights and interests.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Interest
Haier Biomedical strictly abides by the Anti-Unfair Competition Law of the People's Republic
of China and other relevant laws and regulations, prohibiting any unfair competition Implement network Safeguard user Ensure information
practices such as market confusion, misleading consumers, and bribery, thereby maintaining security management information security
a fair order of market competition. We have clearly stipulated in the Code of Conduct for
• Optimize network • Improve information
Employees that all employees are required to uphold the principles of integrity and fairness • Establish a robust
construction security management
toward competitors, customers, and suppliers in their business activities, provide accurate user information
• Optimize network security protection • Enhance risk
product information, and avoid any actions that undermine fair competition or infringe upon
devices mechanism mitigation
consumer rights and interests.
• Minimize network threats
Haier Biomedical regulates behaviors to prevent conflicts of interest in the Code of Conduct
for Employees , making every effort to avoid situations where personal interests may conflict
with the interests of the Company. The Company requires all employees to complete a Haier Biomedical has fully deployed the HUES endpoint security software, which enables
Conflict of Interest Disclosure Form annually, reporting actual or potential conflicts of interest autonomous management of endpoint security policies and provides comprehensive
and implementing conflict avoidance procedures, thereby ensuring fairness and justice in the protection for the Company's information security. We regularly conduct specialized
Company's operations. information security audits to identify and remediate potential security vulnerabilities, drive
the analysis and rectification of security issues, and continuously strengthen the development
security protection capabilities.
Haier Biomedical attaches great importance to the information security and privacy
protection of both internal and external stakeholders. Strictly adhering to the Cybersecurity Haier Biomedical has obtained ISO 27001 certification for its information security management
Law of the People's Republic of China , the Personal Information Protection Law of the People's system. The Company's SAP system has successfully achieved Level 3 certification under the
Republic of China , and other relevant laws and regulations, the Company continuously Classified Protection of Information System Security . During the reporting period, the Company
experienced no major information security incidents.
improves internal policies such as the Code of Conduct for Biomedical Information Security to
comprehensively safeguard the information and privacy security of all relevant parties.
User Privacy Protection
Information Security Management Haier Biomedical has developed and continuously improved the Privacy Policy , which clearly sets
out requirements for the collection, storage, use, management, and deletion of users' personal
Haier Biomedical continuously improves its information security management policies and
information, ensuring the security and compliance of data throughout all processing stages
procedures, optimizes its data security protection system, and strengthens the development
and building a strong defense line for customer privacy data security. We distribute to middle
of an information security culture, ensuring systematic and standardized information security
and senior management information on new regulations and case studies related to personal
management. We have integrated information security and customer privacy protection into
information protection in the pharmaceutical and healthcare industries, thereby enhancing
our corporate compliance governance system, and established a control mechanism covering employees' awareness of data compliance and their ability to protect information security. During
the entire data lifecycle. the reporting period, Haier Biomedical experienced no user privacy leakage incidents.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Technology Ethics 2.1.6 Responsible Marketing
Haier Biomedical has developed the Medical Technology Haier Biomedical adheres to the principles of compliant and
Ethics and Governance Policy . In R&D activities such as responsible marketing. The Company strictly complies with
scientific research, technology development, and application, the Law of the People's Republic of China on the Protection
we adhere to technology ethics guidelines and codes of of Consumer Rights and Interests , the Provisions on the
conduct, respect personal privacy, ensure data security, and Administration of Instructions and Labels of Medical Devices
ensure that technological activities comply with ethical and (Decree No.6 of the China Food and Drug Administration) ,
moral requirements. and other relevant laws and regulations. We have formulated
and released the Responsible Marketing Policy , which
Haier Biomedical embeds technology ethics requirements clarifies responsibilities and sets behavioral standards for
into product design and management processes, adhering honest advertising, advertising compliance, and brand
to privacy and data protection principles in scenarios communication, thereby effectively safeguarding user
involving sensitive patient and pathological data. To this end, rights and interests. Through these efforts, we aim to build
we have implemented sensitive data protection through a trustworthy brand image and contribute to fostering a
a dual-track approach of technical structure and process healthy and orderly market ecosystem.
control. For example, for smart devices such as AI security
cabinets, the Company adopts edge computing technology In 2025, the Company further refined its marketing
to identify non-compliant actions on local device chips, compliance management requirements and developed and
uploading only alarm signals and desensitized structured released the Core Compliance Guidelines for Medical Device
data to the hospital's internal system, ensuring that sensitive Advertising Marketing , providing clear compliance guidance
data such as patient medication preparation processes and for relevant teams such as marketing, sales, and training.
prescription information are processed locally. In biobank To ensure the implementation of the policy, the Company
management, we apply automatic masking to sensitive organized specialized training for over 30 employees in
fields such as patient names and ID numbers, rigorously relevant positions, systematically covering topics such as
protecting the privacy security of sample-related information compliance requirements for medical device advertising,
such as donor genetic information and pathological data, key points for marketing content review, and analysis of risk
and preventing data leakage risks. cases, effectively enhancing the compliance awareness and
responsible marketing risk prevention capabilities of the
In addition, we regularly conduct training on data security participants.
and AI compliance, integrating values such as respecting
privacy and ensuring data security into employees' daily In addition, Haier Biomedical actively promotes the global
work, continuously deepening responsible data application management of responsible marketing. In the course of
awareness. its international business operations, the Company strictly
complies with international laws and regulations such as the
EU General Data Protection Regulation (GDPR) and the U.S.
Data Privacy Frameworks to ensure that marketing activities
in all operating regions are conducted in a compliant
and orderly manner, thereby effectively safeguarding the
legitimate rights and interests of global users.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical regards supply chain management as a key Proactively expand into
enabler for achieving sustainable value chain development. new industries
Adopting a lifecycle approach, we have established a supply Understand market demand
chain management system covering supplier admission, Supplier management
evaluation, collaboration and optimization, and have Supplier access
and improvement
embedded ESG principles and management requirements
Quantify supplier perfor-
into procurement decisions and supplier collaboration Improve the supplier
mance by using the supplier
processes. By continuously enhancing supply chain risk management system
management mechanism
management mechanisms and advancing responsible
procurement practices, we are committed to working with
our partners to build a more resilient supply chain ecosystem.
Supplier Full-Cycle
Supplier review and evaluation Management Process Supplier pricing
Implement dynamic Establish a pricing model
Haier Biomedical continuously refines its supplier management partitioning by following the Promote pricing
system by formulating the Supply Chain Evaluation Strategy Supplier Evaluation Strategy standardization
and establishing a full lifecycle management process ranging
from admission to exit. These measures aim to enhance the
supply chain's risk resistance capability and ensure stable and Identifying new
reliable operation of the supply chain. Supplier delivery fulfillment
supplier products
During the supplier onboarding phase, we organize joint Gradually build trust Improve the identification
assessments by multiple departments including procurement, with suppliers system for new parts
quality, and R&D to strictly review supplier qualifications and
ensure compliant onboarding. In the course of cooperation,
the Company continuously optimizes its supplier evaluation Haier Biomedical has established and continuously optimized the Procurement Platform "Specialized, Refined, Differentiated
mechanism, conducting comprehensive assessments of all and Innovative" Model to enhance the digital management level of the supply chain. During the reporting period, the Company
suppliers across multiple dimensions such as cost, delivery, established a supply chain database covering data such as processes, labor hours, and raw material prices, enabling cost
technology, and quality. Based on the assessment results, transparency analysis and providing data support for procurement decisions.
we have established a scientific supplier classification and
tiered control mechanism, dividing suppliers into three Procurement Platform "Specialized, Refined, Differentiated and Innovative" Model
categories: strategic, important, and general. We prioritize
in-depth cooperation with strategic suppliers, signing long-
term strategic cooperation agreements and advancing
Specialized industry suppliers Supplier access authorization
collaborative development plans to achieve mutual growth Specialized Refined
and shared success.
Innovative procurement Innovative Differentiated Differentiated and tailored
models and processes procurement solutions
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical Established a Supplier Intelligent CASE 2.2.2 Responsible Supply Chain
Verification Mechanism.
Haier Biomedical integrates responsible procurement into its full lifecycle procurement
In 2025, Haier Biomedical launched a new supplier blacklist intelligent verification practices. We have established and require all suppliers to sign the Supplier Code of Conduct ,
mechanism, which links the procurement system in real-time with Haier Group's supplier which specifies requirements for suppliers in areas such as quality control, integrity and
blacklist database. During the supplier entry phase, the intelligent system automatically green procurement, human rights protection, and conflict minerals management, thereby
triggers the verification process to screen partner information in real-time. If a blacklist promoting the shared implementation of green development principles among upstream
match is detected, it immediately terminates the entry process and issues an alert, and downstream enterprises in the supply chain. During the reporting period, 100% of Haier
thereby preventing cooperation with suppliers that have serious compliance issues such Biomedical's suppliers signed the Supplier Code of Conduct .
as fraud or corruption from the source, and effectively enhancing the compliance level of
the supply chain. Ensuring Procurement Quality
Haier Biomedical places great emphasis on the product quality of its suppliers and continuously
Haier Biomedical is committed to enhancing the stability and continuity of its supply chain, improves its supplier quality assessment mechanism. The Company signs quality agreements
providing solid support for the Company's business operations and long-term development. with all suppliers, clarifying quality requirements and responsibilities. We have integrated
We continue to promote the localization of key materials to reduce procurement costs, supplier management into Haier Group's quality management system and product launch
shorten delivery cycles, and improve product quality. At the same time, we have established a quality assurance management system, achieving full lifecycle quality control from supplier
risk control mechanism for imported materials, comprehensively assessing existing inventory, onboarding to phase-out, thereby ensuring the stability and reliability of product quality.
in-transit orders, and safety stock requirements. Based on this assessment, we scientifically
formulate reserve plans and place orders in a timely manner to mitigate the risk of material Full Lifecycle Quality Control Mechanism
supply disruptions and ensure business continuity.
• ISO 9001 and other quality system certifications, as well as assessments
Supplier of on-site quality control, technology, and delivery capabilities, are set
Haier Biomedical Promotes Localization of Imported Materials CASE onboarding as mandatory entry barriers to ensure supply quality from the source.
During the reporting period, in response to the "bottleneck" issues faced by imported • Through co-creation with suppliers, component testing, complete
New product
machine testing, and small-batch validation, we implement multiple
materials from the United States such as T-type thermocouples and oil separators, Haier introduction
with supplier layers of quality control to achieve the goal of zero defects for new
Biomedical introduced specialized suppliers and collaborated with its R&D department
products upon launch.
to jointly advance the development of localized substitute products. After multiple rounds
of component and complete machine testing, the Company successfully achieved the • All suppliers are required to sign quality agreements, and key
localization substitution of these materials, resulting in a 50% reduction in component quality requirements and inspection standards are clearly defined in
costs and a 70% shortening of delivery cycles, saving RMB 1 million in procurement costs procurement contracts and quality agreements.
for the year. The Company plans to replicate and promote this model to other imported Supplier • Quantitative quality management indicators such as batch pass
materials, continuously enhancing supply chain resilience and product competitiveness. Assessment rate and market defect rate are established, and monthly supplier
assessments are conducted.
• Annual supplier audits are carried out, and process stability
During the reporting period, Haier Biomedical introduced 45 new suppliers and eliminated 23 monitoring is confirmed.
suppliers. As of the end of the reporting period, Haier Biomedical had a total of 620 suppliers,
of which 612 were domestic suppliers and 8 were suppliers from other countries or regions. • Suppliers are classified and managed in tiers based on assessment
In 2025, Haier Biomedical successfully achieved its supply chain management targets, with results. Suppliers with unsatisfactory assessment results receive quality
Supplier
guidance and are required to make corrective improvements within
the on-time delivery rate of 100% and a defect rate not exceeding 0.58% for scenario-based phase-out
a specified timeframe. If corrective actions remain unsatisfactory,
projects.
material replacement or supplier phase-out are implemented.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical uses an information system to conduct Advocating for Transparent and Honest
online evaluations and monthly assessments of its suppliers,
Procurement
covering multiple dimensions such as quality performance,
system capability, and continuous improvement. During Haier Biomedical upholds the bottom line of integrity-
the reporting period, the Company assessed a total of driven operations and is committed to building a fair and
the Company further optimized its supplier performance suppliers to sign a supplier integrity agreement, namely the
assessment mechanism by introducing deduction items for Haier Group Special Agreement on Integrity , which explicitly
major quality complaints and positive/negative incentive requires them to abide by business ethics standards and
measures for quality performance, while increasing the strictly prohibits violations such as corruption, fraud, and
weighting of quality-related indicators to 30%. In addition, other misconduct. In addition, we arrange for internal
the Company completed 25 annual audits of key suppliers auditors to conduct in-depth visits to key suppliers to
and low-performing suppliers, conducted 41 senior promote compliance concepts and strengthen awareness of
management interviews with suppliers, and conducted 42 integrity and honesty. As of the end of the reporting period,
unannounced inspections and corrective action follow-up Haier Biomedical’s supplier integrity agreement signing rate
inspections, all aimed at continuously improving the overall reached 100%.
quality performance and compliance level of the supply
chain. All issues identified during audits were closed out Promoting Environmentally Friendly and Green
within one month.
Procurement
Haier Biomedical also actively conducts supplier quality
training through channels such as annual supplier conferences Haier Biomedical actively promotes green procurement
and on-site training. For suppliers with unsatisfactory practices and has clearly defined in its Supplier Evaluation
assessment scores, the Company organizes product-specific Strategy the compliance requirements for supplier
training to help them become familiar with the latest laws, environmental commitments and hazardous substance
regulations, and regulatory requirements related to quality, management. During the supplier entry phase, we require
identify common quality risks, and master corresponding suppliers to provide relevant qualification documents such
response methods. During the reporting period, we provided as ISO 14001, RoHS and REACH compliance certificates, and
on-site quality training for more than 20 suppliers, effectively require them to sign an environmental commitment letter.
enhancing their quality control capabilities. During the reporting period, the Company further refined
its hazardous substance control standards, incorporated
In 2025, Haier Biomedical successfully achieved its quality compliance status into supplier performance assessments,
management target of a material defect rate not exceeding and prohibited non-compliant suppliers from batch
to 2024. source.
During the cooperation with suppliers, we regularly conduct
spot checks on batch products from suppliers to ensure
that their materials comply with environmental regulatory
requirements. In addition, we actively collaborate with
suppliers on the research, development, and upgrading of
environmentally friendly materials, working together to build
a green and low-carbon supply chain.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical Collaborates with Suppliers to Develop CASE Equal Treatment of Small and Medium-sized Enterprises
Eco-friendly Manufacturing Processes
Haier Biomedical places a strong focus on fair cooperation with all partners. We strictly adhere
Haier Biomedical actively implements the concept of a green supply chain, engaging to market order and the spirit of contract, consistently upholding the principles of timely
in technical collaboration and joint R&D with strategic suppliers to continuously drive performance and honest payment in all business dealings. Based on the Company's business
innovation in materials and processes, thereby supporting the eco-friendly upgrading of its nature and supplier structure, we currently primarily cooperate with service providers and
products. In 2025, addressing pain points of the traditional "cold plate + powder coating" manufacturers that possess the appropriate qualifications and scale. In our daily operations,
process such as environmental pressure, high costs, and long delivery cycles, the Company there have been no instances of overdue payments to small and medium-sized enterprises.
collaborated with suppliers to develop an eco-friendly process using PCM (pre-coated We will continue to improve our supplier management system to ensure that all partners
metal) plates. This new process eliminates the on-site powder coating step, reducing achieve win-win development on an equal and transparent basis.
environmental pollution while effectively minimizing the risk of scratches during material
handling. As a result, it has achieved a 10% improvement in delivery efficiency and a 5%
reduction in overall machine costs, significantly enhancing product competitiveness.
Upholding Supplier Human Rights
Haier Biomedical places great importance on human rights protection within its supply chain.
The Company includes clauses prohibiting child labor, forced labor, and discrimination in
its procurement contracts. During on-site supplier audits, we prioritize assessments of labor
systems, occupational health, and workplace safety, encouraging suppliers to provide their
employees with a fair, safe, and healthy working environment.
Haier Biomedical also prioritizes on the health and safety of supplier employees. Each year,
the Company provides occupational health and safety training for supplier personnel working
on its premises and issues necessary personal protective equipment. The training covers safety
management policies, on-site operational procedures, hazard identification and reporting, and
emergency response. All supplier personnel must pass an assessment before commencing
work. During the reporting period, a total of 96 supplier employees participated in the training,
achieving 100% coverage.
Conflict Minerals Management
Haier Biomedical continuously improves its conflict minerals management system and
procedures, promotes the development of supply chain transparency and traceability systems,
and works closely with upstream and downstream partners to ensure the compliance of
mineral sources from the very beginning. During the raw material procurement process, for
suppliers whose products may involve conflict minerals such as tantalum, tin, tungsten, and
gold, the Company conducts on-site audits and regular surveys to encourage them to establish
and implement documented control procedures, thereby eliminating the procurement and
use of conflict minerals.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical regards product quality and safety as its primary responsibility. We have Laboratory Ecosystem Scenario Quality
established a comprehensive product quality management system. Through clear division
of responsibilities, strict process controls, and scientific indicator guidance, we ensure the Responsible for performance, safety Responsible for the full lifecycle quality
effective operation of the system, providing a solid guarantee for the continuous delivery of compliance, reliability, and other management of scenario projects
safe and reliable products. testing and validation prior to product and ecosystem products, covering
launch, and undertaking relevant manufacturer introduction, development
testing for domestic and international review, implementation acceptance,
product registration and certification and market improvement stages;
to support the smooth market entry process and market quality status are
of new products. synchronized through monthly scenario
quality meetings, and quality information
is reported during monthly production-
sales coordination meetings.
Component Quality
Responsible for the full lifecycle quality management of components from R&D, pilot
production, mass production to after-sales service; work coordination and information
synchronization are achieved through weekly summaries and cross-team monthly sharing.
To ensure that quality requirements are consistently implemented throughout the entire
process, we have established a quality integrity system centered on the Haier Biomedical
Quality Red Line. This system clearly defines the Code of Conduct for Quality Integrity and
the regulations regarding penalties for dishonesty. Through cross-departmental collaboration
mechanisms, we continue to promote standardized control across research and development,
management closed-loop and strengthening three-dimensional audits, we continuously
Haier Biomedical has established a quality management structure and supervision consolidate the effectiveness of quality management.
mechanism with clearly defined authorities and responsibilities to ensure the implementation
of its quality strategy. The Board of Directors and senior management of the Company
are responsible for approving the quality policy and objectives, as well as supervising the
establishment of the quality management system, resource allocation, and its daily operations.
Under this framework, Haier Biomedical has formed a cross-functional organization led by the
Quality Manager to coordinate the management of the entire product lifecycle. The quality
management structure comprises three core functional areas that work in synergy to cover
the full product lifecycle:
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
the entire product lifecycle, centered on risk prevention. strategies, we continuously monitor changes in the internal
Haier Biomedical adheres to the quality management philosophy Through quality planning, process control, and continuous and external environments to systematically identify potential
of "customer - first" focusing on critical product issues and user improvement, we integrate customer needs, international risks and development opportunities closely related to product
pain points. The Company has established a three-stage quality compliance standards, and ecosystem collaboration goals quality and safety. This approach supports the implementation
strategic goal: from "zero defects" in products to "Zero Complaints" into every stage of the value chain. This approach promotes and dynamic adjustment of our strategy. During the reporting
from users, ultimately achieving "building the best customer the enhancement of product quality throughout its full cycle, period, we identified the following key risks and opportunities
reputation". providing reliable assurance for the global life health sector. centered on product quality and safety:
Haier Biomedical Quality Strategic Objectives and Haier Biomedical Full-Chain Quality Management Strategy Quality Risks
Preventive System
The primary risks facing Haier Biomedical stem from
regulatory compliance and business transformation.
t
rke Quality Co The continuous updates to domestic and international
Interaction Ma rpo
s planning ra medical device regulations require the Company to
risks le te
sa pl
respond rapidly to regulatory changes across multiple
r- a
te
regions. Failure to respond in a timely manner
nn
Af
ity
in
may impact product market access and increase
g
m
t
en
compliance costs. At the same time, we are expanding
or
R&
vem
nf
Improvement Create the foremost user Design into scenario-based businesses. The existing product
D
co
reputation and become risks
pro
risks quality management model must adapt to new
m
n
Purc
the global leader in life
Syste
business requirements; failure to adjust in a timely
Quality im
Pro
io
ct qualificat
science quality manner may impact delivery quality and efficiency.
hasing
cess efficiency
User The reliability of certain critical components in actual
satisfaction
applications also requires further verification to avoid
impacting project stability and user experience.
du
Delivery Process
ro
risks risks Quality Quality
Quality Opportunities
P
improvement control
Regarding opportunities, supply chain optimization and
innovation in quality management models demonstrate
To effectively implement its strategy, the Company has positive potential. By evaluating and implementing
established annual strategic objectives based on dimensions advanced packaging solutions such as honeycomb
such as user feedback and market data analysis. These objectives Lo ri n
g
gi cardboard boxes, we aim to optimize costs while
sti c tu
guide each business segment in meeting quality requirements cs ufa maintaining product quality. At the same time, business
n
and drive continuous improvement in quality management. Qua Ma transformation has driven the Company to extend
li t y i n s p e c t i o n
quality management activities to earlier stages such as
solution review and process control, providing a new
pathway to enhance the success rate of scenario delivery
Quality strategic objectives for the reporting period First-time correctness Rapid response
and user satisfaction.
To effectively address risks and seize related opportunities, we
User satisfaction for First-pass delivery qualification continuously refine our quality management system and quality
scenario-based projects rate for scenario-based projects
assurance system while advancing digital intelligence and
quality control capabilities to enhance product delivery levels.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Quality Management System
Haier Biomedical has established a quality management system and internal quality standards
centered on the Risk Management Control Procedure and the Design and Development
Management Control Procedure . During the reporting period, we revised 32 quality system
documents to provide a comprehensive policy basis for standardizing quality management.
In process management, we implement a quality management mechanism covering the
entire product lifecycle. Through a three-stage management model of "prevention beforehand,
control during the process, and improvement afterward", we systematically drive quality
enhancement.
Pre-event In-process Post-event
management management management
Quality Management System Certificate
Conduct in-depth research Conduct process Quality improvement
on user scenarios and inspections and track initiatives have expanded from
Quality Assurance System
pain points to advance the implementation of individual chain groups to the
product performance quality improvement entire Company, for example,
Quality assurance capabilities serve as the fundamental support for the excellence and
improvements during the measures. by organizing horizontal sustainable development of Haier Biomedical products. We have established a systematic
development phase, such inspections and improvements assurance system centered on two dimensions: new product launch quality and "zero defect".
as optimizing humidity across materials such as
control and airflow design wiring harnesses and printed At the new product launch stage, we established a quality assurance system for product
for medicine cabinets. products. launches. The Quality Manager and the Quality Interface Lead spearheaded the formation of
a "1+1+N" special task force and implemented a full-process zero-defect assurance plan for
new product launches. This plan controls key items for 31 new products by implementing
quality plans and release procedures, component certification, testing certification, production
Through internal and external audits and certification activities, we continuously verify and line certification, and installation certification to ensure accountability. Quality requirements
consolidate the effectiveness of our quality management system. During the reporting period, are comprehensively integrated into all stages of the product lifecycle, both prior to and
Haier Biomedical underwent and passed more than 40 external audits based on domestic following market launch. Through key milestones including user research, risk assessment and
and international standards. elimination, and user trials, we ensure that the entire process from design to delivery meets
user needs and enhances product competitiveness.
Regarding certification achievements, Haier Biomedical has maintained the validity of core
quality system certifications including ISO 9001, ISO 13485, and the U.S. FDA QSR 820 Haier Biomedical Product Launch Quality Assurance System
throughout the reporting period. Additionally, the Company obtained the world’s first MDR
User research and Risk Manufacturing
certificate in the low-temperature storage field required for access to the EU market, as well as master sample analysis
Model risk elimination
assessment risk elimination
the Korean KGMP certification. In addition, the Company successfully passed the on-site audit
conducted by relevant regulatory authorities in Belarus, further expanding its qualifications for Deliver to users Product release User trial use
Experimental risk Component risk
elimination elimination
global market access.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
To achieve the "zero defect" standard for products, we have established quality assurance Digital Intelligence Construction for Quality
mechanisms across design, manufacturing, and procurement. Leveraging information
technology tools such as product lifecycle management, quality-oriented information Haier Biomedical actively responds to the national strategies of "integration of informatization
platform, and after-sales service systems, we have constructed a comprehensive "zero defect" and industrialization" and "digital transformation", continuously advancing the integration
quality assurance system covering the entire product lifecycle. of quality management and digital technologies. We explore innovative pathways driven by
digitalization to enhance quality and empower operations, establishing a foundation for our
Haier Biomedical’s "zero-defect" Quality Assurance System intelligent management system. At the same time, leveraging specific technology platforms
and tools, we have achieved digital control and efficiency improvements across all key stages
of the full process.
Product lifecycle management system
Design 100% control of quality checkpoints for new
ment right brain syst
Scenario integration products/changes nage em
Ma
and margin design
Quality-oriented information platform
s Target system
ie
guidance via platform
og
quality data to serial numbers
ol
Product
hn
Purchasing
tec
Traction
Us
Manufacturing Supplier online Work scenario Standard compliance
er
rain
implementation enforcement via
Hygienic-style evaluation
rep
After-sales service system via platform Corporate R&D
platform
ft b
factory management planning
uta
Component 100% closed-loop market quality information Implementation Enforcement
Digital-intelligent le
controland review
tion
DNA
Services Purchasing
Best user
experience
Logistics Manufac-
Early turing Sensitivity
Detect
Risk early-warning Process/
intelligence via reputation sensitivity
platform via platform
h
ug
Empowerment
Fu
ro
ll-
y t th
ch
Knowledge accumulation e
ai
n
qu m t
n
ve bili
and empowerment via
al
ity platform o
ne pr ssi
ura im ce
l ous ll ac
nod tinu fu
es Con
Haier Biomedical has established a quality digital-intelligence management process covering
the entire journey from raw material inbound to product outbound. By integrating digital
capabilities into every link of production and quality management, it supports the advancement
of quality management work toward greater intelligence and efficiency.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical’s Quality Management System of Digital Integrated Supply Chain Management Platform CASE
Intelligence
Guided by its ecosystem brand strategy, Haier Biomedical has established a dual-platform
Supply Chain Informatization procurement system covering the globe and advanced the upgrade of supply chain
• The combination of advanced information quality control.
integration (CRM + SRM + Supplier Evaluation
The procurement system is centered on a modular quality visualization cloud platform
System), comprehensive supply chain resources,
and mature Just-In-Time (JIT) management
that integrates supplier production data and user feedback in real time to form a closed
mode constitutes supply chain capabilities with loop for dynamic quality optimization. It establishes a preferred material library driven
core competitive advantages, establishing the by multi-dimensional rules and leverages blockchain technology to enhance traceability
foundation for robust quality control at the source across the entire lifecycle from design to delivery, thereby improving supply reliability.
of materials.
During the reporting period, the platform’s functions were further deepened. We
Quality Digitization have achieved comprehensive online management of supplier inspection reports and
• Through internet-based information technology, we advanced supplier performance monitoring to a system-driven automatic scoring and
systematically display orders, incoming materials, strategy-triggered model, thereby enhancing the efficiency of collaborative supplier
processes, sampling inspections, and shipping management.
status, achieving comprehensive informatization
of data throughout all processes and ensuring
information sharing and efficiency. Digitalization of Quality Management — Quality Management Platform CASE
• The implementation of quality information
and data collection and feedback mechanisms Haier Biomedical has established a digital quality platform based on big data analytics
enables high-efficiency collaboration in quality technology, covering stages such as quality planning, inspection task management,
management. and process monitoring. By comprehensively collecting quality data, providing real-
time feedback, and centralizing processing, this platform enables full-process visibility,
Manufacturing Intelligence
controllability, manageability, and strategic planning for product quality. It offers
• 100% informatization monitoring of operational collaborative support to quality management personnel at all levels, enhancing
parameters is conducted with automated facial management efficiency while mitigating quality risks and ensuring product quality.
recognition at critical procedure points.
• Real-time monitoring and dynamic optimization
through big data analysis (SPC) are implemented. Manufacturing Intelligent — IoT Factory CASE
• Real-time visualization of production indicators
is accessible for real-time access to production, Haier Biomedical’s digital and intelligent IoT-enabled factory leverages automation,
quality, equipment, and logistics information, digitalization, and smart connectivity to achieve precise control across the entire
among others. production process, while enabling real-time monitoring of quality data to effectively
mitigate production risks. At the same time, we advanced the development of intelligent
medical manufacturing facilities, enabling equipment interconnectivity, data integration,
To enhance the intelligent level of quality control and risk
and intelligent control. We are progressively establishing a new production management
prevention capabilities, Haier Biomedical has established and
model that spans the entire product lifecycle.
operated a series of core digital platforms, focusing on key
business areas such as supply chain management, closed-
loop quality management, and intelligent manufacturing.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Enhancement of Quality Control Capabilities Focusing on quality improvement, Haier Biomedical has established a normalized control and closed-loop system covering
four aspects: quality information collection, issue improvement, persistent problem resolution, and system consolidation. This
While improving its policies and processes, Haier Biomedical enables systematic management of various quality issues arising throughout the product lifecycle, helping products achieve
has focused on strengthening key capabilities in quality "zero defect" standards.
control. We have established a traceability and collaborative
improvement mechanism covering the entire product Haier Biomedical Quality Issue Closed-loop System
lifecycle, formulated risk response procedures such as
product recalls, and promoted quality culture initiatives to Information Issue
Collection Improvement
ensure reliable product performance throughout its lifecycle.
• Collecting quality issue information through • Direct on-site analysis and handling of
Leveraging our Quality Management System ( QMS), we
market feedback, data analysis, defective immediate issues at user locations
established a quality information traceability mechanism
product/part analysis, public opinion
covering the entire product lifecycle, achieving information • Organizing TOP issue lists with 100% closed-
monitoring, etc
interconnectivity across order processing, production, loop implementation
and logistics transportation. This mechanism supports • Identifying issues immediately after
• Conducting improvement evaluations
collaborative quality information sharing across multiple information collection to prevent quality
through daily quality improvement meetings,
touchpoints including users, equipment, and production, issues from escalating
weekly and monthly analysis meetings
while enabling forward and backward traceability to
facilitate rapid identification of quality issues and closed-
loop improvements.
System Persistent Problem
During the reporting period, we further clarified traceability Solidification Resolution
requirements for key materials such as circuit boards and • Improving key checkpoint lists to achieve • Identifying persistent quality issues and
compressors, and conducted training and confirmation error prevention in high-risk areas signing accountability agreements with
regarding traceability labeling for the relevant modules. chain groups
• Conducting long-term reliability testing
and analysis • Promoting organization-wide quality
Full Lifecycle Quality Information Traceability System
improvement through monthly quality
star evaluations and quarterly quality
improvement project announcements
Supplier factory test Acceptance test
Under this framework, we implemented multiple improvement initiatives during the reporting period. Based on market
feedback, we established quality objectives at both the Company and chain group levels, cascading quality responsibilities
across all functions. By constructing a digital quality dashboard, we identified key process differences and established
improvement tasks. At the same time, we established a full-process quality operation evaluation rule oriented toward optimal
Production process Contract assessment user experience to systematically promote a quality closed loop. During the reporting period, Haier Biomedical conducted a
Factory inspection Market service diagnosis
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical has established a major incident early warning mechanism globally and defined the product recall Simultaneously, Haier Biomedical places emphasis on
management process in accordance with the Adverse Event Reporting, Recall, and Information Disclosure Control Procedure cultivating quality awareness among employees and
to ensure that recalls can be initiated promptly when necessary, thereby minimizing the impact on users. During the reporting relevant stakeholders. Training is conducted through internal
period, no product recalls occurred due to major quality or safety incidents. seminars, case sharing, practical drills, and lectures by
external experts to enhance employees’ quality awareness
Haier Biomedical’s Product Recall Process and practical capabilities.
During the reporting period, we organized activities such
Issue as the annual meeting for sheet metal suppliers, training
Recall plan Recall Recall report Recall Recall
information on the process management of hazardous substances,
preparation execution submission effectiveness records filing
collection assessment and specialized training on regulations for medical device
operations to strengthen relevant personnel's understanding
of quality requirements and standards. During the year,
we conducted 11 quality training sessions, enhancing the
Haier Biomedical integrates the philosophy of "reverence for life and quality" into daily operations. Through multi-channel communication team's capability to respond to quality risks. In addition,
and diverse activities, the Company continuously fosters a quality culture that encourages participation from all employees. we regularly conduct the Gold Standard Quality Award
selection. Quarterly evaluations are carried out across
Forms of Quality Culture Promotion dimensions such as quality performance improvement,
technological innovation, and user reputation. Incentives,
Setting We regularly organize evaluations such as the "ZBB Talent Chain Celebrity List," "Haier Group Monthly including physical awards and team-building funds, are
Benchmarks Awards," "Wanlian Monthly Customer Stars," and "Monthly Quality Star" and other assessments provided to stimulate the internal drive of all employees to
competitions and announce the results via emails, iHaier and other channels to all employees to pursue excellence in quality.
commend those who have made outstanding contributions.
Official WeChat Our official WeChat accounts, such as Wanlian Maker Home and Haier Biomedical, regularly share our
Account latest products, trends and quality management concepts to relevant parties such as our customers.
Promotion
We-media We showcase outstanding company personnel achievements and excellent cases through we-media
Operation platforms such as "Most Beautiful Haier People" and "Haier Integrated Media" for all employees to learn
from.
Promotional Quality slogans, red lines, warnings and other content are placed at prominent locations in production
Slogans workshops and office buildings to continuously enhance employees’ quality awareness.
Annual Meeting of Sheet Metal Suppliers
Makers’ Speech Themed activities on quality culture building and quality management are held regularly to enrich our
Competition employees’ lives.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical attaches great importance to quality risks at all stages of the product Haier Biomedical is committed to a "user-centric" approach, continuously upgrading service
lifecycle and has established a risk management mechanism covering the entire product processes, improving service quality, and comprehensively advancing the construction of its
lifecycle. In accordance with the ISO 14971 standard, we utilize a risk matrix tool to customer service assurance system. At the same time, we have integrated customer service
systematically identify, assess, and manage quality risks, thereby advancing the transition of management into our product lifecycle management and total quality management systems,
quality management from reactive control to preventive management. consistently enhancing product performance and service quality to promote long-term
mutual benefit and win-win outcomes for both customers and the Company.
During the product design phase, we utilize DFMEA1 to identify potential failure risks,
establish design control measures, and verify their effectiveness, thereby forming a closed-
loop risk prevention mechanism. Simultaneously, we established and continuously maintain a 2.4.1 Governance
biomedical design risk database to provide risk warning support for design activities. Haier Biomedical has established a robust customer service management framework. The
Strategy and ESG Committee and relevant management are responsible for reviewing the
In the after-sales and continuous improvement phase, we have established a dynamic risk
strategic direction of customer service and overseeing the progress of major matters such
management process. We conduct root cause analysis on customer complaints and utilize
as customer complaint handling, satisfaction improvement, and service innovation. At the
the findings to update the design pitfalls database to prevent recurrence of issues. We
same time, the Company has established a rigorous supervision and assessment mechanism,
continuously aggregate failure modes under unidentified application scenarios, expand the
incorporating key service indicators such as customer satisfaction rate and customer timely
scope of risk identification, and build a quality risk defense system that evolves.
service response rate as important dimensions in management performance evaluation.
In addition, the Company has explicitly stipulated that major customer service incidents
mechanism, ensuring closed-loop management and continuous improvement of customer
To effectively measure and continuously improve the effectiveness of quality management,
service processes, thereby safeguarding customers' legitimate rights and interests, enhancing
Haier Biomedical has established clear, quantifiable key performance indicator targets and
customer experience, and mitigating related public opinion risks.
regularly tracks their achievement. During the reporting period, we established annual
targets based on dimensions such as quality loss amount, defect rate for the current year, Haier Biomedical strictly complies with the Law of the People's Republic of China on the
and unboxing defect rate, and advanced the implementation of various quality improvement Protection of Consumer Rights and Interests , and continuously improves its customer service
initiatives guided by these targets. policies to ensure standardized and normalized customer service processes. In 2025, the
Company updated a number of its internal customer service management policies, aiming to
optimize the full-cycle product service experience and enhance customer satisfaction.
Targets Achievement Status
The amount of quality loss decreased by 8% year-over-year Achieved Service Provider Network Added establishment standards and requirements for self-
Establishment Process operated service providers.
The annual defect rate decreased by 10% year-over-year Achieved
Clarified the number of follow-up visits and the timeline
User Satisfaction Follow-up
The defect rate upon unboxing decreased by 8% year-over-year Achieved for issuing follow-up visit reports, strengthening the
Management Regulations
standardization and timeliness of follow-up visit activities.
Special Incident Handling Clarified the handling process for special market incident,
Process improving the ability to respond to emergencies.
DFMEA, which stands for Design Failure Mode and Effects Analysis.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical is guided by the service goal of achieving "zero complaints" and continuously
To enhance the user service experience in Hong Kong, Haier Biomedical established a
optimizes its customer service quality management. In 2025, the Company continued to
localized service network in Hong Kong in 2025, supported by a dedicated service team
deepen the development of its customer service assurance system and enhance service
providing 24/7 response services. Following the completion of this localized service
capabilities and quality across three dimensions: service assurance upgrading, service network, the service response time in Hong Kong was reduced from 24 hours to 4 hours,
efficiency improvement, and digital platform development. and customer satisfaction improved significantly.
Global Full-Scenario Service Ecosystem Development
Heartwarming Service and User Warmth
Haier Biomedical builds differentiated customer service advantages through three pathways:
scenario-based, digital, and global. We transform high-quality services into brand loyalty and Haier Biomedical has established "Heartwarming Service" as the core identity of its brand
long-term commercial value. The Company focuses on the full-scenario needs of customers service culture, building customer relationships that transcend product functionality through
in life science and healthcare and is evolving from single-product after-sales support to an proactive care, value-added services, and emotional connection. In 2025, the Company
integrated service ecosystem. continued to launch themed initiatives such as "Spring Festival Heartwarming" and "Back-
to-School Heartwarming", conveying service strength through brand warmth and enhancing
Global Full-Scenario Service Ecosystem Development customer loyalty. During the reporting period, Haier Biomedical carried out more than 14,000
Heartwarming Service activities, reaching over 550 customers, delivering 1,403 experience
messages, and converting 279 leads.
Warranty For selected product models, the warranty period has been
Upgrades and extended from 3 years to 5 years, and service fees such as "Spring Festival Heartwarming" Special Campaign CASE
Value-added stair carrying and on-site visits have been waived, effectively
Services enhancing user reputation and service experience. During the 2025 Spring Festival holiday, Haier
Biomedical's Heartwarming Service Team actively
carried out the "Spring Festival Heartwarming" special
Building a To meet customers' scenario-based service needs, the campaign, providing users with equipment inspection,
Scenario-Based Company has established a scenario ser vice network maintenance, and usage guidance services to ensure
Service Network across 29 provinces and key regions nationwide. It added stable equipment operation during the holiday period.
service providers, and 22 scenario operation and maintenance across the country, served more than 200 users, and
eliminated over 50 potential equipment hazards, "Spring Festival Heartwarming"
service providers. The service scope covers diverse scenarios
receiving positive feedback from users. Special Campaign
including laboratory pure water supply, cold storage operation
and maintenance, sample transportation, 3Q validation, and
laboratory relocation.
"Back-to-School Heartwarming" Campaign CASE
Global Service The Company has deployed localized service providers in 24 During the 2025 back-to-school season, Haier Biomedical carried out equipment maintenance
Deployment countries across 5 regions including Europe, the Americas, and training services for users such as universities and scientific research institutions, helping
Asia-Pacific, Africa, and the Middle East, improving service to ensure the smooth operation of scientific research and teaching activities. The service
response time and customer experience. team visited user sites, conducted comprehensive inspection and maintenance of laboratory
equipment, and provided operational training, serving over 150 users.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Digital Platform Upgrades Enhancing Customer Service Capability
Haier Biomedical continues to upgrade its digital customer service platform, viewing Haier Biomedical continues to strengthen its customer complaint management. The
digitalization as a core driver for improving service quality. Through continuous iteration of Company has established a comprehensive customer complaint management system,
digital and intelligent tools, the Company has made service processes more transparent and capturing feedback through multiple channels, including telephone, WeChat mini-programs,
efficient, while providing data support for service quality improvement. This has reshaped and offline touchpoints. The process strictly follows the "intake – assignment – follow-up –
the entire service system from customer request response to closed-loop management, closed-loop" procedure, ensuring that complaint handling outcomes meet the Company's
empowering service innovation and resource optimization, and delivering more reliable and service standards and fulfill customer expectations. For each complaint, we conduct an in-
precise value experiences to customers. depth root cause analysis, develop improvement measures, and provide feedback to relevant
departments, forming a continuous improvement closed-loop that steadily raises service
standards and customer satisfaction.
• Upgraded the After-Sales Service System (ASSS) to achieve integrated management
of service data, including service work order classification and statistics, satisfaction In 2025, Haier Biomedical organized multiple training sessions for service-related personnel
trend analysis, and engineer performance management, providing data support for focusing on product technology and service standards, effectively enhancing the professional
continuous service quality improvement. skills of service personnel and ensuring that customers receive exceptional service quality.
• Optimized the WeChat mini-program service portal to enable full-process visualization
of service work orders. Customers can now track service progress and service personnel
information in real time, and provide online evaluations after service completion,
• Online Live Training: A total of 45 online live training sessions were organized, covering
significantly improving service transparency and customer experience.
• Explored the application of AI and digital tools in service appointment, predictive fault 12 product series including centrifuges, automation, sample network, and vaccine
diagnosis, and knowledge base management, further enhancing service efficiency and network.
engineer responsiveness.
• Return-to-Qingdao Centralized Training: Two centralized training sessions were held in
Qingdao, with 72 participants completing the program.
In 2025, Haier Biomedical obtained the ITSS (Information Technology Service Standards)
certification, further demonstrating the Company's professional capabilities in the field of • On-site Training: A total of 21 on-site training sessions were conducted, including
information technology services. At the same time, the Company continues to hold the CTEAS 16 sessions on centrifuges and 5 sessions on automation, covering 17 provinces and
After-Sales Service System Seven-Star (Excellence) certification and the National Product After- regions.
Sales Service Five-Star certification (both within their validity period), reflecting its outstanding
after-sales service performance.
At the same time, Haier Biomedical has implemented an engineer certification system
to encourage service employees to continuously enhance their professional capabilities.
During the reporting period, the Company added 755 newly certified engineers, including
competence of its service team.
Haier Biomedical Obtained ITSS Certification
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical is committed to building a robust and efficient customer service assurance system. The Company has fully
integrated risk management processes related to customer service into its ESG and operational risk management system.
Through diverse channels such as customer feedback and satisfaction surveys, the Company proactively identifies and assesses
potential customer service risks and opportunities at each stage, develops and implements targeted response strategies, and
continuously optimizes customer service experience and risk prevention capabilities.
Major Customer Service-Related Risks and Mitigation Measures
Risk Category Risk Description Mitigation Measures
Service Quality • As the service network expands to 24 countries, the • Established an engineer certification
and Response difficulty of maintaining consistent service quality across system, certifying an additional 755
Efficiency Risk regions increases, creating a risk that response times engineers in 2025.
and service standards in some regions may fall short of
• Conducted on-site training and
expectations.
province-wide training to enhance
• Variations in engineer skill levels may lead to fluctuations service standardization.
in service quality, affecting user satisfaction.
Customer • Biomedical products are used in high-value, highly • Established a closed-loop complaint
Complaint sensitive professional scenarios. Product failures or h a n d l i n g m e c h a n i s m , p r o ce s s i n g
Escalation and service errors may lead to severe customer complaints 119,510 work orders throughout the
Reputation escalation and even reputational damage. year with a customer satisfaction rate of
Risk 99.94%.
• Improper handling of market emergencies (e.g., product
quality issues, extreme weather affecting ser vice • Issued the Special Incident Handling
response) may amplify negative impacts. Process to improve the standardization
of emergency response.
Global Service • Providing localized services in countries with different • Continuously monitor data protection
Compliance legal and regulatory systems presents compliance regulator y developments in target
Risk challenges. Cross-border data transfer is subject to markets.
various national data protection regulations (e.g., EU
• Promote the standardization of service
GDPR).
providers and strictly review access
• Different regions have varying certification requirements qualifications in accordance with the
for medical device service qualifications, which may Service Provider Network Establishment
affect service provider access and compliant operations. Process.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical has established a comprehensive customer
service metric and target system. By setting quantifiable and
traceable KPIs, the Company drives systematic service quality
improvement and transparent management, continuously
optimizing the customer service experience. Looking ahead,
the Company will continue to enhance customer service
performance in key areas such as service response time,
building a high-end service talent pipeline, and advancing
digital service upgrades, aiming to make the leap from
"high-level service" to "excellent service."
Annual Core Metric and Target System of Customer Service
Metric 2025 Performance Future Target
After-sales service work order handled 119,510 work orders Maintain steady annual growth
Customer satisfaction rate 99.94% Maintain ≥99.9%
Service timely response rate 99.32% Maintain ≥99%
Service Call Over 260,000 calls Increase service access year by year
Number of users served 29,000+ users Expand user coverage
Heartwarming Service activities 14,000+ activities Continue to expand proactive care service scale
Global localized service coverage 5 regions, 24 countries Continue to expand global coverage
Domestic service network coverage 29 provinces and regions Gradually expand to nationwide coverage
Service response time 4 hours (global) Continue optimizing response times and explore a 2-hour target
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Leading People-Centered
Shared Prosperity
Haier Biomedical regards employees as the core driving force for organizational
development and integrates human health and well-being into its mission and
practice. We construct a unique talent cultivation system to help employees
continuously grow on their career paths and promote their sharing of
development opportunities and co-creation of life value with the Company.
Meanwhile, relying on our own business expertise and resources, we actively
participate in social public health undertakings, dedicating ourselves to
contributing professional strength to improving the health level of all people.
Performance Highlights in this Section
Obtained ISO 45001 Average training hours Number of working
occupational health and per employee days lost due to work-
safety management
system certification
SDGs-related responses in this Section
Total number of Employee training Total public welfare
employees percentage donation amount reached
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical adheres to the core concept of "user-centricity" and continuously deepens
its talent management and development strategies, motivating employees to improve their Establish a business-oriented dynamic forecasting and calibration system; conduct
professional skills and realize their self-worth. We strive to build a high-quality "RenDanHeYi" monthly talent demand seminars, semi-annual competency reviews, and annual
(Individual-Goal Alignment) talent development pattern, optimize the implementation of talent planning; output strategic talent demand forecasts.
management and professional talent development systems, and are committed to providing
an equal, inclusive, healthy, and happy workplace for every employee. We continuously
strengthen talent attraction and retention, conveying warmth and care to employees through Strategic Talent Pipeline
practical actions.
Construct a classified and graded talent reservoir system; focus on three categories
localized talents—to achieve precision strategic talent pipeline development.
Haier Biomedical continuously improves its talent attraction mechanism. We adhere to the
talent philosophy of "identifying the right talent, nurturing talent, and developing talent".
By decoding the traits of high-value talents, we dynamically optimize recruitment profiles
Efficient Allocation through Operational Management
to ensure that talent introduction precisely matches business strategic needs. We insist on
"professional people doing professional things". By upgrading and implementing the talent
development systems for various professional lines, we standardize the entry and allocation Implement refined operational management of the strategic talent reservoir to
of talent resources at the institutional level. During the reporting period, we optimized our ensure efficient demand-based matching; organize monthly tracking and exchange
talent structure and continued to introduce technological innovation talents, highly educated sessions and corporate news sharing to maintain talent engagement.
talents, and industry experts. A total of 22 core talents for key positions were introduced,
providing talent support for technical breakthroughs and market expansion.
To improve talent allocation efficiency, Haier Biomedical has established a forward-looking
talent pipeline. By establishing a classified and graded talent reserve system, we provide talent
support for continuous business expansion. We actively respond to the globalization strategy
and implement localized recruitment for overseas talents, attracting outstanding talent with
international professional backgrounds to support the steady expansion of our global business.
While strengthening external talent recruitment, we are also gradually optimizing internal
"order-taking" and movement management rules, supporting internal employee mobility
and promoting the rational allocation and efficient utilization of talent resources. During the
reporting period, the total number of new employees at Haier Biomedical reached 495. The
proportion of vacant positions filled by internal employees reached 33.64%, achieving the
circulation and activation of the internal talent ecosystem.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical strictly complies with various labor laws and regulations applicable in the locations of operation, continuously standardizing employee management to ensure that the
legitimate rights and interests of employees are fully protected. We uphold a people-oriented management philosophy and are committed to creating an equal, open, diverse, and inclusive work
environment.
Compliant Employment
We strictly follow laws and regulations such as the Labor Law of the People's Republic of China, the Labor Contract Law of the People's Republic of China . In combination with the Company’s
own development needs, we recruit the talent required for business development through diverse public recruitment channels. We formulate and implement the Haier Biomedical Recruitment
and Employment Policy , standardizing various procedures for new employee recruitment and employment while clarifying recruitment and employment standards to ensure that all links of
recruitment work are fair, just, and open.
We have constructed a strict compliance management system to eliminate violations of the International Labor Organization (ILO) conventions, such as child labor and forced labor. To ensure
employment compliance, we implement identity verification procedures for new hires in the onboarding management system to verify candidates' identity and age information, thereby
preventing child labor at the recruitment stage. Meanwhile, we establish transparent recruitment processes and employment systems, explicitly prohibiting any form of forced labor. For potential
non-compliant employment risks, we have formulated identification and correction procedures and will immediately launch response plans upon discovering any abnormal situations. For special
cases that may involve child labor, we have also implemented specialized rights protection measures to ensure that the physical and mental health of minors receives the necessary protection.
We promote an efficient office mechanism. By optimizing processes and improving work efficiency, we guide employees to scientifically plan their working hours and reduce unnecessary overtime
to safeguard employees' rights to rest and leave, thereby enhancing their workplace well-being. Meanwhile, we implement a normalized monitoring mechanism for overtime hours, regularly
calculating overtime duration and paying overtime compensation in full according to national regulations to protect the legal rights of employees to obtain labor income.
Child Labor and Forced Labor Incident Handling Process
Identify child Implement Provide
Conduct
labor and remedial employee care
investigation
forced labor measures and and support
and verification
incidents corrections services
Execute Carry out
Immediately Strengthen
reporting and responsibility
cease violations training
communication investigation
Child Labor Incident Rights and Interest Protection Measures
Complete Ensure secure
Identify settlement of Enhance
Mandate work Conduct health repatriation
child labor remuneration preventative
cessation examinations of affected
incidents and benefits protocols
employees
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Diversity, Equality, and Inclusion
Haier Biomedical is committed to building a diverse, equal, and inclusive workplace environment. We formulate and implement Haier Biomedical attaches high importance to any opinions,
the Haier Group Code of Business Conduct , using institutional standards as a guide to resolutely safeguard the legitimate complaints, and feedback related to employee rights
rights and interests of employees. We establish a fair professional development platform for employees and strictly prohibit and human rights. By establishing diversified grievance
discriminatory behavior in management links such as recruitment, promotion, transfer, and salary grading based on dimensions and communication channels, we support employees in
such as gender, age, ethnicity, region, marital status, or religious beliefs. providing immediate feedback on matters where rights
are compromised—such as discrimination, harassment,
Haier Biomedical upholds the core principles of fairness and justice, providing equal development opportunities for all abnormal working hours, and forced labor—and promptly
employees and strictly implementing equal pay for equal work for men and women. We strive to create a positive, healthy, and provide feedback on handling results to the complainants
mutually respectful working environment, resolutely eliminating any form of discrimination, harassment, or retaliation to protect after implementing response measures, completing the
employees' physical and mental health and personal dignity. We consistently maintain a zero-tolerance stance toward human rectification follow-up on the complained matters.
rights violations and provide necessary legal aid to employees when needed to promote the construction of a harmonious and
inclusive workplace environment.
Reporting and Communication Channels
Furthermore, we place strong emphasis on the care and support of female employees. We regularly organize International
Women’s Day initiatives, as well as screening and health consultation programmes for cervical and breast cancer. By addressing
the specific needs of female employees, we are committed to supporting their health and wellbeing through practical actions. Email: Public Reporting Email - Maker's Voice Mailbox
Online platforms: Haier Community, Cultural Discussion
The human resources management philosophy of "Non-discrimination, Diversity, and Equal Opportunity" Community, Maker's Voice Anonymous Platform
Tel.: Haier Biomedical Compliance Hotline
Non-discrimination Diversity Equal Opportunity
• Execute the principles of • Encourage employees to conduct • Fair Promotion Mechanism:
"fairness, justice, and openness" communication and business Ensure that employees
in recruitment, selection, and collaboration across cross-cultural obtain equal opportunities
incentive evaluation; strictly backgrounds. for rank promotion based on
prohibit discriminatory behavior individual capabilities and work
• Provide diversified training courses
based on dimensions such as performance, eliminating non-
and cultural exchange activities to
gender, age, race, religious belief, objective interference factors in
enhance employees' cross-cultural
ethnicity, and marital status. the promotion process.
awareness and communication
• Build a workplace free from capabilities. • Equal Rights Protection: Guarantee
discrimination, harassment, and equal treatment for all employees
• Attract talents with different
retaliation, and maintain a zero- in dimensions such as salary
industrial backgrounds,
tolerance stance toward human calculation, benefit allocation,
professional skills, and cultural
rights violations and workplace and statutory leave, unaffected
characteristics to construct an
retaliation. by factors such as gender, age, or
inclusive team ecosystem.
race.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
As of the end of the reporting period, the total number of employees at Haier Biomedical is 2,945. The employee structure is as follows:
Male China Under 30 Technical Sales Minority
Female Other countries 30 - 50 Finance Administration Non-minority
Over 50 Production
On-the-job Employee On-the-job Employee Numbers On-the-job Employee On-the-job Employee On-the-job Employee
Numbers and Percentages and Percentages Categorized by Numbers and Percentages Numbers and Percentages Numbers and Percentages
Categorized by Gender Geographical Region Categorized by Age Group Categorized by Function Categorized by Ethnic Group
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
dimensional cultivation systems for different categories and levels of employees. To support
Haier Biomedical regards talent development as a key element supporting the realization of the adaptation of talent resources to corporate strategic goals, we conduct specialized
corporate strategic goals. We establish a standardized talent training system, talent cultivation capacity enhancement for employees centered on leadership, professional skills, and general
programs, and clear career promotion paths to support employee capacity building and
skills, achieving the alignment between personal development and corporate strategic goals.
professional development, driving the symbiotic co-existence of employee self-growth and
corporate development.
Core Capability Development Mechanisms
Employee Training
Leadership Professional Competence General Skills
Haier Biomedical places strong emphasis on unlocking employee potential and enhancing
professional skills. To improve organizational efficiency and support employee development, we
have established a structured talent development framework, strengthening our talent pipeline Implement specialized Design industry cutting- Comprehensively
through optimized resource allocation and effective talent management mechanisms. training in strategic edge technology training, enhance the
thinking enhancement skills certification, and comprehensive
and organizational project implementation qualities of employees
Talent Development Support System management innovation, plans for key positions through digital tool
and strengthen decision- such as technical application, cross-
Talent Evaluation System Mentors and Learning Platform making capabilities R&D and production cultural communication,
and holistic perspective operations, ensuring professional quality
Construct a talent evaluation mechanism Build an internal mentor network and
based on the three dimensions of a digital learning platform; Safeguard in combination with dynamic alignment improvement, and other
performance, professional ability, and the advancement of professional skills practical simulations between professional courses, cultivating
core values; Accurately identify talent and professional capabilities of talents and cross-departmental capabilities and business versatile talents
development potential and position by configuring personalized career collaborative projects requirements adaptable to diverse
suitability. development resources to support business scenarios
employees' continuous learning.
Career Development Channel Haier Biomedical places strong emphasis on building a robust talent pipeline. We construct
classified and graded specialized training systems to precisely meet the growth needs
Refine and implement the dual-channel promotion mechanism; Optimize the dynamic of management talents at different levels. By investing core management resources and
allocation of talent resources and enhance organizational innovation capabilities and professional practical platforms, we are committed to ensuring the professional depth and
efficiency by implementing internal rotation and open job competition systems.
strategic execution of the talent pool, continuously cultivating future leaders with a global
vision and innovation capabilities.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Reserve Talent Echelon Construction Campus Maker Cultivation CASE
General Implement the "Accelerated Development Program of Future Haier Biomedical has constructed a specialized talent cultivation mechanism for newly
recruited campus makers, accelerating their professional transformation through a
Manager Business Leaders"; systematically enhance the strategic decision-
systematic cultivation path. During the integration phase for new makers, we conduct
Reserve making capabilities and global vision of core management talents
centralized training, job rotations, and job practice to help them deepen their understanding
Talent Pool through cross-functional rotation experience, strategic project
of corporate culture, industrial logic, and the compliance system. Furthermore, we
tackling, and executive mentorship.
implement a mentor-led and class teacher full-process operational mechanism, providing
new campus makers with growth tools and career guidance while identifying high-potential
Chain Group Launch the "Accelerated Training Program of Future Excellence makers and promoting their rotation development. During the advancement phase, we
Leader Managers", focus on the collaborative efficiency of the supply chain provide resources such as workplace skill enhancement, sharing sessions led by platform
leaders, cross-field expert guidance, and professional skill teaching, driving new campus
Reserve and business chain and adopt a model integrating training with
makers to transition from basic operations to independent business responsibility.
Talent Pool actual combat to ensure the implementation of end-to-end full-
process governance capabilities for management personnel.
New Maker Cultivation CASE
Young High- Initiate the "Spark Program Accelerated Training Plan", support the
potential professional growth of high-potential talents through cross-field For new employees recruited through social channels, the Company designed a six-month
Maker learning and multi-dimensional resource allocation, promoting the "New Employee Integration and Cultivation Plan," covering corporate culture advocacy,
Reserve effective transformation of talent value in business scenarios. job skill enhancement, and team collaboration capability cultivation. The Company has
Program established a mentoring mechanism, providing diverse learning opportunities such as
situational simulations and team projects, helping new makers quickly adapt to the work
environment, master core job skills, and integrate into the organizational culture.
Haier Biomedical is actively developing a next-generation talent cultivation system. We provide
customized growth paths for fresh graduates and new employees, offering professional
During the reporting period, Haier Biomedical advanced the strategic objectives of its overseas
resource support through systematic integration projects. We strive to help new employees business platform by strengthening its talent pipeline to support global expansion. We focused
shorten their onboarding and adaptation period, ensuring they enhance their professional on developing emerging talent into high-performing professionals who are empowered to
quality and grow rapidly in business practices, injecting new vitality into organizational take initiative, deliver effectively, and drive results, supporting the accelerated growth of our
development. international operations.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
New Employee Training for Overseas Business Platform
During the reporting period
The total training hours for Haier Biomedical an average training time of per
Culture and Safety Product Training Case Study Training User Interaction employees reached employee reached
Training
hours hours
Conduct cultural Implement Summarize and Strengthen the
integration training systematic product output successful cultivation of
and implement training; drive user cases regularly; practical combat the training coverage rate reached
team consensus;
strengthen cultural
the cognitive
transformation of
form reproducible
business experience
capabilities; ensure
that new employees 100 %
identity to enhance new employees from and market best possess the ability
employees' sense "product-oriented" practices by to face users
of mission and to "solution-service" constructing a independently,
organizational through scenario- systematic case accurately identify
cohesion. based solutions. library. needs, and provide
professional services Among them, the training percentage and average training hours categorized by
through experience employee gender are as follows:
sharing and practice.
Haier Biomedical implements talent globalization and specialization strategies, customizing
multi-dimensional specialized training for employees to help them systematically improve 35.61
their professional capabilities and management literacy. Meanwhile, we have created an
online Maker learning map, providing learning paths for multi-faceted skills to give full play to
employees' potential.
Overseas English Training CASE
Male Female Male Female
During the reporting period, Haier Biomedical launched an external English specialized
training project, with a total of 320 employees signing up to participate. The project
Percentage of Trained Average Training Hours by Gender
implements a one-year teaching cycle and has constructed a classified curriculum system Employees by Gender
covering general English, business English, and industrial English. Through systematic
language capability building, we help employees improve their communication efficiency
in cross-cultural business scenarios, providing precise talent capability support for global
business expansion.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Employee Promotion
Haier Biomedical Promotion Pathways
Haier Biomedical continuously refines its talent development
mechanism and constructs clear career development Platform Owner Chief Expert
paths to provide employees with a broad professional
development platform and equal promotion opportunities. Chief Engineer
We formulate and implement the Haier Biomedical Maker Sub-platform Owner/Deputy Manager /CXO
Development Policy , creating dual talent promotion channels Principal Engineer
for both management and professional tracks. This supports
Senior Engineer
employees in achieving vertical rank promotion and cross-
Chain Group Owner/Micro-unit Owner
channel horizontal role transitions, thereby enhancing talent
Intermediate Engineer
mobility within the organization.
Junior Engineer
Sub-chain Group Owner/Interface Personnel
Assistant Engineer
Management (M) Pathway Professional (P) Pathway
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical adheres to the principles of legality, fairness, and incentive-driven growth,
Comprehensive Assessment Objective management
continuously optimizing the compensation system to provide employees with market-
competitive salaries and benefits. We implement diversified compensation incentive strategies. 360-degree assessment mechanism: Performance coaching mechanism: Direct
Based on the value-based compensation mechanism, we combine short-term incentives with Employees evaluate their direct managers conduct monthly performance
long-term incentives and dynamically adjust employee compensation according to annual supervisors and give feedback on a interviews and coaching for employees,
or role changes, motivating employees to improve performance and aligning individual value monthly basis through the system, helping employees clarify improvement
with corporate development. promoting bilateral communication directions
and continuous improvement
Remuneration Incentive System
Short-term Incentive Long-term Incentive Value realization Career development
Value evaluation and distribution based Conducting work based on performance
Annual Salary Adjustment and Business Partnership Incentives: Establish a
on talent classification: Refining rank objectives, clarifying direction, continuously
B o n u s I n ce n t i v e s : E x e c u t e a performance self-evaluation system to motivate
development evaluation standards, improving, and facilitating career growth
dynamic annual compensation employees to co-create and win together with
precisely assessing all employees' and continuous improvement
adjustment mechanism and set up the Company. Support employees in deeply
capabilities, and ensuring alignment
salary adjustment window periods. participating in business decision-making and value
with enterprise strategy direction
Utilize diversified incentive tools creation processes to achieve the unification of
such as performance bonuses and personal career growth and corporate development.
special project bonuses to ensure
Employee Stock Ownership Plan (ESOP): Implementing
that employee value contributions
a Type II Restricted Stock Incentive Plan, granting
are realized in a timely manner,
no more than 1.2 million A-share ordinary shares
enhanc ing the f lexibilit y and
to no more than 309 employees, sharing enterprise
market competitiveness of the
development achievements with core talent
compensation system.
through equity.
Haier Biomedical continuously optimizes the scope of employee performance evaluation and
is committed to building a scientific performance evaluation system. We focus on the four
dimensions of comprehensive evaluation, objective management, value creation, and career
development to ensure the deep integration of employee performance and value creation.
We implement differentiated performance evaluation standards for employees at different
levels, supported by tailored incentive schemes to fully motivate employee engagement and
performance. During the reporting period, we further optimized the dimensions of employee
performance evaluation. For key positions, the performance evaluation scope transitioned from
being purely result-oriented to emphasizing both results and achievement paths, strengthening
control over the operational process. Meanwhile, we further optimized the performance
evaluation mechanism for general Makers, effectively enhancing the stability of compensation
incentives. Furthermore, we introduced an organizational performance evaluation mechanism
to promote high unity between individual employee value and organizational goals.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical continuously improves working conditions and employee experience. By conducting rich care activities, providing a competitive welfare system, and maintaining transparent and
smooth communication mechanisms, we comprehensively enhance employees' sense of belonging, satisfaction, and happiness.
Employee Welfare
Haier Biomedical adheres to a people-oriented approach and continuously optimizes its To continuously improve the quality of work and life for employees and enhance their sense
compensation and welfare system. During the reporting period, we launched differentiated of workplace happiness, we regularly conduct employee care activities, including cultural
flexible attendance schemes, supporting various business chains and groups in independently and sports entertainment as well as holiday benefits. Furthermore, we implement a sound
choosing attendance modes based on team characteristics and the actual needs of assistance mechanism for employees in difficulty. Through the Group’s Love Rescue Platform
employees. This further optimizes the work experience of employees while ensuring and activities such as visiting and consoling sick employees, we help employees in need
management standardization. We strictly comply with national laws and regulations, legally overcome difficulties and convey corporate warmth.
paying full contributions to pension, unemployment, work injury, medical, and maternity
insurance, as well as the housing provident fund for all employees. In 2025, the coverage rate
of social insurance and physical examinations for employees both remained at 100%.
Employee Welfare System
Six Insurances and Two Funds Paid Leave
• Besides the statutory five insurances and one fund, the Company provides enterprise annuities for employees to • Besides statutory holidays, the Company also provides paid
enhance economic security after retirement. annual leave, leave for parent-teacher meetings, leave for
• We also purchase supplementary commercial insurance for employees to further improve their medical and accompanying children during high school and university
accident protection levels. entrance examinations, parental leave, parent-care leave, etc.
• We also provide three days of maker's leave and two days of
spring break for fresh graduates.
Meal Stipend Physical Examination
• We provide free annual health examination opportunities
• The canteen offers diverse dining options with
for employees.
meal subsidies;
• There are food festival activities from time to
time to enrich employees' dining experiences. Diverse Benefits
• We provide allowances for high temperatures in the summer, heating in the winter, and clothing.
We also provide the work anniversary rewards, birthday gifts and corresponding holiday benefits.
Talent Housing Women's Care
• We provide rental talent housing application opportunities for qualifying employees. • We establish lactation rooms in factories and office buildings.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Democratic Communication
Haier Biomedical is committed to building an open, transparent, and efficient employee communication system. Through To enhance organizational health and improve the employee
diversified democratic communication channels, we patiently listen to employees' opinions and suggestions, formulate work experience, Haier Biomedical has established a
and implement rectification plans, and ensure that employees receive timely and effective feedback, thereby continuously normalized employee feedback mechanism. By regularly
improving employee satisfaction and happiness. conducting all-staff satisfaction and engagement surveys,
we systematically evaluate the organizational atmosphere
Democratic Communication Channels and management efficiency across multiple dimensions,
including vitality, strategic consensus, cultural consistency,
employee participation, and organizational adaptability.
Maker's Voice Public Mailbox
In response to the problems identified in the surveys, we
• The Company establishes the Maker's Voice public mailbox (chuangkexinsheng@haierbiomedical.com), formulate specialized solutions and clarify the closed-loop
encouraging employees to actively provide feedback on needs and suggestions regarding platforms, work, and processing time to ensure that management improvement
life. mailto: chuangkexinsheng@haierbiomedical.com measures are effectively implemented. The 2025 survey
• The Company strictly maintains the confidentiality of employee information and actively resolves problems, results showed that the scores for engagement, satisfaction,
committed to creating a good environment for entrepreneurship and innovation. and cultural atmosphere reached 4.39, 4.25, and 4.41,
respectively. Company vitality, strategic consensus, and
• After receiving emails, the public mailbox transfers issues to relevant responsible departments within 24 hours, organizational adaptability continued to improve, receiving
and the responsible departments must respond within 24 hours, resolving issues raised by employees as much high evaluation and recognition from Makers.
as possible through bilateral communication.
• At the beginning of each month, the Maker's Voice mailbox publicizes to all employees the issues collected in
the previous month, responsible department responses, issue resolution progress, and other information.
Democratic Evaluation
• Haier Biomedical has semi-annual democratic evaluation among divisions to promote the normalization of
democratic management.
Cultural Discussion
• Through "Cultural Discussion" activities, we encourage employees to reflect on problems in the work and
workplace environment, with timely feedback and improvements on major concerns.
Employee Self-governance Committee
• Committee members actively work to build a good workplace environment, listen to employee needs,
feedback, and suggestions, and help employees resolve problems promptly.
Face-to-Face Chats
• Through face-to-face chats, the Company seeks to understand employees' genuine needs and suggestions to
improve management initiatives, support decision-making, and achieve mutual progress for both employees
and the Company.
EAP Platform
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
implementing the dual systems of "hierarchical risk management and control" and hazard
Haier Biomedical attaches great importance to the occupational health and safety of identification and remediation". We have built a closed-loop management mechanism of
employees and is committed to creating a safe and healthy working environment. We "controlling risks at the source and addressing hazards throughout the process". We carry out
continuously strengthen the construction of the safety management system, formulate hierarchical risk management and control, conducting full-process identification for five major
and implement scientific accident prevention mechanisms, and apply comprehensive categories of risk, clarifying hierarchical control responsibilities, and dynamically updating
occupational health management measures to protect employee well-being and the risk lists. At the same time, we implement hazard identification and remediation, clarifying
sustainable development of the enterprise. investigation lists, frequencies, and responsibilities to achieve closed-loop rectification of
hidden dangers.
Health and Safety Management System
By continuously improving the compliance and standardization levels of safety management,
Haier Biomedical strictly complies with laws and regulations such as the Work Safety Law of we have built a solid barrier for the sustainable operation of our business. During the reporting
the People's Republic of China . The Company has formulated and implemented the Haier period, we promoted the transition of the risk prevention and control model from post-
Biomedical System Audit Manual to standardize the audit and management criteria for core incident response to pre-incident prevention, achieving a 100% closed-loop rectification rate
modules such as organizational responsibility, institutional processes, and emergency training. for safety hazards. Meanwhile, we achieved the goal of zero accidents across five categories,
In 2025, we systematically upgraded the "139 Safety Management System," integrating the including fire and production fields, with 0 working days lost due to work-related injuries.
"Three Managements and Three Musts" requirements, clarifying the safety responsibility list for
all staff, and promoting an all-staff, comprehensive, and full-process management model. In During the reporting period, we achieved a 100% coverage rate for risk identification, a 100%
addition, we execute dynamic compliance benchmarking and quarterly review mechanisms, coverage rate for major risk management and control, a 100% closed-loop rate for hazard
incorporating safety management compliance into evaluations to ensure that safety remediation, and a 100% completion rate for major hazard remediation. Safety accidents
management requirements are effectively implemented. decreased by 60% year-on-year, effectively enhancing the Company's safety management and
safety incident response capabilities.
As of the end of the reporting period, Haier Biomedical has obtained ISO 45001 occupational
health and safety management system certification.
Production Safety
Haier Biomedical regards production safety as the core of operational management and
always upholds the highest safety standards. We strictly comply with work safety laws and
regulations, such as the Guidelines for the Preparation of Emergency Plans for Production
Safety Accidents of Production and Operation Units, Measures for Management of Emergency
Plans for Production Safety Accidents, Regulations on Emergency Response to Production
Safety Accidents, Shandong Province Measures for Emergency Response to Production Safety
Accidents. We have formulated and implemented internal systems such as the Hazardous
Chemicals Management System of Qingdao Haier Biomedical Co., Ltd. , striving to construct a
comprehensive production safety management system.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Key Measures for Safety Management Haier Biomedical actively promotes safety culture in the workplace. By conducting multi-
level safety training and organizing emergency drills, we strengthen the internal emphasis on
production safety, ensure the implementation of safety standards, and jointly create a safe
Equipment Implement a specialized equipment management system with
and healthy work environment. During the reporting period, we continuously optimized the
Safety full participation; ensure safe operation through regular safety
personnel-based management mechanism, conducted 18 security practical training sessions,
Management inspections and equipment labeling management. Conduct
and organized a total of 6 fire and emergency drills, effectively enhancing employees' safety
and Risk rigorous risk assessments for all equipment before use,
culture awareness.
Assessment identifying potential hazards and taking preventive measures.
Build a full-process closed-loop control mechanism for Specialized Drills for Fire Safety Month CASE
abnormal equipment operation based on the smart safety
platform to achieve online tracking and rapid disposal of
In October 2025, Haier Biomedical conducted specialized drills for Fire Safety Month
operational risks for dangerous equipment.
to further strengthen fire early warning, initial fire response, and personnel escape
Enhance the safety assurance level of operating areas by capabilities. We focused on key risk areas such as production workshops and storage
implementing physical environment repairs and installing centers. By simulating real fire scenarios, we carried out practical operations for fire-
automatic identification and early warning systems. extinguishing equipment, smoke escape simulations, and fire hydrant linkage tests, while
collaborating with local fire rescue agencies for professional guidance. Through diverse
Electronic Monitor equipment operation status in real time through forms such as scene simulation, group competitions, and skill assessments, we achieved
Monitoring and electronic systems and conduct safety assessments based extensive coverage of all departments, effectively improving employees' emergency
Real-time Data on data analysis to ensure that problems are identified and response speed and self-protection and mutual assistance capabilities in the event of a
Analysis handled promptly during equipment operation. sudden fire.
Five-Prevention Ensure the correct use and regular maintenance of equipment Specialized First Aid Training CASE
Management by formulating and strictly executing the "Ten Essentials
and Operating and Five Requirements" operating standards, minimizing
In light of the operational characteristics and potential safety risks of the biomedical
Standards equipment failures and operational risks.
industry, Haier Biomedical organized and implemented specialized first aid training. We
invited experts from professional institutions to conduct systematic teaching combining
Safety Establish specialized monitoring and enhanced personnel theoretical lectures and model-based practical operations, focusing on core first aid skills
Inspections monitoring mechanisms for high-fatality-risk operating areas; such as CPR, trauma bandaging, and Automated External Defibrillator (AED) application.
and Hazard achieve risk control for key areas through dedicated patrols, The program achieved precise empowerment for high-risk position personnel and safety
Rectification in route optimization, and regular patrol records. officers through one-on-one certification assessments, effectively addressing gaps in
Key Areas employees' emergency first aid skills. During the reporting period, the Company’s number
Ensure the integrity of fire-fighting facilities and rapid response
to fire alarms through upgrading fire-fighting key projects, of certified first aiders increased by 60%, providing professional talent support for a safe
networking fire-fighting systems, and linkage testing of fire- work environment.
fighting facilities.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Occupational Disease Prevention
Haier Biomedical strictly fulfills its responsibilities for occupational disease
hazard identification and prevention. By constructing a systematic occupational
health management system, we safeguard employees' occupational safety and
health rights. We legally establish and maintain Occupational Health Records
and regularly submit Occupational Hazard Project Declaration Form to the
health administrative department to ensure the compliance of occupational
health management processes.
In terms of risk monitoring, we establish a normalized monitoring mechanism,
hiring professional third-party institutions to conduct occupational disease hazard
factor detection annually and completing an occupational disease hazard status
evaluation every three years to achieve dynamic early warning and assessment
of health risks in high-risk positions. For employees exposed to occupational
hazards, we regularly organize specialized occupational health checkups and
execute job reassignment or follow-up examination procedures based on
physical examination feedback to ensure that employees' health conditions
remain compatible with job requirements.
In 2025, we systematically carried out occupational disease hazard identification
and response based on on-site processes and workstation environments. We
identified potential chemical, physical, and other related hazard factors in
certain positions and clarified the potential health risks these hazards might
pose to employees. Based on the risk identification results and items, we
strengthened the implementation of employee health and safety protection
measures and conducted specialized safety education to continuously improve
the occupational health risk prevention mechanism.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical always adheres to the vision of "Making Life Better", taking the enhancement Medical accessibility Medical ecological Medical and public
of global patients' well-being as its own mission, fully leveraging its strengths, and striving to development empowerment health upgrades
make high-quality products accessible to more users. We maintain close cooperation with
• Promoting the flow • Spreading medical • Upgrading healthcare
global public welfare organizations and support community development through cash and
of quality healthcare knowledge, infrastructure,
product donations. During the reporting period, Haier Biomedical donated a total of RMB 1.406 resources to primary- enhancing partners' implementing
million in cash and materials. level institutions, professional digital and
vulnerable groups, capabilities and intelligent solutions,
and economically less improving the overall strengthening public
developed areas quality of medical health systems, and
Principles Respond to stakeholder requirements Fulfill the responsibilities as a services through enhancing the overall
• Reducing medical
of Public to build a community of common corporate citizen based on our core professional products service capacity
health for mankind strengths access costs, and
Welfare and technical training and technological
ensuring fair and
and educational capabilities of the
accessible healthcare
resources healthcare sector
resources
Focus Medical Medical Medical and
In-kind Community Employee
Fields accessibility ecological public health
donation empowerment public welfare
development empowerment upgrades
Leveraging its advanced technology and extensive experience, Haier Biomedical works
alongside government agencies, non-governmental organizations, universities, and other
global ecosystem partners to fulfill its social responsibilities and continuously promote the
global development of access to healthcare. The Company is committed to making high-
quality medical services more accessible and convenient. As a long-term partner of Gavi, the
Vaccine Alliance, Haier Biomedical has consistently supported global immunization health
with its products and technologies. Since its establishment in 2000, Gavi has provided
services to 1.2 billion children worldwide2, effectively improving child health and well-being
across the globe.
Source: Gavi official website https://www.gavi.org/
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Strengthening Immunization Protection Haier Biomedical Provided Smart Vaccine Solution to Azerbaijan CASE
Haier Biomedical continues to deepen its universal healthcare practices, leveraging smart
In December 2025, Haier Biomedical successfully delivered 100 HYC-61 vaccine refrigerators,
cold chain technology to ensure the quality and safety of drugs and vaccines throughout the
entire chain of production, storage, and transportation, while improving grassroots vaccination
Azerbaijan, supporting the development of a smart vaccine management network
rates and smart medical management capabilities. The Company actively implements the
in Nakhchivan. For a long time, vaccine management in Nakhchivan City had faced
"Belt and Road" initiative, delivering advanced medical solutions to grassroots communities
challenges such as reliance on manual paper records, long distribution cycles, and
and developing countries, and contributing to the construction of public health systems in
economically underdeveloped regions. Our products and solutions have reached more than outdated storage monitoring methods. In response to these challenges, Haier Biomedical
reliability, and intelligence", enabling fully traceable management of vaccines throughout
Haier Biomedical is fully aware of the critical importance of vaccine safety in preventing the entire process from transportation and storage to vaccination. This delivery marks a
infectious diseases and safeguarding public health. To address challenges in underdeveloped new phase of digital upgrade for public health in Nakhchivan City, significantly improving
regions and traditional vaccination management—such as slow information flow and low vaccine storage safety and vaccination efficiency, and providing solid support for the
efficiency—Haier Biomedical has launched a full-process smart vaccine solution. This solution development of regional immunization barriers.
adopts an "intelligent equipment + information platform + public service" model to connect
the entire chain of vaccine transportation, storage, and vaccination, achieving full traceability
throughout the entire process. As of the end of the reporting period, Haier Biomedical's
vaccine cold chain solution has covered more than 140 countries and regions worldwide,
safeguarding the last mile of vaccine safety.
Vaccine Transportation Vaccine Storage
Haier Biomedical provides specialized For diverse scenarios including large-
equipment such as vaccine refrigerated scale centralized storage, fixed
trucks, transport boxes, and mini ultra- vaccination sites, and mobile vaccination,
low temperature freezers to achieve full Haier Biomedical offers customized and
monitoring of cold chain temperature reliable storage solutions. The storage
co n t r o l a n d va cc i n e ex p i r y d a te s , equipment is seamlessly integrated with
ensuring that vaccine bioactivity remains the information platform, supporting
intact during transit. The equipment is real-time tracking and inquiry of vaccine
designed with portability and ease of information, and enabling intelligent
operation in mind, saving valuable time management throughout the entire
for safe and efficient transportation. process from warehousing to vaccination.
Haier Biomedical Provided Smart Vaccine Solution to Azerbaijan
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical Helped Uganda Build a Central Vaccine Cold CASE Haier Biomedical Supported Vaccine Safety in Africa CASE
Storage Facility
In 2025, as part of its efforts to enhance global health equity and accessibility, Haier
In May 2025, Haier Biomedical successfully delivered the NMS Central Vaccine Cold Biomedical donated solar-powered vaccine refrigerators to the Central African Republic.
Storage Project in Uganda. As the largest vaccine storage center in the country, this The Company also provided systematic product operation and maintenance training to
project has significantly enhanced Uganda's local vaccine storage capacity and public local health authorities and partners, helping strengthen local public health capacity
health security, marking a major milestone for Haier Biomedical in the African public through systematic training in product operation and maintenance. This solution is
health sector. powered by solar energy and, even in extreme conditions with ambient temperatures of
Following on-site assessments, Haier Biomedical developed a customized vaccine cold
up to 121 hours. This effectively ensures the stability of vaccine storage in remote areas,
chain solution. The facility adopts a PLC intelligent control system to achieve precise
strengthens the cold chain service capacity of local primary healthcare institutions, and
temperature control, fault alerts, and automatic switching between primary and backup
provides tangible technological support for improving child immunization coverage and
units. Combined with LORA remote temperature and humidity monitoring and audible/
building a robust public health defense line.
visual alarm functions, the system ensures safe and reliable vaccine storage. Additionally,
the project utilizes environmentally friendly refrigerants and green PU insulation panels,
together with defrost water subcooling and exhaust air pre-cooling technologies, to
achieve green and low-carbon operations.
Haier Biomedical Delivered the Central Vaccine Cold Storage Project to the
Ministry of Health of Uganda
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Supporting Public Health System Development
Haier Biomedical is committed to leveraging IoT, big data, and intelligent technologies as core drivers to empower public health system upgrades at all levels—from grassroots to regional, and from
domestic to global. By providing comprehensive full-scenario solutions, we not only facilitate the extension and more balanced distribution of quality medical resources in China, but also actively
respond to global development initiatives. We fully integrate innovative technologies, equipment, and service models into healthcare systems at different stages of development, enhancing the
accessibility, quality, and resilience of medical services. In doing so, we provide solid support for addressing health inequalities and building a more resilient universal health coverage system.
Haier Biomedical Supported the Construction of the China-aided Bobo- CASE Haier Biomedical Supported the Development of a Smart Integrated CASE
Dioulasso Hospital project in Burkina Faso Healthcare Network in Tibet
In December 2025, Haier Biomedical contributed to the successful completion of the In August 2025, Haier Biomedical completed the full delivery of the Smart Medical
China-aided Bobo-Dioulasso Hospital Project in Burkina Faso. As the medical equipment Community project developed in partnership with Sangzhuzi District, Shigatse City, Tibet.
supplier for the entire hospital, Haier Biomedical provided a total of 2,188 units (sets) As a key Qingdao aid-to-Tibet project, this initiative specifically addresses challenges
across 133 categories of medical equipment, offering strong support for local healthcare in plateau regions such as uneven distribution of medical resources and lagging IT
development and local healthcare and medical development. Additionally, the Company infrastructure. The Company integrated 5G, big data, AI and other technologies into
assembled a professional technical team to provide equipment operation training and the platform to build a regional medical network covering the district central hospital,
long-term operation and maintenance support to the local community, achieving deep 2 community health service centers, 10 township health centers and 161 village
empowerment through a transition from "product export" to "ecosystem co-construction." clinics, thereby creating a full lifecycle health management closed loop encompassing
"prevention, screening, diagnosis, treatment, management and rehabilitation".
With a total floor area of 42,000 square
meters and 500 beds, the hospital The project equipped 161 village doctors
covers all functional medical areas with smart follow-up kits supporting bilingual
including outpatient, emergency, Chinese-Tibetan interaction, voice broadcast,
laboratory/diagnostics, and inpatient and real-time medical insurance settlement,
services. It is one of the most modern enabling digital rounds and electronic
hospitals on the African continent. prescribing. At the same time, it established
Once operational, it will serve millions collaborative platforms for two-way referrals,
of people in the surrounding region remote consultations, and imaging, laboratory
and become a core hub of Burkina testing and ECG sharing, breaking down
Faso's healthcare service system. information silos among medical institutions,
effectively enhancing grassroots diagnostic
Haier Biomedical Supported the Construction of the China- and treatment capabilities, and bringing Haier Biomedical Supported the Construction of
Aided Bobo-Dioulasso Hospital Project in Burkina Faso quality medical services to villagers' doorsteps. a Smart Medical Community Project in Tibet
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical has always been steadfast in fulfilling its social responsibilities as a
To encourage regular blood donations within the community and ensure a stable and
corporate citizen. By fully leveraging the Company's technological and channel advantages
sufficient blood supply, Haier Biomedical, together with the Alar Central Blood Station of
in the healthcare sector, we actively carry out and participate in public welfare activities and
the First Division of Xinjiang Production and Construction Corps, built a Blood Donation
community initiatives, transforming technological achievements into tangible benefits for
Cabin ahead of World Blood Donor Day 2025. Covering an area of 45 square meters, the
people's livelihoods, and contributing to global health causes.
cabin features five well-designed functional zones: reception, physical examination, initial
screening, blood collection, and rest. It incorporates eco-friendly materials and an intelligent
Haier Biomedical Provided Emergency Aid to the Earthquake-Affected CASE temperature control system, and is equipped with electric sofas, an LED "starry sky" ceiling, and
Region in Shigatse, Tibet electronically dimmable privacy glass, creating a comfortable environment for blood donors.
After collection, blood is stored at low
In January 2025, a 6.8-magnitude earthquake struck Dingri County in the Shigatse
temperatures in Haier Biomedical
region of Tibet. Immediately after the disaster, Haier Biomedical activated its emergency
blood refrigerators. Equipped with
response mechanism and provided 24/7 "Three Exemptions" caring service to users in the
smart IoT technology, these storage
affected area, including free on-site inspection, testing, and repair services, ensuring the
devices enable full traceability
normal operation of local medical equipment. At the same time, the Company urgently
throughout the blood collection
donated RMB 500,000 to support disaster relief efforts. Of this amount, RMB 100,000 was
and storage process, ensuring blood
used to procure urgently needed supplies such as cables, power strips, heaters, cotton
quality and safety. Haier Biomedical Built a Blood Donation Cabin
quilts, and ready-to-eat food, while the remaining RMB 400,000 was donated to the
Shigatse City Charity Federation for emergency rescue and post-disaster reconstruction.
Through these concrete actions, Haier Biomedical brought warmth and support to the
Haier Biomedical Organized Employee Voluntary Blood Donation Activity CASE
people in the disaster-stricken area.
In January 2025, Haier Biomedical actively organized its employees to participate in
the voluntary blood donation campaign themed "Haier's 40 Years of Entrepreneurship,
Thousands of People Warm the Winter," jointly held by the Qingdao Municipal Health
Commission and the Red Cross Society of China, and prepared thoughtful gifts for
participating employees, taking concrete actions to pass on the hope of life.
During the event, Haier Biomedical's self-
developed mobile blood collection vehicle
became a highlight. Featuring advanced design
and comprehensive functionality, the vehicle
supports diverse scenarios such as group blood
collection, fixed-point blood collection, and
mobile blood collection in counties and districts.
With its lightweight design and efficient
powertrain, it achieves low fuel consumption and
Haier Biomedical provided Relief Supplies to the Earthquake-Affected Region
high load capacity, effectively enhancing blood Haier Biomedical Organized Employee
collection efficiency and cost-effectiveness. Voluntary Blood Donation Activity
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Driving Ecological
Harmony
Haier Biomedical comprehensively implements the green development concept,
dedicating itself to promoting energy efficiency throughout the product lifecycle
through technological innovation and empowering value chain decarbonization
through its products. We refine the environmental management system, strictly
implement pollutant control and resource conservation measures, and deepen the
identification of and response to climate risks and opportunities to continuously
enhance our comprehensive resilience under climate and resource constraints.
Through cutting-edge innovative solutions, we also continue to empower
biological sample management, contributing to global biodiversity conservation.
Performance Highlights in this Section
Passed the annual audit of the ISO Reached Invested
system. 2.367 million kWh RMB 257,700
in renewable energy in environmental
consumption within the protection funds
Completed the annual review of
campus SDGs-related responses in this Section
the National Green Factory and
obtained certification.
accounting for
Continuously carried out energy- 18.18% in environmental
saving and carbon-reduction actions of the Company’s total protection initiatives
throughout the entire lifecycle. electricity consumption
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical's Green Value Chain System
Green Procurement Green Logistics
Environmental protection access New energy vehicles Optimized
mechanism for suppliers transportation routes Reduced
Joining the Working Group of the Green Green transportation carbon emissions
Sustainable Initiative Health System Procurement Logistics
Green Manufacturing Green Office
Upgraded manufacturing processes, Investment in photovoltaic power
Green Achieve carbon peaking for Scope Green generation
and promoting recycling and circular Manufacturing Office
economy
Reducing energy consumption and Achieve carbon neutrality for Enhancing employees' environmen-
Scope 1 and Scope 2 by 2060 tal protection awareness and imple-
emissions and achieving closed-loop
menting energy-saving measures
management in production processes
Promoting paperless office practices
Green Green
Products Collaboration
Green Collaboration
Green Products
Empowering partners with green
Enhancing the environmental protec-
practices
tion characteristics of products
Supporting biodiversity conservation
Emphasizing the sustainability and
eco-friendliness of products
Structural Support System Assurance Compliance Operations Goal Driving Philosophical Guidance
Support Establishing a carbon peaking and Establishing an environmental Strictly abiding by environmental Formulating and tracking environ- Guided by green design and
System
carbon neutrality strategy commit- management mechanism, obtain- protection laws and regulations to mental carbon peaking and manufacturing principles to
tee and building a sound environ- ing international environmental ensure the legality and compli- carbon neutrality to ensure the promote the greening of products
mental framework protection system certification, ance of operational activities implementation of the green and services throughout their
and constructing a response development strategy lifecycle
system for climate change risks
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
challenges, we integrate energy-saving, consumption-reduction, and carbon-reduction
To reduce product carbon footprints and drive the value chain decarbonization process, we technologies into the product R&D and design process, assisting users in optimizing energy
integrate green concepts into every stage of the entire lifecycle, including product R&D and consumption management and process carbon reduction by building a portfolio of energy-
design, raw material selection, production and manufacturing, logistics and transportation, efficient products.
and recycling. By continuously promoting technological innovation and the application of
energy-saving technologies, we fully empower downstream users to improve energy use
efficiency and drive the industry’s green transition while optimizing our own operational Haier Biomedical Green Product Energy-Saving Series
energy efficiency.
Ultra-Low Constant Temperature Medical
Green Product Actions Temperature Freezer and Humidity Chamber Refrigerator
Energy Saving and Consumption Reduction Validate and apply Integrate core Apply technologies
Significantly reduce product energy consumption and enhance product operational technologies such as technologies such including hydrocarbon
efficiency through technological innovation. multi-stage energy as ART smart energy refrigeration, triple-
cascade recovery, control, non-equilibrium layer glass doors, and
Application of Eco-friendly Materials
evaporator D-tube rapid temperature and cooling system coupling
Fully launch the non-eco refrigerant switching plan and promote the use of eco-
cooling, SVIP aviation humidity control, to increase the overall
friendly refrigerants; advance the replacement of traditional processes with eco-
insulation, and stepless and low-energy energy-saving and
friendly boards across multiple product categories, and carry out the planning and
ultra-green cooling to semiconductors to consumption-reduction
implementation of fluorine-free polyurethane foam layer schemes.
achieve low-consumption achieve energy savings ratio of medicine
Lifecycle Planning operation of ultra-low of over 80% year-on-year. refrigerators to more
Promote standardized and platform-based product planning and optimize temperature freezers. than 50%.
component design to reduce environmentally harmful processes and achieve
efficient resource utilization.
Green Packaging
Optimize packaging structures, implement lightweight and modular reconstruction, Haier Biomedical adheres to technological innovation, driving product energy efficiency
and introduce renewable materials such as honeycomb cartons to replace upgrades through core technology. During the reporting period, we achieved multiple key
traditional packaging materials, thereby reducing packaging resource consumption technological breakthroughs in fields such as energy-saving refrigeration and intelligent
and enhancing the environmental attributes of the entire product lifecycle. temperature and humidity control, continuously promoting the green and low-carbon
development of downstream industries.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Green Technology Breakthroughs
We always promote green product design, R&D, and manufacturing with high standards
Eco-Drive Technology Achieve a 30% increase in product energy efficiency, a and strict requirements, and relevant achievements have been widely recognized by the
reduction of 50% in daily power consumption; reduce carbon environmental protection certificates, including 75 models. In 2025, we had two models newly
emissions by approximately 2.8 tons per unit annually on certified and registered for U.S. Energy Star program, bringing the cumulative total to 34.
average.
Haier Biomedical relies on green technology innovation and product advantages to provide
efficient and low-carbon equipment support and solutions for scientific research users,
Adaptive Steady- Optimize the operational accuracy and energy efficiency of
including testing institutions and higher education institutions. While ensuring their research
State Temperature environmental chambers, controlling internal temperature
precision and compliance requirements, we reduce operational energy and resource
and Humidity Control fluctuation within ±0.1°C and maintaining humidity fluctuation
consumption, jointly promoting the green transition in the biomedical field.
Algorithm within ±2.5%, while reducing daily power consumption to
below 3.5 kWh.
Multi-Seal Insulation Reduce the energy loss of medicine cabinets, enabling the
Technology product to achieve an energy-saving rating of over 50% and the
average daily power consumption is reduced to 2 kWh.
Non-Equilibrium Improve the operational efficiency of test chambers, achieving
Temperature and an 80% increase in product energy efficiency and obtaining
Humidity Reliable the first domestic energy-saving and environmental protection
Refrigeration evaluation certificate for drug stability test chambers.
Technology
Zero-Carbon Solar Guarantee the safety of vaccine storage in power-deficient
Direct Drive Cold areas, maintaining a constant temperature of 8°C for up to
Storage Technology 120 hours after a power outage in a 43°C high-temperature
environment. This solution has covered over 80 countries,
benefiting approximately 45 million people annually.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical Supports the Upgrade of Eurofins Laboratories CASE
To jointly promote the standardized and green upgrade of global laboratories, Haier Haier Biomedical regards environmental compliance as the baseline of its production
Biomedical reached a strategic cooperation with Eurofins, a globally leading third-party and operations and continuously refines its internal environmental management system.
testing institution. We provide them with constant temperature and humidity chambers By constructing a top-down environmental governance pattern, the Company integrates
integrated with Peltier temperature control technology and water droplet vaporization environmental protection responsibilities into the entire process of organizational operations.
humidification technology, assisting them in reducing power and water consumption Through the continuous deepening of green operations and environmental protection,
during operation on the basis of ensuring the accuracy and reliability of experimental data. while consistently reducing our own carbon footprint, we take practical actions to ensure
the long-term implementation of the green development strategy, driving the collaborative
enhancement of corporate value and environmental value.
Haier Biomedical Super Series Products Enter the University of CASE
Sheffield and the University of Liverpool 4.2.1 Environmental Management Structure
To continuously improve environmental governance and management efficiency, we have
As a globally leading provider of biosafety and low-temperature cold chain solutions, Haier
constructed an environmental management structure consisting of the Board of Directors,
Biomedical’s Super series ultra-low temperature products have entered the University of
the Environmental Leadership Group, and functional departments. During the reporting
Sheffield and the University of Liverpool in the UK. By providing laboratories with energy-
period, we established the Security and Safety Committee and built a cross-departmental
saving, environmentally friendly, and efficient ultra-low temperature products, we assist
coordination mechanism. By holding monthly joint security and safety meetings, we achieve
users in achieving their scientific research goals while reducing energy consumption and
the synchronized deployment of environmental management work with the overall strategy.
carbon footprints during equipment use.
Furthermore, guided by sustainable development, we clarify management policies and
principles for key links such as energy management, resource use, and pollution prevention
and control to improve environmental management performance.
Environmental Management Structure
• Formulate the Company's environmental management strategic
Board of direction and targets
Directors
• Review the implementation of the annual action plan and
environmental management system
• Oversee and coordinate the planning, promotion and
implementation of the annual work plan
Environmental
Protection • Improve and optimize the overall environmental management
Leading Team
policies to ensure the efficient implementation of various
environmental management measures
Functional • Promote and implement environmental management work
and Business
Departments • Implement various environmental management measures
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
We set environmental goals centered on key aspects such as compliant environmental 4.2.2 Environmental Compliance System
operations, energy and resource conservation, and emission reduction. Through regular
tracking and assessment, we promote the continuous improvement of environmental On the basis of continuously refining the environmental management structure, we further
performance. focus on compliance leading and construct an environmental compliance management
system oriented toward risk prevention and control and continuous improvement. We clarify
cross-departmental environmental management responsibilities and efficient collaboration
Target Type Target Progress
mechanisms to ensure the effective implementation of environmental management work
Compliant 100% compliance with laws and Achieved across different levels and functions, continuously deepening environmental protection and
Operations regulations and relevant requirements pollution prevention and control work.
Environmental Compliance Management Framework
Energy and Enhance energy efficiency Carry out full lifecycle energy
Factory Leader
Resource-saving conservation and carbon
reduction actions. This year,
purchased electricity amounted Safety and Environmental
Equipment Department Cost Office Department of Energy
to 9,816,200 kWh. Protection Department
Continuously increase proportion of This year, the proportion of Environmental Protection Solid Waste
Equipment Safety Officer Cost Manager
clean energy use renewable energy use is 18.18%, Administrator Administrator
an increase of 5.19% compared
with the previous year
Responsibilities of the Environmental Compliance Management Framework
Emissions 100% compliance in waste disposal Achieved
Head of the Environmental Persons responsible
Reduction Department of Safety for environmental
Business leader protection
Protection departments
at factory boundaries
Fully responsible Presides over the Studying and Responsible for the
factory boundaries environmental the environmental local waste pollution of waste pollution
protection and protection functional prevention and control prevention and control
waste pollution institution, organizing laws and regulations, work in their respective
During the reporting period, we actively carried out environmental governance work and prevention and control employees to study implementing relevant departments, ensuring
invested RMB 257,700. These funds were used for hazardous waste disposal, equipment work, establishing and implement regulations and that environmental
maintenance and repair, and environmental improvement. The Company received no and allocating national and local company systems, protection and
environmental administrative penalties throughout the year. environmental environmental understanding the production are carried
protection functional protection laws situation of resource out simultaneously,
institutions, and and regulations, utilization and pollution organizing employees
guiding and and enhancing emissions, and putting to study and implement
supervising the work of environmental forward improvement environmental protection
relevant departments awareness suggestions to the regulations, and strictly
superior leaders and implementing the
relevant departments Company's relevant rules
and regulations
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
In terms of environmental compliance management and execution, Haier
Biomedical strictly follows relevant laws, regulations, and industry standards
such as the Environmental Protection Law of the People's Republic of China
and the Work Safety Law of the People's Republic of China . The Company
executes internal management systems such as the Environmental
Operation Management Control Procedures of Qingdao Haier Biomedical. ,
continuously strengthening the systematic management and control of
National Green Factory
environmental factors—including wastewater, exhaust gas, solid waste, and
Certification
noise—to ensure the compliant discharge of pollutants and the compliant
operation of the environmental management system.
ISO 14001 Environmental
Management System
During the reporting period, we passed the annual audit of the ISO 14001 Certification
environmental management system and completed the annual review of
the National Green Factory and obtained certification.
Haier Biomedical actively conducts environmental risk assessments, proactively identifies potential environmental safety risks,
and implements internal management systems such as the Emergency Response Plan for Sudden Environmental Incidents
to systematically enhance risk prevention, control, and response capabilities. Guided by emergency response plans, we take
targeted measures against environmental safety risks, effectively implementing production safety and environmental protection
through accident monitoring and prevention as well as regularly organized emergency training and rescue drills.
We have also established a systematic emergency organizational structure, with the Emergency Rescue Command Leading
Team, leading the way and the Emergency Response Office and its subordinate functional groups coordinating emergency
preparation and disposal work.
During the reporting period, we completed 17 special rectifications, 14 emergency drills, and 2,080 hidden danger
investigations, signed 2,829 safety responsibility statements, and had no major environmental pollution incidents occur
throughout the year.
Emergency Organization Structure
Emergency Rescue Command Leading Team
Emergency Response Office
Communication Alert and Emergency Rescue Medical Aid Material Support Accident
Contact Group Evacuation Group Group Group Group Investigation Group
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Green and Low-Carbon Transformation Actions
Haier Biomedical regards the efficient utilization of resources
• Actively respond to "dual carbon" strategic goals, systematically optimize the energy structure, and promote the application of
and energy as the core of green operations, constructing
renewable energy while continuously tapping into the energy-saving potential of production and operations.
and refining a resource-saving and environmentally friendly
• Advance projects such as green power procurement, distributed photovoltaic construction, and waste heat recovery to reduce
production and operation system. We continuously optimize
carbon emissions while lowering unit energy costs.
the energy structure, improve energy efficiency, promote
recyclable and eco-friendly packaging materials, and • Conduct special energy-saving diagnostics and technical upgrades for key energy-using systems and equipment, implementing
measures such as scheduled start-stop and intelligent regulation.
introduce water-saving technologies and water recycling
systems in production and operations to reduce overall
resource consumption. Meanwhile, we actively advocate Energy Security and Supply Guarantee Actions
and implement green office practices, promoting the low- • Refine the emergency plan system for energy supply and consumption, enhancing response and guarantee capabilities for
carbon transition of all operational links, and are committed sudden situations.
to contributing to the development of the circular economy • Optimize load management and peak-shaving energy use strategies to achieve optimization of energy costs on the basis of
and the construction of ecological civilization while ensuring continuous and stable production.
achieving our own "dual carbon" goals.
Digital and Lean Management Actions
refined energy management and control.
Haier Biomedical comprehensively implements the Energy
Management Policy , taking green energy application and
Energy consumption across Haier Biomedical’s operations primarily comprises electricity, natural gas, and heating. Through targeted
the overall improvement of energy efficiency as key links
measures—including energy efficiency technology upgrades, the ongoing deployment of photovoltaic systems, and enhanced
in operational management. To meet the needs of low-
maintenance to optimize performance—we have reduced energy waste, increased the share of clean energy in our power mix, and
carbon and energy-intensive management, we have clarified improved overall energy efficiency. During the reporting period, Haier Biomedical’s total renewable energy consumption reached 2.367
the centralized responsibility for energy management and million kWh, accounting for 18.18% of the total electricity consumption.
strengthened full-chain management from decision-making
to execution. By configuring specialized positions such as Based on our operational requirements, we continuously implement energy efficiency and consumption reduction initiatives, while
energy conservation, carbon accounting, and green power setting scientific, data-driven energy cost reduction targets to support the transition to a low-carbon production model and reduce
management, we provide professional support for refined energy costs.
energy management.
Meanwhile, we continuously refine the online energy
monitoring system, which enables real-time data collection 2025 Energy Management Targets In 2025, energy costs
and the analysis of energy consumption for key equipment were reduced by
and production links. This drives the intelligent transformation
of management from "post-event statistics" to "pre-event
• Conduct energy-saving diagnosis and transformation for key energy-using systems and
equipment, and implement low-carbon projects such as scheduled startup, increasing energy RMB 500,000
storage, and intelligent regulation.
prediction and in-event control". Based on the Company’s
annual energy consumption and green power targets, we • Standardize carbon accounting and energy consumption statistics to provide accurate data compared to the previous
year, with an actual target
have established a closed-loop management mechanism of support for the Company’s carbon asset management and ESG disclosure.
completion rate of
monthly analysis, quarterly review, and annual evaluation to
• Refine energy supply and consumption plans, and optimize load management and peak-
ensure that all measures are implemented effectively. shaving strategies to achieve optimal costs under the premise of ensuring production stability. %
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Refined Control Project for CASE 4.3.2 Production Resource Usage
Heating System
Haier Biomedical values the responsible use of natural resources. We focus on resource usage optimization, the promotion
To reduce heating-related energy consumption and of eco-friendly materials, and the application of innovative technologies to achieve the efficient utilization of production
operating costs, we implemented refined control resources. In addition we utilize low-carbon and environmentally friendly production and operation models, reducing resource
measures for the park’s heating system during the consumption and waste generation throughout the process. This was achieved through the by implementation of circular
year. This included operational practices such as economy concepts and constructing a resource closed-loop management system.
shutting down systems outside working hours and
during holidays, alongside dynamically adjusting heat
Water Resource Management
exchange parameters in response to weather conditions.
Water resource management is a key priority for Haier Biomedical. Through the implementation of the Water Resource
These measures have strengthened demand-based
Management System , we standardize water use across all operations to reduce unnecessary consumption and minimize waste.
thermal energy management and improved overall
We have set a clear goal to reduce total water consumption by 1.5% by 2025 compared to 2024. To achieve this we implement
efficiency. During the reporting period, the annual
water-saving measures across multiple aspects within our operations, including process optimization, recycling, and equipment
heating cost savings decreased by RMB 77,900 year-on-
upgrades, resulting in the continuous improvement of water resource use efficiency.
year, significantly improving energy utilization efficiency
while ensuring a comfortable working environment. During the reporting period, the Company’s total water consumption was 81,300 m3, and the water consumption intensity was
During the reporting period, the energy consumption
data of Haier Biomedical is as follows. Water-Saving Measures
Water-saving Process Analyze water consumption nodes in production links and implement process
Haier Biomedical's Energy Consumption for 2025
Transformation transformation and technical updates to reduce water usage.
Indicator 2025 Unit
Constructing Water Perform reclaimed water reuse through rainwater collection and production process
Recycling Systems water recovery to improve the water resource recycling rate.
Total energy consumption 13,023.45 MWh
Adding Pure Water Improve water quality while reducing scale generation and cleaning water
Total consumption of non- 10,656.03 MWh Equipment consumption.
renewable energy
Refining Equipment Reduce equipment failures caused by water quality issues and lower maintenance
Operation and Maintenance frequency.
Total consumption of renewable 2,367.42 MWh
energy
Internal Advocacy Enhance employee water-saving awareness and require employees to turn off
faucets promptly through multi-form water-saving advocacy such as fixed-point
Proportion of renewable energy 18.18 % posting of reminders.
consumption
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Optimization and Transformation Project for the Foaming Process Water System CASE
During the reporting period, to address issues such as unstable water quality and low recycling rates in the original foaming
process—which led to equipment scaling and high maintenance costs—we implemented a specialized water system
optimization and transformation. By adding pure water equipment to stabilize water quality, optimizing processes to build
a recycling system, and refining maintenance control, we achieved a dual improvement in water resource utilization and
production stability. After the transformation, the process water recycling rate increased from 30% to 60%, daily average raw
water consumption decreased by 50%, and the frequency of equipment failure maintenance dropped by 60%, enhancing
the operational reliability and comprehensive energy efficiency of the production system while achieving the water-saving
and consumption-reduction targets.
Packaging Material Management
Haier Biomedical is committed to building a comprehensive green packaging system, continuously promoting packaging
structure optimization and eco-friendly material innovation to reduce resource consumption and environmental impact from
the source. 100% of our product packaging is made of degradable or recyclable materials, and we have comprehensively
banned the use of polyvinyl chloride (PVC), polystyrene (PS), and other harmful substances such as mercury. During the
reporting period, we fully promoted packaging lightweighting and compacting design reconstruction, prioritizing the use of
renewable and biodegradable eco-friendly materials. While reducing the amount of packaging consumables, we promote the
recycling of packaging materials and deeply practice the circular economy concept.
Packaging Structure Optimization and Material Upgrade
Packaging Structure Optimization Eco-friendly Material Upgrade
We continue to promote the lightweighting, compacting, We prioritize renewable and degradable eco-friendly
and modular design of packaging structures. Through packaging materials and continuously promote the
reducing layers and thickness and ensuring precise iteration of the material system. During the reporting
size adaptation, we have achieved a reduction of period, we introduced honeycomb cartons to gradually
approximately 15% in packaging consumables while replace some small-sized BC corrugated packaging.
ensuring protection performance. During the reporting Utilizing the characteristics of this material—such
period, specifically for the vertical cabinet packaging of as being lightweight, having high cushioning, and
solar vaccine cabinets, we achieved the compatibility of strong load-bearing capacity—we achieved an average
a single package with multiple product models through reduction of 20%–30% in raw material consumption
structural reconstruction, reducing packaging material after replacement, further reducing the entire lifecycle
consumption by nearly 20% and significantly enhancing environmental footprint while enhancing packaging
material utilization efficiency and logistics compatibility. sustainability.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Office Resource Management
Haier Biomedical fully implements sustainable development requirements, comprehensively integrating green and low-carbon
concepts into daily operations. During the reporting period, we further focused on systematic and digital management and
control. By deepening paperless office practices and refined electricity and water conservation management, we continuously
improve the efficiency of office resource use and reduce environmental impact.
Green Office Practices
Environmentally Friendly Paper Use and Efficient Office Work
• Promoted double-sided printing, paperless office, and electronic financial reimbursement to reduce paper waste and improve work
efficiency.
• Implemented paperless electronic communication processes to achieve 100% online file circulation, approval, and archiving.
Maintained a 100% electronic contract signing rate and improved file circulation efficiency by 60%.
• Promoted electronic whiteboards and wireless screen mirroring in meeting scenarios. Digitized archives with cloud storage to drive a
significant decline in paper use across the entire chain.
Energy Conservation and Green Power Consumption
• Upgraded lighting systems and promoted the use of energy-saving light bulbs.
• Executed the “power off when leaving” policy and arranged for safety personnel to conduct daily electricity re-inspections to ensure
equipment is completely shut down during non-working hours.
• Promoted smart sockets and implemented time-sharing power supply control for office equipment.
• Standardized air conditioning at an energy-saving temperature of 26°C during summer. Required the scientific use of AC and ensured
units are turned off upon departure.
Green Dining and Resource Conservation Green Transportation and Low-carbon Travel
• Encouraged ordering meals on demand to reduce waste, and • Chose eco-friendly modes of transport.
actively responded to the Clean Plate campaign. • Installed new energy charging piles within the park, supported
• Improved employees' environmental awareness, advocated and encouraged employees to use new energy vehicles for
rational dining, and reduced food waste. commuting, and promoted low-carbon travel.
Waste Classification and Recycling Green Water Use and Resource Control
• Implemented classification and recycling for office waste to • Set up water-saving reminders in public water areas such as
reduce environmental pollution and promote resource reuse. pantries and restrooms to advocate for “taking water as
needed” and cultivate conservation habits.
• Eliminated constant running water through daily inspec-
tions and promotional guidance to achieve effective control
of total office water consumption.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical always regards the compliant management and standard-meeting discharge
of pollutants as an important baseline of environmental management. We strictly comply with
laws and standards related to pollutant discharge in the locations of operation and formulate General wastes
corresponding management regulations and control procedures for different pollutants, taking
active measures to strengthen environmental management and continuously reduce pollutant • Production Department - Responsible for the classification, collection, and sealed packaging of
emissions. waste, and centrally deliver it to the scrap storage for classified storage
• Scrap Storage Administrator - Taking the lead in the collection, storage, and treatment of general
• Recycling Vendor - Responsible for confirming the weighing data together with the waste
Haier Biomedical strictly complies with laws and regulations such as the Environmental Protection administrator and the weighing personnel, and cleaning up the site on a regular basis
Law of the People's Republic of China , the Law of the People's Republic of China on the Prevention
and Control of Environmental Pollution by Solid Wastes , and the Measures for the Prevention and Hazardous waste management
Control of Environmental Pollution by Waste Hazardous Chemicals and implements the Waste
Management Control Procedure to ensure the compliant disposal of waste. We continuously refine • Equipment-related Departments - Responsible for disposing of scrap equipment resources, and
the waste management process and conduct standardized management and control over the classifying and storing hazardous waste such as used oil and oil drums in the hazardous waste
entire process of waste generation, storage, transportation, and disposal in accordance with national storage, with strictly prohibited mixture with general waste for treatment
and local regulations, reducing the adverse impact of waste on the environment. • Energy Project Administrator - Responsible for sourcing hazardous waste treatment manufactur-
ers, signing contracts, and liaising with environmental regulatory authorities
The general waste we produce mainly includes 29 categories, such as waste paper, waste iron, and • Safety and Environmental Protection-related Departments - Responsible for the safety inspection
waste wood, while hazardous waste covers 10 categories, including waste circuit boards, waste and maintenance management of the hazardous waste storage and scrap storage
activated carbon, and liquid foaming materials.
Disposal of returned and exchanged market products
Regarding general and hazardous waste, we implement strict classification control and construct
a three-tier responsibility management system. In the storage and disposal links, we execute
• After-sales Repair Department - Responsible for receiving market machines for return and
partitioned and isolated storage for hazardous waste, and carry out the recycling of general waste
replacement and prototype machines for development testing. Waste materials such as casings,
and the biochemical treatment of kitchen waste, strictly preventing potential environmental risks
doors, glass, and metal from disassembled units must be managed through recycling vendors to
from waste stacking. For waste that cannot be processed internally, we entrust professionally
ensure that waste is segregated and controlled and avoid mixing them together
qualified third-party institutions for compliant disposal according to law.
During the reporting period, we further standardized the disposal and transportation processes for
hazardous waste. To improve transfer safety, we implemented mechanisms for regular qualification Haier Biomedical responds to the nation-
audits of partners, transportation route optimization, certification for transportation personnel, and
al call for “Waste-free City” construction
regular training and emergency drills, further deepening risk management and control during the
and actively promotes the construction
transfer process. Furthermore, we strengthened the management and control of hazardous chemical
of waste-free factories, having passed the
storage, optimizing storage facilities and zoning according to national standards, and implemented
dynamic risk management and monthly storage safety inspections to ensure the continuous Qingdao municipal-level “Waste-free
implementation of classified collection and compliant disposal of hazardous waste. Factory” certification.
To improve the transparency and timeliness of waste management, we introduced QR code
traceability technology, achieving real-time connection and overdue warning mechanisms with the
national solid waste management system. During the reporting period, the Company’s compliant
disposal rate of solid waste reached 100%, and the resource utilization rate of general solid waste
reached 98%. “Waste-free Factory” Certification.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Exhaust Gas Emission Control Measures
To reduce the impact of production and operations on the
atmospheric environment, Haier Biomedical strictly follows
laws and regulations such as the Atmospheric Pollution Organized emission of industrial exhaust gas
Prevention and Control Law of the People's Republic of China .
The Company strictly executes the Environmental Operation • Photo-oxygen catalytic equipment and baghouse filters: Deploy photocatalytic oxidation equipment and bag filters
Management and Control Procedure , implementing "one for real-time treatment to ensure stable and compliant exhaust gas discharge.
source, one policy" differentiated management for exhaust
gas generated from multiple sources. We ensure that exhaust • Welding Exhaust Gas Control: Install gas collection hoods above welding stations; exhaust gas is discharged after
gas emissions meet environmental protection requirements being processed by dust collectors through ventilation devices to reduce the diffusion of welding fumes in the
by d e p l oy i n g a 2 4 - h o u r o n l i n e m o n i to r i n g sys te m , workshop.
complemented by weekly inspections and annual third-party • Foaming and Adsorption Exhaust Gas Control: Implement sealed isolation for foaming and adsorption processes;
monitoring. exhaust gas is collected by ventilation devices and discharged after being treated by photocatalytic oxidation
facilities.
The exhaust gas produced during our production process
• Flammable Gas Monitoring: Deploy flammable gas detection alarms in key processes such as foaming and welding
mainly originates from welding, foaming, and adsorption
to achieve early warning of environmental risks and safety accidents.
processes, including welding fumes, foaming exhaust gas,
and volatile organic compounds (VOCs) generated during • Equipment Maintenance: Establish daily inspection and maintenance mechanisms for environmental protection
adsorption. We select clean raw materials, auxiliary materials, facilities such as exhaust fans; implement mandatory replacement of key consumables—including exhaust pipes, filter
and energy, and implement normalized maintenance for bags, and activated carbon—every half year.
exhaust gas treatment equipment to reduce exhaust gas • Catalytic Combustion: Utilize photocatalytic oxidation to treat organic exhaust gas; mineralize pollutants through the
generation from the source. We also equip employees in reaction between strong oxidizing substances and exhaust gas molecules, achieving a treatment efficiency of over
relevant positions with labor protection facilities such as 95% with almost no by-products such as nitrogen oxides.
respiratory filtration devices to continuously optimize the
production and operation environment while safeguarding
employees' occupational health. During the reporting period,
we achieved 100% compliant exhaust gas discharge, and Unorganized emission of industrial exhaust gas
VOCs emissions decreased by 30% year-on-year.
• Maintain good ventilation in the workshops by reasonably regulating the opening and closing of exhaust fans and
factory windows under the premise of meeting production process requirements, thereby reducing the impact of
fugitive emissions.
Kitchen fume and exhaust gas
• Discharge kitchen fume after treated by purification devices to meet standards.
• Conduct quarterly cleaning and maintenance of the kitchen fume extraction system and add high-efficiency oil
fume purifiers to enhance oil fume treatment efficiency.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Haier Biomedical attaches importance to wastewater discharge during production and To mitigate the impact of business activities on employees and surrounding communities,
operations and rigorously carries out compliant wastewater discharge management. We Haier Biomedical has constructed a three-tier management system consisting of
strictly comply with laws and regulations such as the Water Pollution Prevention and source noise reduction, transmission control, and personal protection. By optimizing
Control Law of the People's Republic of China and implement internal systems such as the equipment selection, improving production processes, and strengthening daily production
management, the Company achieves reduction control at the source of noise. Furthermore,
Environmental Operation Management and Control Procedure to standardize wastewater
we entrust third-party institutions to conduct regular monitoring of workshop and boundary
disposal and discharge processes, ensuring that wastewater discharge meets national
noise to ensure that emission indicators meet national limit requirements. In response to
environmental protection standards. The Company's wastewater mainly originates from
abnormal monitoring results, we implement root cause analysis and rectification plans,
domestic sewage in canteens, dormitories, and office areas, all of which are discharged continuously refining the noise compliance management system while safeguarding the
compliantly through the municipal sewage pipe network. safety of the working environment.
Wastewater Pollution Control Measures Noise Control Measures
• Equipment Selection and Procurement: Prioritize the selection of low-noise equip-
• Domestic Wastewater Management: Discharge living wastewater from the plant
ment and achieve noise reduction at the source by isolating high-noise equipment or
area into the municipal pipe network.
installing soundproof covers and vibration damping pads.
The oily wastewater from the canteen is pre-treated in the oil separation tank and
• Daily Maintenance: Perform regular lubrication and maintenance on equipment to
then uniformly discharged. Ensure that qualified third-party institutions regularly
ensure smooth operation and reduce noise generation.
perform cleaning and maintenance on canteen wastewater treatment devices to
guarantee stable and efficient equipment operation. • Reasonable Layout and Scheduling: Optimize equipment layout to avoid the centralized
arrangement of high-noise equipment and rationally schedule the operating hours of
• New construction and expansion projects: Strictly implement national environmental high-noise equipment to reduce the impact on the surrounding environment.
protection laws and regulations for new and expansion projects, and ensure that
• Employee Protection: Equip employees in high-noise positions with earplugs and
wastewater treatment facilities are designed, constructed, and put into operation
earmuffs and conduct regular hearing tests to safeguard employees' occupational health.
simultaneously with the main body of the project, implementing environmental
requirements from the source of construction.
• Treatment of equipment waste oil: Implement sealed packaging and partitioned
storage mechanisms for waste oil and oil-containing waste (such as oil gloves and oil
impregnated cotton yarn) generated from equipment maintenance.
Timely hand over such waste to qualified professional institutions for compliant
disposal to avoid environmental pollution caused by the leakage or volatilization of
pollutants.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
As global climate challenges intensify, Haier Biomedical recognises the impact of climate
change on its operations and long-term development. We continue to refine the governance
framework for climate change and carbon peaking and carbon neutrality, deepen the
identification of and response to climate risks and opportunities, and focus on enhancing
our business resilience and climate adaptation capabilities with energy saving and carbon
reduction as the core strategy and path, promoting the industry’s climate transition.
Haier Biomedical has constructed a "dual carbon" governance structure consisting of the
"Group's Carbon Peaking and Carbon Neutrality Committee— the Carbon Peaking and Carbon
Neutrality Professional Committee—Functional Departments". It is led by senior management,
and the members cover core talents from various departments such as R&D, manufacturing,
supply chain, and marketing. By integrating professional resources from multiple fields, we
incorporate low-carbon strategic goals into all aspects of the business to ensure the effective
implementation of emission reduction plans.
Group's Carbon Peaking and Carbon
Neutrality Committee
Carbon Peaking and Carbon
Neutrality Professional Committee
Product Energy Government International
Manufacturing New Business Brand Strategy Procurement Marketing
Design
Department Management Affairs
Department Department Department Department
Department Department Department Department
Governance Structure of the Carbon Peaking and Carbon Neutrality Professional Committee
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Based on the framework and recommendations of the Task Force on Climate-related Financial Disclosures (TCFD), we proactively identify and analyze the climate change risks and opportunities that
our operational and production activities may face. We comprehensively assess the potential impact on various stages of business operations and formulate corresponding response strategies and plans,
achieving proactive climate risk management and effective response measures.
Climate Change Risks Inventory
Risk Type Potential Impact Response Measure
• Formulate the Special Emergency Response Plan for Natural Disaster Accidents, establish an
Floods and other disasters caused by typhoons and heavy rain may damage emergency command headquarters and specialized action groups, and adopt graded response
Typhoon and and classified disposal measures for extreme weather.
factory facilities, office buildings, and critical equipment, leading to asset loss and
Heavy Rain
impairment, and threatening employee travel safety. • Conduct regular emergency drills for extreme climate.
• Strengthen the construction of flood control, typhoon prevention, and drainage infrastructure.
Acute Risk • Promote energy-saving technical upgrades for cooling and cooling equipment in office spaces and
production bases to improve equipment energy utilization efficiency.
Extreme heat at operation sites may lead to a surge in cooling loads for high- • Scientifically plan production scheduling and operation arrangements, flexibly adjust working
Extreme Heat energy-consuming facilities, increasing energy costs; meanwhile, it affects the health hours based on temperature changes to reduce the impact of high temperatures on production
Physical and safety of employees engaged in outdoor work organization.
Risk • Refine high-temperature early warning and guarantee mechanisms, providing employees with
necessary heatstroke prevention supplies and protective equipment.
• Continuously monitor the operation of critical equipment such as air conditioners; introduce smart
The continuous rise in mean temperature will increase the number of extreme energy management systems as appropriate to achieve energy consumption monitoring and early
Rising Mean heat days in summer, causing abnormal energy consumption loads on cooling warning for power-using equipment, and optimize energy use plans accordingly.
Temperature equipment in office spaces and production bases, thereby increasing equipment
Chronic failure rates, daily maintenance costs, and energy costs. • Increase investment in energy-saving technical upgrades to improve overall operational energy
Risk utilization efficiency.
• Closely monitor geographical and climatic information in coastal areas and link up with local
Sea level rise may cause damage to coastal operation sites and assets, leading to
Sea Level Rise governments and environmental protection agencies to ensure timely response under extreme
asset impairment and depreciation.
flooding scenarios.
Changes in Against the background of global climate change and the national "dual carbon" • Establish a normalized mechanism for tracking climate policies and assessing their impact to pre-
Policy and climate and strategy, domestic and international environmental or climate policies and plan compliance paths.
Legal Risk environmental mandatory disclosure requirements are becoming stricter, thereby increasing • Conduct timely and truthful disclosure of climate and environmental performance in accordance
policies environmental and climate compliance costs for enterprises. with external policies, regulatory rules, and requirements.
To comply with the low-carbon transition trend of the market and industry, the • Assess the feasibility of relevant technologies to reduce the risk of investment failure, and
Low-carbon Company needs to invest significant costs to develop low-carbon and green implement technology R&D in batches according to internal budgets.
Technology
Technology technologies to enhance the energy-saving and carbon-reduction attributes of
Risk • Fully leverage the low-carbon technology advantages of products, services, and solutions to
Development products and operational energy utilization efficiency, leading to increased R&D and
operating costs. maximize economic benefits.
Transition
Risk Customers (such as hospitals, universities, research institutions, etc.) have an
Changes in
increasingly significant preference for the low-carbon and eco-friendly attributes of • Continuously promote the innovative R&D of green products and low-carbon full-scenario solutions
Customer
Market Risk products. If the Company fails to respond timely to market demand for green, low- to meet emerging market demands, and enhance customer loyalty by empowering downstream
Behavior and
carbon, and energy-saving products, it may face risks of customer loss and a decline users to reduce carbon.
Preferences
in market share.
Against the background of global climate change, stakeholders (especially investors, • Continuously refine the climate governance system, strengthen the application of energy-saving
customers, and the public) are continuously increasing their focus on the Company’s and carbon-reduction technologies, and continuously improve climate-related performance to win
Reputation trust from all parties.
Brand Image climate governance and performance. If the Company has negative public opinion
Risk
regarding carbon reduction performance, environmental compliance, or climate risk • Strengthen the stakeholder communication mechanism, regularly publish ESG reports and
response, it may damage the Company’s image and lead to customer loss. specialized disclosure documents, and actively respond to climate issues.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Climate Change Opportunities Inventory 4.5.3 Risk Management
Opportunity Potential Impact Response Measure Haier Biomedical is committed to establishing and refining the climate risk and opportunity
Type management mechanism. We have integrated the identification of and response to climate
risks and opportunities into the Company's daily operations and management decisions.
Resource By introducing high-efficiency • Co n t i n u o u s l y p r o m o t e e n e r g y - s av i n g
Based on the results of risk and opportunity identification, we formulate corresponding
Efficiency production equipment and energy- technical upgrades and implement refined
saving renovation measures such energy management to improve operational
mitigation and adaptation strategies to ensure that climate risk management is synergistic
as optimizing air conditioning and energy utilization efficiency. with the Company's long-term development strategy.
l i g h ti n g sys te m s , t h e Co m pa ny
• Actively layout clean energy, increase the
will be assisted in reducing energy
and operating costs and improving
proportion of self-consumed photovoltaic 4.5.4 Metrics and Targets
power, improve the energy use structure,
profitability.
and reduce dependence on traditional Haier Biomedical actively responds to national "dual carbon" reduction goals and strategic
energy. priorities, focusing on developing a climate action pathway aligned with its business
model and long-term development strategy. We routinely track climate-related metrics
Products and As the global medical and scientific • Increase R&D investment in green products and performance to continuously enhance the transparency and refinement of climate
Services research fields transition toward low- and launch more products and services
governance. During the reporting period, our greenhouse gas (GHG) emission data3 is as
carbon operations, the Company’s with energy-saving and carbon-reduction
follows:
green products and solutions attributes to comprehensively enhance the
fa ce m a r ke t o p p o r t u n i t i e s . Th e green and low-carbon competitiveness of
Company can occupy the high- products.
end market through technological
Indicator Unit 2025
• Actively explore grants or subsidies for green
empowerment, obtaining higher
and low-carbon products to accelerate the Scope 1 greenhouse gas emissions tonnes of CO2e 206.37
brand premiums and operating
market application of green technologies.
income.
Scope 2 greenhouse gas emissions tonnes of CO2e 7,072.30
Total greenhouse gas emissions tonnes of CO2e 7,278.67
Total greenhouse gas emission intensity kg of CO2e/RMB 10,000 31.26
As factories in Haier Haematologi, Suzhou, and other locations commenced operations in 2025, their
production activities have not yet stabilized. To ensure data consistency, accuracy, and comparability, their
data have not been included in the Company’s greenhouse gas emissions accounting for the current year.
The Company will include them in the statistics once their production operations have stabilized.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Biodiversity Center in the Netherlands
CASE
A healthy ecosystem is fundamental to Haier Biomedical’s long-term sustainability. We strictly
comply with laws and regulations such as the Environmental Impact Assessment Law of the Haier Biomedical supports global biodiversity conservation with innovative low-temperature
People's Republic of China. In project site selection, construction, and daily operations, we fully storage technology, providing reliable ultra-low temperature storage solutions for the
incorporate considerations for the surrounding environment and biodiversity conservation, Naturalis Biodiversity Center in the Netherlands. As a top international natural history research
minimizing adverse impacts on ecosystems to the greatest extent possible. Our operating institution, the cutting-edge research of the Naturalis Biodiversity Center highly depends
sites do not involve ecologically sensitive areas or ecological protection red lines, and we are on the long-term integral preservation of precious biological samples. Through professional
committed to ensuring the safety of the surrounding environment and ecosystems through and stable ultra-low temperature equipment, Haier Biomedical provides a safe and stable
a strict environmental compliance management system. We also actively participate in preservation environment for its key biological sample resources, strongly supporting
biodiversity conservation initiatives, support ecological restoration and habitat protection continuous research in fields such as genetics and ecology.
practices, and enhance the ecological awareness of employees and stakeholders through
environmental education to jointly build a community of all life on Earth.
Supporting Agricultural Scientific Research and Ecological
Haier Biomedical is fully engaged in the life sciences and medical innovation fields. Relying on
leading ultra-low temperature and automated storage technologies as well as IoT solutions, it Protection
provides solid and reliable platform support for global germplasm resource banks, biological
sample banks, and genetic resource protection. This assists in global biodiversity conservation, Haier Biomedical Light Incubators Empower a New Ecosystem CASE
agricultural breeding innovation, and major disease research, contributing fundamental for Agricultural Research
strength to safeguarding human life and health and the sustainable development of the
planet. In the current era of efficient and sustainable agricultural development, Haier Biomedical
centers its efforts on temperature control technology. Focusing on the characteristics of
Empowering Low-Temperature Storage of Biological Samples agricultural research and comprehensively considering multi-dimensional factors such
as "temperature, light, water, air, and fertilizer" required for plant growth, we innovatively
In the field of biodiversity conservation and sustainable scientific research, reliable technical developed the light incubator HGP-860 to create a stable and controllable cultivation
infrastructure is the key to ensuring the long-term safe preservation of genetic resources and environment for samples. In November 2025, Haier Biomedical light incubators officially
biological samples. Through independently developed advanced low-temperature storage entered Kadoorie Farm and Botanic Garden in Hong Kong, injecting strong momentum
equipment and smart management solutions, Haier Biomedical provides stable and precise into agricultural research and biodiversity conservation.
sample preservation environments for global biodiversity research institutions, aiding in the
long-term protection and scientific application of precious biological resources.
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Appendix
ESG Performance Indicators
Economic performance
Indicators Unit 2023 2024 2025
Operating income One hundred million RMB 22.81 22.84 23.28
Net profit to parent One hundred million RMB 4.06 3.67 2.55
Environmental performance
Indicators Unit 2023 2024 2025 Indicators Unit 2023 2024 2025
Environmental protection investment Water
Investment in Total water consumption m3 76,265 81,736 81,300
Ten thousand RMB 30.54 35.00 25.77
environmental protection
Water consumption
m3/ten thousand RMB 0.33 0.36 0.35
Time in environmental intensity
hours 2,860 2,574 2,139
protection
Greenhouse gas
Energy
Total GHG emission Tonnes of CO2e 6,812.06 7,309.07 7,278.67
Total energy consumption MWh 12,915.81 10,908.69 13,023.45
Scope 1 Tonnes of CO2e 252.07 458.12 206.37
Direct energy MWh 1,869.86 1,783.84 2,440.05
Scope 2 Tonnes of CO2e 6,559.99 6,850.95 7,072.30
Indirect energy MWh 11,045.95 10,383.29 10,583.40
kg CO2e /ten thousand
GHG emission intensity 29.87 32.00 31.26
Purchased electricity MWh 9,949.83 9,492.39 9,816.18 RMB
Purchased heat MWh 1,096.12 890.90 767.22 GHG emission reduction Tonnes of CO2e / / 418.84
Total consumption of non- Investments in GHG
MWh 11,368.16 9,492.39 10,656.03 Ten thousand RMB / / 23.60
renewable energy emission reduction
Total consumption of Waste
MWh 1,547.65 1,416.30 2,367.42
renewable energy
General waste Tonnes 930.45 480.00 409.10
Percentage of renewable
% 11.98 12.98 18.18 Hazardous waste Tonnes 8.60 3.65 4.89
energy consumption
Energy consumption kWh/ten thousand Total waste disposal Tonnes 824.46 480.00 409.10
intensity RMB
Total hazardous waste
Tonnes 6.98 3.65 5.32
disposal
Waste recycled Tonnes / / 34.9
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Social performance
Indicators Unit 2023 2024 2025 Indicators Unit 2023 2024 2025
Product and service Production person 893 990 1,058
Domestic customer satisfaction % 99.94 99.96 99.94 Number of new hires person 573 462 495
Customer complaint resolving rate % 100 100 100 Male person 418 281 327
Total patents item 1,321 1,595 1,620 Female person 155 181 168
New invention patents application item 146 143 148 Number of ethnic minority employees person / 45 42
Total software copyrights item 296 392 428 Percentage of ethnic minority
% / 1.60% 1.43%
employees
Number of external regulatory
times / 27 41
inspections Percentage of female employees % 28.00 29.90 30.00
Number of suppliers Percentage of female in senior
% 37.50 75.00 66.67
management
China / 559 589 612
Percentage of vacancies filled by
Other countries and regions / 9 9 8 % 38.30 30.73 33.64
internal candidates
Employment Training for employees
Number of employees person 2,636 2,807 2,945 Average training hours Hour/person 34.32 35.26 36.29
Male person 1,898 1,967 2,062 Percentage of employees trained % 100 100 100
Female person 738 840 883 Training coverage % 100 100 100
By region Ten thousand
Employee training expenditure / / 86
RMB
China person 2,607 2,771 2,908
Training coverage by gender
Other countries and regions person 29 36 37
Male % 72 70 70
By age group
Female % 28 30 30
Under 30 person 810 793 772
Average training hours by gender
Male Hour/person 34.61 35.58 36.58
Over 50 person 126 110 138
Female Hour/person 33.59 34.52 35.61
By function
Anti-corruption training coverage % 100 100 100
Technical person 933 835 841
Anti-corruption training coverage for
Sales person 680 693 753 % / / 66.67
the Board
Finance person 33 41 40 Anti-corruption training coverage for
% / / 100
the Management
Administration person 97 248 253
Fair competition training coverage % 100 100 100
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Shanghai Stock Exchange Guidelines Index
Indicators Unit 2023 2024 2025 Dimension Number Issue Index
Employee engagement and satisfaction 1 Climate response 4.5 Address Climate Change
Percentage of highly engaged 4.4.2 Exhaust Gas Management
% 87.00 89.40 87.80 2 Pollutant discharge
employees 4.4.3 Wastewater Management
Percentage of highly satisfied 3 Waste disposal 4.4.1 Waste Management
% 83.00 88.60 85.00
employees
Ecosystem and biodiversity
Percentage of Employees Covered by 4 4.6 Biodiversity Production
% 100 100 100 conservation
CBAs Environment
Environmental compliance
Ten thousand 5 4.2.2 Environmental Compliance System
Per capita revenue generation / 81.36 83.57 management
RMB
Occupational health and safety
Occupational health and safety training
% / / 100
coverage for employees 8 Circular economy 4.3.2 Production Resource Usage
Number of work-related fatalities person 0 0 0 3.2.2 Community Contribution and Rural
Revitalization
Number of working days lost due to
days 0 0 0
work-related injury 3.2.2 Community Contribution and Rural
Lost time injury frequency rate LTIFR % 0 0 0
The completion rate of risk rectification % 100 100 100
Emergency response rate % 100 100 100 12 Ethics of science and technology
Protection
Society 13 Supply chain security
Equal treatment of small and
medium-sized enterprises
Product and service safety and
quality
Data security and customer 2.1.5 Information Security and Privacy
privacy protection Protection
Sustainability-
related Anti-commercial bribery and
governance 20 2.1.3 Business Ethics
Employee lost time injury frequency LTIFR= Number of work-related injuries *1000000/ Total working hours anti-corruption
*100% 2.1.4 Anti-unfair Competition and
Prohibition of Conflicts of Interest
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
GRI Standards Index
Item Content Index Item Content Index
Universal Standards 2-16 Communication of critical concerns Sustainability Governance
GRI 1: Foundation 2021 2-17 Collective knowledge of the highest governance body Sustainability Governance
GRI 2: General Disclosures 2021 2-18 Evaluation of the performance of the highest governance See our 2025 Annual Report
body
The organization and its reporting practices
Profile 2-20 Process to determine remuneration See our 2025 Annual Report
reporting constraints.
information during the reporting
period. 2-23 Policy commitments See individual sections
the Report.
Activities and workers
Profile
Governance Profile
body
GRI 3: Material Topics 2021
management of impacts 3-1 Process to determine material topics Sustainability Governance
reporting
Prohibition of Conflicts of Interest
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Item Content Index Item Content Index
Topic Standards 302-2 Energy consumption outside of the organization 4.3.1 Energy Efficiency Management
GRI 201: Economic Performance 2016 302-3 Energy intensity 4.3.1 Energy Efficiency Management
information. Some data are omitted
due to confidentiality constraints. 302-5 Reductions in energy requirements of products and 4.1 Green Products
services
due to climate change GRI 303: Water and Effluents 2018
plans
GRI 202: Market Presence 2016
to local minimum wage constraints. 303-5 Water consumption 4.3.2 Production Resource Usage
community constraints.
GRI 204: Procurement Practices 2016 to, protected areas and areas of high biodiversity value
outside protected areas
GRI 205: Anti-corruption 2016 biodiversity
policies and procedures species with habitats in areas affected by operations
GRI 206: Anti-competitive Behavior 2016 305-1 Direct (Scope 1) GHG emissions 4.5.4 Metrics and Targets
and monopoly practices Prohibition of Conflicts of Interest
GRI 301: Materials 2016 constraints.
GRI 302: Energy 2016 305-7 Nitrogen oxides (NOx), sulfur oxides (SOx), and other Not applicable
significant air emissions
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
Item Content Index Item Content Index
GRI 306: Waste 2020 403-8 Workers covered by an occupational health and safety 3.1.6 Occupational Health and Safety
management system
GRI 404: Training and Education 2016
GRI 308: Supplier Environmental Assessment 2016 assistance programs
criteria and career development reviews
actions taken
GRI 401: Employment 2016 employees
men constraints.
provided to temporary or part-time employees GRI 406: Non-discrimination 2016
GRI 402: Labor/Management Relations 2016 GRI 407: Freedom of Association and Collective Bargaining 2016
of association and collective bargaining may be at risk
GRI 403: Occupational Health and safety 2018
GRI 408: Child Labor 2016
investigation
GRI 409: Forced or Compulsory Labor 2016
on occupational health and safety
GRI 410: Security Practices 2016
safety impacts directly linked by business relationships
peoples
About This Chairman's About Haier Sustainability Global Technology Expansion, Innovation-Led: Integrity and Shared Success: Sharing the Future: Leading Green Symbiosis:
Content Report Statement Biomedical Governance Serving Global Health Safeguarding the Life Barrier Ensuring Steady Development People-Centered Shared Prosperity Driving Ecological Harmony Appendix
UNGC Principles Index
Item Content Index Human Rights Index
GRI 413: Local Communities 2016
Principle 1: Businesses should support and respect the
assessments, and development programs
Rural Revitalization 3.1.1 Talent Attraction
rights abuses
Labor Index
impacts on local communities
GRI 414: Supplier Social Assessment 2016 Principle 3: Businesses should uphold the freedom of
association and the effective recognition of the right to 3.1.5 Talent Care
taken 3.1.1 Talent Attraction
compulsory labor;
GRI 415: Public Policy 2016
Principle 5: the effective abolition of child labor; and 3.1.1 Talent Attraction
and service categories Principle 6: the elimination of discrimination in respect of
employment and occupation
GRI 416: Customer Health and Safety 2016
Environment Index
safety impacts of products and services Structure
Principle 7: Businesses should support a precautionary approach
GRI 417: Marketing and Labeling 2016 to environmental challenges; 4.2.2 Environmental Compliance System
labeling
service information and labeling
Principle 8: undertake initiatives to promote greater
communications 4.5 Response to Climate Change
GRI 418: Customer Privacy 2016 4.6 Biodiversity Conservation
customer privacy and losses of customer data Protection 4.1 Green Products
environmentally friendly technologies
Anti-Corruption Index
Principle 10: Businesses should work against corruption in all its
forms, including extortion and bribery
首页
微信公众号
证券之星APP
